Skip to main content
Clinical Microbiology Reviews logoLink to Clinical Microbiology Reviews
. 2024 Oct 10;37(4):e00186-23. doi: 10.1128/cmr.00186-23

How long do bacteria, fungi, protozoa, and viruses retain their replication capacity on inanimate surfaces? A systematic review examining environmental resilience versus healthcare-associated infection risk by “fomite-borne risk assessment”

Axel Kramer 1,✉,#, Franziska Lexow 2,#, Anna Bludau 3, Antonia Milena Köster 3, Martin Misailovski 3,4, Ulrike Seifert 5, Maren Eggers 6, William Rutala 7, Stephanie J Dancer 8,9,#, Simone Scheithauer 3,#
Editor: Graeme N Forrest10
Reviewed by: Pierre Parneix11, Silvio Brusaferro12
PMCID: PMC11640306  PMID: 39388143

SUMMARY

In healthcare settings, contaminated surfaces play an important role in the transmission of nosocomial pathogens potentially resulting in healthcare-associated infections (HAI). Pathogens can be transmitted directly from frequent hand-touch surfaces close to patients or indirectly by staff and visitors. HAI risk depends on exposure, extent of contamination, infectious dose (ID), virulence, hygiene practices, and patient vulnerability. This review attempts to close a gap in previous reviews on persistence/tenacity by only including articles (n = 171) providing quantitative data on re-cultivable pathogens from fomites for a better translation into clinical settings. We have therefore introduced the new term “replication capacity” (RC). The RC is affected by the degree of contamination, surface material, temperature, relative humidity, protein load, organic soil, UV-light (sunlight) exposure, and pH value. In general, investigations into surface RC are mainly performed in vitro using reference strains with high inocula. In vitro data from studies on 14 Gram-positive, 26 Gram-negative bacteria, 18 fungi, 4 protozoa, and 37 viruses. It should be regarded as a worst-case scenario indicating the upper bounds of risks when using such data for clinical decision-making. Information on RC after surface contamination could be seen as an opportunity to choose the most appropriate infection prevention and control (IPC) strategies. To help with decision-making, pathogens characterized by an increased nosocomial risk for transmission from inanimate surfaces (“fomite-borne”) are presented and discussed in this systematic review. Thus, the review offers a theoretical basis to support local risk assessments and IPC recommendations.

KEYWORDS: replication capacity, viability, inanimate surfaces, fomites, persistence, resilience, tenacity, bacteria, fungi, protozoa, viruses, transmission, HAI, fomite-borne risk pathogens

INTRODUCTION

Information about pathogen replication capacity (RC) after surface contamination is an important basis for infection prevention and control (IPC) including the risk assessment of healthcare-associated infections (HAI) and nosocomial outbreaks. In addition, this information is of high importance for outpatient settings and community outbreaks.

Pathogens can be spread from contaminated surfaces by direct patient contact, airborne dispersal (small and large aerosols), or indirectly via hand and medical devices after contamination from hand-touch surfaces (Fig. 1a). Exogenous transmission of HAIs in Europe corresponds to only about 5%–20% of the total number of HAI incidents (1), making the hand the main vector for pathogen transmission from contaminated inanimate surfaces (231). Consequently, international guidelines assign a key role in cleaning/disinfection of areas beside patients, especially surfaces receiving frequent hand/skin contact (3235). An additional benefit is the relatively low cost of interventions aiming at controlling this source as opposed to many others, for example, impregnated catheters (36). However, as recently witnessed during the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic, the role of decontamination of inanimate surfaces can also be overrated (37). Inappropriate use of disinfectants leads to costly interventions alongside risk of disinfectant tolerance and even antibiotic resistance, environmental pollution (3840), and adverse effects for humans (4144). Therefore, it would be useful to obtain greater insight into the RC of pathogens on inanimate surfaces to implement the most appropriate, risk-assessed decontamination procedures.

Fig 1.

Fig 1

(a) Transmission routes from contaminated inanimate surfaces and environmental influences. (b) Examples of the variety of different replication capacities depending on the pathogen and surface material.

Since hands are the main vehicle for potential nosocomial pathogens, hand hygiene and surface cleaning should complement each other to prevent HAI (45).

Defining terms of cultivable pathogens from inanimate surfaces

Resilience is the quality to withstand or recover quickly from environmental challenges and therefore being able to keep or come back to the standard or previous condition. Resilience is a positive characteristic from the perspective of the microbes, which in the medical context can have negative implications from the patients’ perspective. To determine the environmental resilience of pathogens, different methods of recovery are available to describe their burden on inanimate surfaces. For viruses, only indirect cultivation is possible because cells are needed for replication. Unfortunately, reverse transcriptase polymerase chain reaction (RT-PCR) does not allow a conclusion to be drawn about the remaining infectivity of viruses [e.g., plaque-forming units (PFU)]. Pathogen-dependent, different terms with different meanings are used for the ability of pathogens to be recovered from inanimate surfaces. To have the same understanding, some common terms will be preceded by a brief explanation. Von Sprockhoff (46) proposed “survivability” synonymously to “tenacity” as the robustness of microorganisms to defined exogenous factors. The term “tenacity” refers to the resistance of bacteria, fungi, protozoa, and viruses to environmental influences. In the Anglo-American language, the term “tenacity” is uncommon; instead, terms such as “resistance,” “sensitivity,” or “survival” are used more often (47). The Latin origin “tenacitas = to hold on” is not helpful for understanding what the term means. In the broader sense, tenacity means, “the determination to continue what you are doing” (48). Another comprehensive definition is “the quality or state of being tenacious” (49). Professionals in clinical disciplines are unaware of the term “tenacity” for microorganisms. Therefore, we need something that linguistically expresses the viability of bacteria, fungi, protozoa, and viruses when they contaminate surfaces, to be able to assess the risk of onward spread of nosocomial pathogens emanating from that surface.

Since bacteria, fungi, and protozoa function autonomously, the terms “persistence,” that is, “viability,” and “survival” are used synonymously. Survival can be understood as persisting viability under disadvantageous circumstances (50). Some microorganisms persist through an adaptive reaction to survive in the environment by reducing metabolism and by morphological, biochemical, and/or genetic adaptations, especially for bacteria in biofilms and/or as bacterial spores (5153). Another mode of adaptation is the transition to viable but non-cultivable (VBNC) cells, which can only be converted back to a replicative, virulent state through certain stimuli (54, 55). Protozoan cysts act as a survival niche and protective shelter (56). The criterion for determining the persistence of microorganisms is whether they can replicate after it has contaminated a surface.

Unlike bacteria, viruses need the synthetic apparatus of intact host cells for their replication. Viruses have neither their own metabolism and energy production nor the possibility of protein synthesis. Therefore, strictly speaking, they are not living beings. The criterion for viral infectivity is the ability to replicate in host cells so that quantification in vitro is possible by resuspension from the surface, transfer to the cell culture and counting dead cells, the so-called cytopathic effect (CPE). Not every virus is capable of inducing CPE while demonstrating other significant features. The viral ability to replicate is referred as “replication capacity” (57), which is used in different contexts, for example, for change under antiviral therapy (58). In parallel, the ability of vectors to transfer antibiotic resistance genes can also be termed “replication capacity” (59). Viral persistence, on the other hand, is understood as the genetic information of viruses presenting in cells of the host organism and the possibility of a virus reactivation under certain circumstances, for example, in the case of immunosuppression of the host (e.g., herpes viruses).

In summary, only RC reflects the viral load on a surface because viral RC correlates with viral infectivity (60). Given that for microorganisms and protozoa, as well as viruses, the criterion of replication determines infectivity and because the term “replication capacity” does not allow different interpretations, the term “replication capacity” (instead of tenacity, persistence, survival, or viability) is proposed to describe recovery from inanimate surfaces.

Risk assessment from inanimate surfaces as the origin of HAI

Information on RC of pathogens on inanimate surfaces could assist with the following aims:

  • To determine the most effective decontamination strategy, first, for known nosocomial pathogens, and second, in the event of the emergence of a new pathogen with initially unknown properties and potential for epi- or pandemic spread;

  • Generally, to provide a risk assessment for IPC measures after pathogen release from patients to interrupt further transmission;

  • To provide a risk assessment of the need for final disinfection measures required after hospital discharge of pathogen carriers, especially for isolated patients;

  • To inform control methods for nosocomial outbreaks;

  • To help determine standard operating procedures (SOP) for surface cleaning and/or disinfection, especially hand-touch sites without any knowledge about the presence of potential pathogens;

  • To help determine SOP for surface cleaning and/or disinfection, following incidents such as sewage or floodwater spillage, building works, etc.;

  • To assess the risk of the possibility of further spread of pathogens after hand contact with contaminated surfaces and medical devices especially for research purposes;

  • To assess the risk-benefit between disinfection efficacy, expense and environmental impact, and thus finally IPC; and

  • To analyze the RC under the influence of probiotic cleaning as a new option for IPC (61).

Walther and Ewald (62) distinguished a highly virulent long-lasting group containing variola (smallpox) virus, Mycobacterium tuberculosis, Corynebacterium diphtheriae, Bordetella (B.) pertussis, Streptococcus (Str.) pneumoniae, and (avian) Influenza A Virus (virulence determined from mortality rate or case mortality). These pathogens have a mean percent mortality of ≥0.01% and a mean survival time of >10 days (d). By contrast, a low-virulence and low-persistent group (mean percent mortality <0.01% and time of survival <5 d) includes viruses such as Rubeola, Mumps, Parainfluenza, Respiratory syncytial, Varicella-zoster, Rubella, and Rhinovirus, alongside the bacteria Mycoplasma pneumoniae and Haemophilus (H.) influenzae. This is even more interesting since these bacteria and viruses belong to totally different species, families, and genera, respectively. While our review focuses on transmission modes via inanimate surfaces [“fomite-borne”; e.g., from materials such as glass, stainless steel, textiles (Fig. 1b)], also other transmission modes (e.g., airborne, waterborne/foodborne) of pathogens are relevant for risk assessment. The longer a nosocomial pathogen persists on a surface, the longer the surface may be a source of transmission and endanger a susceptible patient or healthcare worker. Furthermore, a correlation between virulence and persistence is reported (63), the sit-and-wait hypothesis predicts that virulence should be positively correlated with persistence in the external environment because persistence reduces the dependence on host mobility for transfer to a patient. This has been confirmed for respiratory tract pathogens (63). The virulence of pathogens, including factors, such as infectious dose (ID), RC, and risk of transmission, determines the outbreak potential and should be considered as the basis for the IPC strategy. For surfaces as (temporary) origin of HAI, the RC of pathogens from fomites is essential. The main focus in this context was the transmission mode from inanimate surfaces. High virulent pathogens with outbreak potential due to low ID, long-lasting RC require additional to the non-targeted near-patient (high touch) surface disinfection, a targeted cleaning and disinfection as patient-remote (low touch) surface disinfection, and final surface disinfection. Such pathogens with increased “fomite-borne risk,” characterized by an increased nosocomial risk for transmission from inanimate surfaces, are marked in gray in Tables 3 to 7. Of course, disinfection measures are only one part of the IPC strategy combined with the other standard precautions such as hand hygiene and additional pathogen-related measures such as barrier nursing, isolation, antimicrobial chemotherapy, and antiseptic decolonization. With growing knowledge, the classification of “pathogens with nosocomial risk for spread from inanimate surfaces” can be further developed.

There is a practical way of looking at this. For example, admission to a room previously occupied by a patient infected and/or colonized with a pathogen is a known risk factor for the acquisition of that pathogen (64). This risk can be quantitated and it appears that the relative differences in acquisition risk between the pathogens mirror environmental longevities. As expected, organisms such as Acinetobacter baumannii complex and C. difficile present the highest risk for acquisition, and they also happen to be the most resilient in the healthcare environment (65). This begs the question even over the need for cleaning/disinfection priorities for a recently vacated room, depending on which pathogen infected the previous patient. So, in accordance with survival and replicative properties, decontamination strategies could range from a quick wipe over the hand-touch surfaces for methicillin-resistant Staphylococcus (S.) aureus (MRSA), disinfection of the sink/shower for ESBLs and comprehensive air and surface disinfection for C. difficile, etc. If pathogens are released from the respiratory tract, knowledge of the RC makes it possible to assess whether patient-remote surfaces should also be included in the final disinfection, for example, wall surfaces and slatted curtains. A focus on targeted cleaning and disinfection allows pathogen-related risk to dictate the most appropriate decontamination practice for all patient spaces (45). This risk assessment is the logical consequence of a basic risk without the knowledge of existing pathogens and enables a—in theory—most effective strategy.

To assess the timeline of RC for risk of further spread, it is necessary to consider RC in more detail. This includes baseline inoculum, the surface material, temperature, relative humidity (RH), protein load, organic soil, light exposure, and pH value. Thus, it is not just the type of pathogen or evidence for them (e.g., DNA, RNA), but whether they are capable of being transmitted to, and replicating in, the host (Fig. 1a and b). Transmission potential of pathogens on surfaces is not restricted to the direct and indirect contact transmission route. Some, but not all potential pathogens on inanimate surfaces can be aerosolized and transmitted contact-free. This potential additional risk is not within the scope of this review. But if the RC is known, the infection risk can be estimated for respiratory released and airborne transmissible pathogens.

This review aimed to collect and assess published data related to RC of all types of nosocomial pathogens contaminating inanimate healthcare surfaces as the basis for evaluating healthcare-associated infection risk by fomite-borne risk assessment. For the determination of IPC strategies, both RC and ID should be considered. These data might assist in evaluating the transmission and infection risk and therefore guide the most appropriate IPC measures.

MET‍HOD

Literature from three reviews (6668), with at least partly similar aims, was screened and examined as a basis for the current review. Then a systematic literature search was conducted in accordance with the PRISMA guideline and the German Manual for Literature Research in Databases (69).

Based on the modified PICO scheme (Table 1), the search terms were compiled. The search was restricted to publications from 2020 onwards to obtain hits that were not already included in the latest review (68). The language was limited to German and English. PubMed and Web of Science were both used for the search, which was conducted on 26th January 2023.

TABLE 1.

Search strategy: segments and search terms

Segment Search terms
Pathogens Bacteria, viruses, fungi, protozoa
Conditions Surface, fomite, inanimate, temperature, humidity, light
Setting Nosocomial, hospital acquired
Outcome Persistence, survival, transmission, tenacity

Duplicates were removed using Citavi 6 (Swiss Academic Software GmbH). Four reviewers carried out the screenings blinded (two reviewers per article) using an online document to record the decisions. The articles were compared against predetermined inclusion and exclusion criteria (Table 2).

TABLE 2.

Inclusion and exclusion criteria

Inclusion Exclusion
Narrative review, rapid review, scoping review, systematic review, randomized controlled trial, quasi-randomized controlled intervention study, not randomized controlled studies, pro- and retrospective cohort studies, case-control studies, historically controlled studies, cross-sectional studies Single-arm follow-up studies (case reports, case studies, etc.), commentaries, study protocols, conference abstracts, books, editorials, model studies
Human pathogenic species within the following groups: viruses, bacteria, protozoa, and fungi that are relevant for hospital-acquired infections from surfacesa Other pathogens
Inanimate surfaces—specifically surfaces relevant in hospital settings (e.g., materials such as glass, stainless steel, polymers, textiles). Cave: if the only information found was not on hospital-relevant surfaces, the information is reported to give insight into the possible tenacity of the pathogen. Animate surfaces (e.g., hands, hair, wounds)
Persistence, tenacity, survival, temerity, recultivable, and replicable; a resuspension has to be made from the test surface and then transferred to the cell culture or nutrient medium Anything concerning the treatment, symptoms, or genetic surveillance; studies on the effect of disinfectants; studies on the effect of antibacterial/antiviral surfaces
Since 2020 Before 2020
English, German Other languages
Relevant data/methodology (e.g., inoculum concentration) are given Relevant data/methodology (e.g., inoculum concentration) not given
a

Although ectoparasites can also be transmitted nosocomially (70), they were excluded because they are multicellular arthropods reproducing outside humans.

In the case of different assessments, a third reviewer joined the discussion, and a consensus was reached. First, the titles and abstracts were screened and then the full texts of the included records. Eligible reviews were not included but searched for primary studies, which were then also screened as above.

The data were extracted into an online table by the reviewers. A cross-check was conducted afterwards.

Tables 3 to 7 were modified from the informative appendix (only in German) (71) of the recommendation of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) on Hygiene requirements for cleaning and disinfection of surfaces (72). Table 8 was modified from Jawad et al. (73).

TABLE 3.

Replication capacity of Gram-positive bacteria from inanimate surfacesa

Pathogen Initial inoculum Replication capacity Surface Ref.
Bacillus subtilis spores ~8 lg CFU After 15 d: reduction by 0.3 lg, after
56 d: reduction by ~0.7 lg
Glass (74)
7.1–9.5 lg CFU >200 d: reduction by ~2 lg Polycarbonate (75)
6 lg CFU ≥1 d: 5 lg Stainless steel (76)
Clostridioides (C.) difficile spores 6 lg CFU After 2 d: reduction by ~2 lg, after 4 wk: 8 CFU, after 5 mon 1 CFU Floor (77)
6–7 lg CFU After 6 wk: reduction by ~0.5–0.8 lg; after 12 wk: reduction by <3 lg Steel (78)
C. difficile veg. ~6 lg CFU 15 min: reduction by ~4 lg Glass (79)
Corynebacteria generic 2.7–3.8 lg CFU ≥ 48 h: mean recovery 3.6% Cotton (80)
Corynebacterium diphtheriae Up to 155 CFU 7–90 d (strain-dependent) Dust (81)
Corynebacterium pseudotuberculosis ~6 lg CFU 3 d Plastic (82)
Corynebacterium striatum 6 lg CFU After 48 h: 7.7 lg/6.8 lg/2.6 lg Polyvinyl chloride (PVC)/silicone/stainless steel (83)
Enterococcus faecium 6–7 lg CFU After 12 wk: reduction by <3 lg Steel (78)
~6.5 lg CFU 49 d/51 d/49 d Cotton/wool/silk (84)
250 CFU 7 d up to 28 d: 250–70 CFU/250 to ~32 CFU/250–160 CFU/250 to ~50 CFU Glass/PVC/stainless steel/aluminum (85)
8 lg CFU 1 to 16 wk PVC (86)
8 lg CFU <4 mon: ~2 lg recultivable Ceramic/PVC/rubber/steel (87)
~5 lg CFU 33/>90/>90 d Cotton/polyester/polypropylene (88)
5–6 lg CFU ≥7 d (3 lg/3 lg) Polyester/Terrycloth (89)
10 lg CFU ≥21 d (4–5 lg) Cotton (90)
Enterococcus faecalis 6–7 lg CFU After 6 wk: reduction by <1.8 lg Steel (78)
7.5 lg CFU After 8 wk: 6.5 lg Ceramic/cotton/synthetic fibers (91)
5.2 lg CFU After 1 d: survival of 3% Cotton (92)
~5 lg CFU >90/>90/>90 d Cotton/polyester/polypropylene (88)
6 lg CFU ≥1 d: 5 lg Stainless steel (76)
Enterococcus spp. 7.2 lg CFU Mean survival rate 3 d
(dried in water), 43 d
(dried in egg white)
Glass (73)
Vancomycin-resistant Enterococcus
(VRE)
~6 lg CFU After 6 wk: reduction by ~3 lg Steel (78)
5 lg CFU ≥7 d Furnishings (93)
E. faecalis 4.5 lg Dried 60 min: 3 lg CFU; dried 90 min: 3.6 lg CFU Stainless steel (94)
8 lg CFU 1 to 16 wk PVC (95)
E. faecalis: ~5 lg CFU 22/>80/>80 d Cotton/polyester/polypropylene (88)
E. faecium: ~5 lg CFU >90/>90/>90 d
Micrococcus luteus 7.1–9.5 lg CFU After 120 d: reduction by ~6 lg Polycarbonate (75)
5.2 lg CFU After 2 d: survival of 20% Cotton (92)
Mycobacterium tuberculosis 0.1 mg/mL Recultivable in daylight after 1 d, recultivable in
darkness for 9 d, not recultivable after 40 d
Coverslip (96)
Staphylococcus aureus, methicillin-
susceptible (MSSA)
7.3 lg CFU ≥11 d Glass (73)
5.2 lg CFU After 25 d: survival of 0.8% Cotton (92)
7.5 lg CFU After 8 wk: ~6.5 lg CFU/mL Ceramic/cotton/synthetic fibers (91)
8 lg CFU 2 d/18 d/>45 d/43 d Latex/cotton/vinyl flooring/
granite
(97)
~6.5 lg CFU 37 d/37 d/41 d/37 d Cotton/cotton polyester/wool/
silk
(84)
6 lg CFU 9 d/10 d/3 d Formica/stainless steel/enamel (98)
250 CFU After 21 d: 5 CFU/after 7 d: ~5 CFU/after 21 d: 0 CFU
/after 7 d: ~10 CFU
Glass/PVC/stainless steel/aluminum (85)
7.2 lg CFU Mean survival 26 d (dried in water), 35 d (dried in egg white), after 12 d: ~3 lg CFU loss (water); after 18 d: ~5.7 lg loss (egg white) Glass (73)
Desiccation:
7.3 lg CFU
Wet: 3–4 lg CFU
After 25 d desiccation: 4.4 lg; wet: after 7 d not recultivable Aluminum (99)
6–7 lg CFU Dry < 7 mon, at 32% RH >5 mon Dust (100)
  • a. Dry inoculum: 5–6 lg CFU

  • b. Liquid inoculum: ~6 lg CFU

  • a. After 24 h: 6.7 lg CFU, after 7 d: 22 CFU /after 24 h: 6.3 lgCFU, after 7 d: 1 CFU

  • b. After 7 d: 16.2 lg/6.1 lg

Polymer without silver/with silver (36)
8 lg CFU With dust: <28 d, without dust: <35 d Bottles with and without dust (101)
7 lg CFU ≥ 12 d/12 d/≥14 d Plastic/laminated plastic/polyester (102)
5–6 CFU (mattress cover)
14–34 CFU (drapes)
5–6 CFU (bed sheets)
Recovery after 72 h at 22°C: 98 CFU/1 CFU/17 CFU/3 lg/1 CFU/1 CFU Dry mattress cover/wet mattress cover/dry drapes/wet drapes/dry bed sheets/wet bed sheets (103)
8 lg CFU <21 d/≥21 d (6 lg) Polyester/cotton (104)
5–6 lg CFU ≥206 d/25 d/11 d/≥206 d Mattress inner foam/PVC/cotton/polyester (105)
9 lg CFU ≥21 d : 4–5 lg CFU Cotton (90)
5.7 lg CFU ≥11 d: 4 lg CFU PVC (76)
5.7 lg CFU ≥11 d: 3 lg CFU/≥11 d: 3 lg CFU/≥
11 d: 3 lg CFU
Aluminum/plastic/stainless steel
6 lg CFU ≥1 d: 6 lg CFU Stainless steel
0.05 OD600 ≥7 d: survival rate: 4% Polypropylene (106)
Staphylococcus aureus, methicillin-
resistant, epidemic (EMRSA)
8.7 lg CFU ≤ 60 min/270 min/≥360 min Copper/brass (80% Cu, 20% Zn)/stainless steel (107)
Staphylococcus aureus, methicillin-
resistant (MRSA)
6–7 lg CFU After 6 wk: reduction by 5–6 lg CFU Steel (78)
8 lg CFU 1 d/18 d/41 d/40 d Latex/cotton/vinyl flooring/tile (97)
3.2–4.9 lg CFU After 7 d: recovery 59%–125%; after 14 d: 26%–42%; after 28 d: 0.2%–16%; after 56 d: 0%–1% Dry mop (108)
9 lg CFU <318 d Plastic (109)
8 lg CFU With dust: <126 d; without dust:
<175 d
Bottles with and without dust (101)
5.6 lg CFU) <21/14/3/40/>51 d Cotton/cotton terry/cotton and polyester/polyester/polypropylene (88)
~7.3 lg CFU <96 d Glass (110)
6 lg CFU ≤63 d/≤56 d/≤21 d/≤14 d/≤14 d/
≤3 d/≤5 min
Vinyl/plastic/ceramic/bed sheets/towels/wood/razors (111)
7 lg CFU ≥12 d/11 d/9 d Plastic/laminated plastic/
polyester
(102)
6.3–6.7 lg CFU or 4.3–4.7 lg CFU ≤8 d or <2 d Polypropylene (112)
5–6 lg CFU ≥7 d: <1 lg/1 lg Polyester/terrycloth (towel) (89)
Staphylococcus aureus, vancomycin intermediate (VISA) 8 lg CFU 1 d/3 d/>45 d/>45 d Latex/cotton/vinyl flooring/
granite
(97)
Streptococcus faecalis Desiccation: 6.9 lg CFU
Wet: 3–4 lg CFU
After 25 d desiccation: 4.6 lg; wet: after 10 d not recultivable Aluminum (99)
Streptococcus pyogenes ~7.7 lg CFU <2 h Plastic and ceramic/plastic/
stainless steel
(113)
8 lg CFU Planktonic: 3 d; as biofilm: >120 d Plastic/textiles (114)
5–6 lg CFU ≥206 d/25 d/11 d/≥206 d Mattress inner foam/PVC/cotton/polyester (105)
Streptococcus pneumoniae 2.8–3.6 lg CFU ≥48 h: mean recovery 0.2% Cotton (80)
Streptococci, staphylococci from saliva; combined analysis 5.3 lg CFU for Staphylococcus aureus; 5.9 lg CFU for Streptococcus pyogenes; 5.8 lg CFU for Streptococcus salivarius > 88 h Glass/latex/wood (115)
a

Table modified from reference 71. Pathogens with fomite-borne transmission potential, characterized by an increased nosocomial risk for transmission from inanimate surfaces, are marked in gray; for additional data and details of recultivation and environmental conditions, see the supplemental material (Table A). Legend: CFU = colony forming units, lg = decadic logarithm, min = minute, h = hour, d = day, wk = week, mon = month, PVC = polyvinyl chloride.

TABLE 4.

Replication capacity of Gram-negative bacteria from inanimate surfacesa

Pathogen Initial inoculum Replication capacity Surface Ref.
Acinetobacter baumannii
(complex)
~6.5 lg CFU 19 d/19 d/7 d/19 d Cotton/cotton polyester/wool/silk (84)
6–7 lg CFU After 6 wk: reduction by 4–5 lg Steel (78)
6 lg CFU 11 d/12 d/6 d Formica/stainless steel/enamel (98)
250 CFU After 28 d: ~112 CFU/~112 CFU/~18 CFU/
~20 CFU
Glass/PVC/stainless steel/aluminum (85)
7.1–9.5 lg CFU After 20 d: reduction by about 5.5 lg Polycarbonate (75)
1,200 resp. 1,100 CFU Biofilm-forming <36 d/non-biofilm-forming <15 d Glass (116)
7.3 lg CFU 3 d Glass (117)
7.3 lg CFU Up to 33 d Glass (118)
7.3 lg CFU 7–70 d (strain-dependent) Glass (119)
~8 lg CFU) 3–90 d (strain-dependent) Polystyrene (120)
~7.3 lg CFU <96 d Glass (110)
8 lg CFU 50% of strains mean survival of at least 2 wks (<2 lg recultivable), strain-dependent <4 mon (7 lg recultivable) Ceramic/PVC/rubber/steel (87)
4.1 lg CFU Dried 60 min: 4 lg; dried 90 min: 3.9 lg Stainless steel (94)
6 lg CFU ≥1 d: 4 lg Stainless steel (76)
7 lg CFU ≥60 d: survival rate: 10%, 40%, 40% Cotton/plastic/glass (121)
5–6 lg CFU ≥7 d: 2 lg/3 lg Polyester/Terrycloth (89)
7.2 lg CFU Mean survival rate strain-dependent 2–29 d (dried in water); <59 d (dried in egg white); after 18 d ~ 5.5 lg loss Glass (73)
Acinetobacter johnsonii Mean survival rate 3 d (dried in water); 12 d (when dried in egg white)
Acinetobacter junii Mean survival rate 2 d (dried in water); 13 d (dried in egg white)
Acinetobacter lwolffi Mean survival rate 6 d (dried in water); 8 d (dried in egg white)
7.3 lg CFU 3 d Glass (117)
Acinobacter calcoaceticus anitratus 4 lg CFU After 1 h: 3 lg Hardboard (122)
5.2 lg CFU After 25 d survival of 0.6% of the CFU/after 7 h survival of 40% of the CFU Cotton/glass (92)
Acinetobacter calcoaceticus lwoffii 4 lg CFU/sample After 1 h: 3 lg CFU Hardboard (122)
5.2 lg CFU After 7 d not recultivable Cotton (92)
Acinetobacter radioresistens 7.3 lg CFU 157 d Glass (117)
Bordetella pertussis 8 lg CFU (0.01 mL) <0.04 h–5 d/3–5 d/<0.04 h–5 d/<0.04–4 d/0.2–1 d Glass/plastic/rubber/fabric/paper (123)
Campylobacter jejuni 0.1 mL contaminated
water from screw coolers
 4 h/4 h/7 h/7 h Aluminum/stainless steel/formica/ceramic (124)
8–9 lg CFU After 28 d: ~5 lg (without wood 0 lg after 2 d)/polyurethane and glass: ~survival for 2 d (pore-size-dependent) Wood/polyurethane/glass (125)
7 lg CFU ≤250 min (4 lg)/≥250 min (3 lg)/<250 min (1 lg)/<180 min Stainless steel/formica/ceramic/cotton (126)
Enterobacter cloacae 250 lg CFU After 3 d: ~14 CFU/after 2 d: ~12 CFU/after 3 d: ~13 CFU/after 2 d: ~5 CFU Glass/PVC/stainless steel/aluminum (85)
Escherichia coli 6 lg CFU After 48 h: ~1.5 lg/after 24 h: ~1.5 lg Plastic/carton (127)
9 lg CFU After 100 d: 1 lg Plastic (128)
7.3 lg CFU After 7 d (dry): not recultivable; after >28 d humidity Wood/steel (129)
7–8 lg CFU <120 min Plastic/wood (130)
5.2 lg CFU After 7 h: not recultivable/after 7 h: survival
of 0.8% of CFU
Cotton/glass (92)
7.5 lg CFU After 8 wk: ~6.5 lg CFU/mL Ceramic/cotton/synthetic fibers (91)
7–9 lg CFU After 2 h: reduction by: 1.7 lg/
0.37 lg/1.09 lg/0.44 lg/after 24 h:
0.06 lg
New dry wood/new wet wood/
used dry wood/used wet wood/plastic
(131)
8 lg CFU <4 mon (~ 2 lg recultivable) Ceramic/PVC/rubber/steel (87)
~6.5 lg CFU 45 d/37 d/45 d/45 d Cotton/cotton-polyester/wool/silk (84)
250 CFU After 1 d: ~5 CFU/after 1 d: 2 CFU/after 2 day: 1 CFU/after 2 d: 1 CFU Glass/PVC/steel/aluminum (85)
7.1–9.5 lg CFU After 6 h: reduction by about 6.5 lg Polycarbonate (75)
7.2 lg CFU Mean survival rate 1 d (dried in water), 3 d (dried in egg white) Glass (73)
6–7 lg CFU At 58% RH >8 mon Dust (100)
Desiccation:
6.9 lg CFU
Wet: 3–4 lg CFU
After 25 d desiccation: 0.7 lg CFU/cm2; wet: >12 d Aluminum (99)
5–6 lg CFU After 24 h: 0.2 CFU, after 7 d: not recultivable/after 7 d: 8 CFU Polymer without silver/with silver (36)
1–2 CFU (mattress cover)
2 CFU (drapes)
1–2 CFU (bed sheets)
Recovery after 72 h at 22°C: 4 lg/4 lg/3.7 lg/5.7 lg/3.2 lg/4.2 lg Dry mattress cover/wet mattress cover/dry drapes/wet drapes/dry bed sheets/wet bed sheets (103)
8 lg CFU <10 d/≥21 d (6 lg) Polyester/cotton (104)
5–6 lg CFU ≥206 d/11 d/7 d/≥206 d Mattress inner foam/PVC/cotton/polyester (105)
2.7–3.2 lg CFU ≥48 h (mean recovery too
numerous to count)
Cotton (80)
5.7 lg CFU ≥1 d: 2 lg Vinyl chloride (76)
5.7 lg CFU ≥4 d: 1 lg/≥7 d: 1 lg/≥4 d: 1 lg Aluminum/plastic/stainless steel
6 lg CFU ≥1 d: 3 lg Stainless steel
5.7 lg CFU ≥7 d: 3 lg Plastic
Haemophilus influenzae 6 lg CFU After 1 h: 99.99% reduction Aerosol (132)
2.8–3.5 lg CFU ≥48 h: mean recovery 1.8% Cotton (80)
Helicobacter (H.) pylori 9 lg CFU After 30 min: 7.8 lg, after 60 min: ~1.1 lg/
after 30 min: 8 lg, after 60 min: ~1.3 lg
Plastic/ceramic (133)
Klebsiella pneumoniae 5.2 lg CFU After 1 h not recultivable Cotton (92)
7.5 lg CFU After 8 wk: ~6.5 lg CFU/mL Ceramic/cotton/synthetic fibers (91)
~6 lg CFU After 6 wk: ~1 lg Steel (78)
250 lg CFU After 3 d: ~25 CFU/after 3 d:
17 CFU/after 2 d: 21 CFU/after 2d: 13 CFU
Glass/PVC/stainless steel/aluminum (85)
7 lg CFU After 25 d desiccation: 1.8 lg Aluminum (99)
6–7 lg CFU At 58% RH >15 mon Dust (100)
3.9 lg CFU Dried 60 min: 3.4 lg; dried
90 min:
1.8 lg
Stainless steel/plastic (94)
5–6 lg CFU <3 d/<7 d Polyester/terrycloth (89)
Listeria monocytogenes 6 lg CFU After 48 h: ~3.4 lg/~1.2 lg Plastic/carton (127)
7–8 lg CFU After 180 min: 4 lg Wood/plastics (130)
6 lg CFU After 10 d: 5 lg/after 5 d: 1.5 lg Stainless steel/acrylonitrile butadiene
rubber (ABK)
(134)
9 lg CFU After 50 d: ~7.5 lg CFU; after 50 d (biofilm): ~7.3 lg CFU Stainless steel (135)
8 lg CFU After 20 d: 2 lg Stainless steel (136)
7.3 lg CFU (biofilm) After 21 d: 5.3 lg Stainless steel (137)
Neisseria gonorrhoeae 2 x ~ 20 µL Patient exudate
(with proven infection)
At least until 24 h recultivable Plastic/cotton-polyester (138)
One drop of positive urethral secretion Until 17 h: recultivable; after 24 h:
not recultivable/until 24 h: recultivable; after 48 h: not recultivable
Glass/textile (139)
Pseudomonas aeruginosa
  • a. Dry inoculum: 5–6 lg CFU

  • b. Liquid inoculum: ~6 lg CFU

  • a. After 7 d: 6.2 lg/6.2 lg

  • b. After 7 d: 7.8 lg/7.8 lg

Polymer without silver/with silver (36)
8 lg CFU After 48 h: average <2 lg Door handles/chairs/spirometer tubing (140)
7.5 lg CFU After 8 wk: 6.5 lg Ceramic/cotton/synthetic fibers (91)
5.2 lg CFU After 2 h: not recultivable Cotton (92)
~6.5 lg CFU 13 d/23 d/33 d Cotton/cotton polyester/wool/silk (84)
250 CFU After 2 d on all surfaces < 2 lg Glass/PVC/stainless steel/aluminum (85)
6 lg CFU 4 d/5 d/1 d Formica/stainless steel/enamel (98)
Desiccation:
6.4 lg CFU
Wet: 3–4 lg CFU
After 2 d desiccation: not recultivable; wet: >12 d Aluminum (99)
6–7 lg CFU At 58% RH >8 mon Dust (100)
1–4 CFU (mattress cover)
2 CFU (drapes)
1 CFU (bed sheets)
Recovery after 72 h at 22°C: 3.9 lg/4 lg/3.5 lg/5.5 lg/4 lg/4.1 lg Dry mattress cover/wet mattress cover/dry drapes/wet drapes/dry bed sheets/wet bed sheets (103)
8.7 lg CFU 20 d, 5 d, 4 d Cotton (90)
6 lg CFU ≥ 1 d: 4 lg Stainless steel (76)
5 lg CFU ≥7 d/24 h/24 h/24 h/24 h/≥7 d/24 h/24 h/24 h/≥7 d/≥7 d/5 min/24 h/≥7 d Paper-backed wallcovering/vinyl composition tile/micro vented perforated vinyl wallcovering/latex paint/vinyl wallcovering, nonwoven backing/linoleum/vinyl sheet goods flooring/rubber tile flooring/synthetic-backed carpet/vinyl-backed carpet/fabric upholstery/polyester and acrylic blend upholstery/vinyl upholstery/100% polyester upholstery (93)
Salmonella enteritidis (S. enterica) ~5 lg CFU After 8 h: 2 lg/not recultivable Plastic/carton (127)
7 lg CFU <1,680 min/≥1,920 min: 1 lg/<480 min/<240 min Stainless steel/formica/ceramic/cotton (126)
9 lg CFU Salmonella chester after 100 d: 3 lg; Salmonella oranienburg >200 d Plastic (128)
∼9.3 lg CFU >48 h Petri dish (141)
Salmonella typhimurium 5.2 lg CFU After 7 h: not recultivable Cotton cloth/glass (92)
3.6 lg CFU <6 wk Stainless steel (142)
1 µL of overnight cultures inoculated on agar and incubated at 25°C ST19: after 1 mon 59.7 ± 12.3 % recultivable;
ST313: after 1 mon 13.1 ± 9.6 % recultivable
Plastic (143)
Two drops of bacterial suspension Up to 50 mon Dust (144)
5.2 lg CFU After 1 d: not recultivable Cotton (92)
6 lg CFU After 3 d: 2 lg/after 1 d: 1.75 lg Stainless steel/acrylonitrile
butadiene rubber
(134)
6–7 lg CFU >30 d: reduction between 3 and 6 lg Stainless steel (145)
7–8 lg CFU ≥28 d: 2–3 lg/≥24 h: 3 lg/≥24 h: 4.5 lg Tile/wood/carpet (146)
Serratia liquefaciens 7.2 lg CFU Mean survival rate 3 d (dried in water), 43 d (dried in egg white) Glass (73)
Serratia marcescens 250 lg CFU After 3 d: ~40 CFU/after 3 d: ~15 CFU/after 2 d: ~1 CFU/after 3 d: ~2 CFU Glass/PVC/stainless steel/
aluminum
(85)
7.2 lg CFU Mean survival 12 d (dried in water), 9 d
(dried in egg white)
Glass (73)
Desiccation:
7.3 lg CFU
Wet : 3–4 lg
After 25 d desiccation: 2.6 lg; wet: >12 d Aluminum (99)
5.2 lg CFU After 1 h: not recultivable Cotton cloth/glass (92)
6 lg CFU ≥1 d: 4 lg Stainless steel (76)
Shigella dysenteriae ~5 lg CFU After 4 h: not recultivable Plastic/glass/aluminum/wood/textile (147)
Shigella sonnei 9 lg CFU ≤10 d/≤27 d/≤23 d/≤9 d/≤28 d Glass/cotton/wood/metal/paper (148)
~5.7 lg CFU Survival after 24 h: 100%/100%/100%; after 48 h: 75%/63%/50%; after 72 h: 13%/0%/0% PVC/polystyrene/Sprelacart (synthetic resin) (149)
Shigella flexneri Survival after 24 h: 100%/100%/83%; after 48 h: 67%/58%/33%; after 72 h: 0%
Stenotrophomonas maltophilia ~6.5 lg CFU 7 d/7 d/7 d Cotton/cotton-polyester/wool/silk (84)
Vibrio cholerae 8.2 lg CFU Normal cultivable status 1 h/1 h/1.5 h/1.5 h/3.5 h/4 h/4 h; VBNC status <7 d Aluminum/glass/plastic/steel/iron/paper/textile/wool (150)
8.2 lg CFU 4 h: 2 lg/4 h: 2 lg/3.5 h: 3.5 lg/1 h:3 lg/1.5 h:
2.5 lg/1.5 h: 0.5 lg/1.5 h: 3 lg/1 h: 3 lg
Cotton/wood/paper/glass/plastic/stainless steel/iron/aluminum (151)
a

Table modified from reference 71. Pathogens with fomite-borne transmission potential, characterized by an increased nosocomial risk for transmission from inanimate surfaces, are marked in gray; for additional data and details of recultivation and environmental conditions, see the supplemental material (Table B). Legend: CFU = colony forming units, lg = decadic logarithm, min = minute, h = hour, d = day, wk = week, mon = month, PVC = polyvinyl chloride, VBNC = viable but non-culturable.

TABLE 5.

Replication capacity of molds and yeasts from inanimate surfacesa

Pathogen Initial inoculum Replication capacity Surface Ref.
A. brasiliensis 4 CFU Recovery after 72 h at 22°C: 0 CFU/0 CFU/0 CFU/3 CFU/0 CFU/2 CFU Dry mattress cover/wet mattress cover/dry drapes/wet drapes/dry bed sheets/wet bed sheets (103)
A. flavus 4–5 lg CFU 2 to >30 d/2–20 d/>30 d/8 to >30 d Cotton/polyester/polyethylene/polyurethane (152)
~5.5 lg
CFU
After 24 h: ~5.4 lg, after 48 h: ~5.2 lg, after 5 d: ~5.6 lg/after 24 h: ~5.3 lg, after 48: h ~3.8 lg, after 5 d: 0 lg Aluminum/copper (153)
A. fumigatus 4–5 lg CFU 1 to >30 d/5 to >30 d/>30 d/5 to >30 d Cotton/polyester/polyethylene/polyurethane (152)
~6.8 lg CFU After 24 h: ~6.3 lg, after 5 d: ~6.4 lg/after 48 h: ~6 lg, after 5 d: ~1.7 lg Aluminum/copper (153)
~6.5 lg CFU >30 d/>30 d/>30 d/27 d Cotton/polyester/wool/silk (84)
A. niger 4–5 lg CFU 3 to >30 d/>30 d/>30 d/2 to >30 d Cotton/polyester/polyethylene/polyurethane (152)
~5.3 lg CFU After 4 d: ~5.2 lg, after 24 d: ~5.5 lg/after 4 d: ~5 lg; after 5 d: ~5.1 lg, after 24 d: ~5.4 lg Aluminum/copper (153)
A. terreus 4–5 lg CFU 2 to >30 d/2 to >30 d/>30 d/12 to >30 d Cotton/polyester/polyethylene/polyurethane (152)
C. albicans 4–5 lg CFU 1–3 d/1 d/5–6 d/4–5 d Cotton/polyester/polyethylene/polyurethane (152)
6 lg CFU <7 d Stainless steel (dry)/moist agar without nutrients (154)
6 lg CFU Survival after 2 d: ~1%, after 3 d: ~0.2%/0.3%, after 7 d: 0% Stainless steel/glass (155)
~7.5 lg CFU After 5 d: ~6.5 lg/after 6 h: 5 lg, after 24 h: 0 lg Aluminum/copper (153)
6.5 lg CFU 6 d/6d/12 d/12 d Cotton/polyester/wool/silk (84)
~6.1 lg CFU 6 d Glass (156)
~4.8 lg CFU 48 d Textile
5–6 lg CFU After 7 d: 6.3 lg/after 7 d: 5.1 lg Polymer without silver/with silver (36)
C. auris 6 lg CFU Survival after 7 d: ~38%/~93% Stainless steel (dry)/moist agar without nutrients (154)
~4.8 lg CFU After 4 d: ~3.5 lg, after 14 d: ~0.4 lg Plastic (157)
8 lg CFU After 14 d: ~4.3 lg (biofilm formation) Plastic (158)
C. candidum ~6.5 lg CFU 21 d/6 d/12 d/6 d Cotton/polyester/wool/silk (84)
C. glabrata (Nakaseomyces glabratus) 6 lg CFU Survival after 7 d: ~60%/~90% Stainless steel (dry)/moist agar without nutrients (154)
~4.8 lg CFU 12 d/97 d Glass/textile (156)
~6.5 lg CFU >30 d Cotton/polyester/wool/silk (84)
C. krusei (Pichia kudriavzevii) 4–5 lg CFU 1 d/8 d/3–7 d/4 d Cotton/polyester/polyethylene/polyurethane (152)
~6.5 lg CFU 3 d/6 d/>30 d/21 d Cotton/polyester/wool/silk (84)
C. parapsilosis 4–5 lg CFU 9–27 d/27 to >30 d/>30 d/>30 d Cotton/polyester/polyethylene/polyurethane (152)
6 lg CFU Survival after 14 d: ~1.3%/~4.1% Stainless steel/glass (155)
6 lg CFU Survival after 7 d: 60%/100% Stainless steel (dry)/moist agar without nutrients (154)
~4.7 lg CFU After 21 d: ~2.5 lg, after 28 d: 0.4 lg Plastic (157)
~6.5 lg CFU >30 d Cotton/polyester/wool/silk (84)
~6.1 lg CFU 55 d Glass (156)
C. tropicalis 4–5 lg CFU 1–2 d/1–8 d/7–18 d/6–12 d Cotton/polyester/polyethylene/polyurethane (152)
~6.6 lg CFU 3 d/9 d/>30 d/21 d Cotton/polyester/wool/silk (84)
~6.1 lg 8 d Glass (156)
Cryptococcus neoformans ~6.5 lg CFU >30 d Cotton/polyester/wool/silk (84)
~6.1 lg CFU 27 d Glass (156)
Fusarium solani ~5.8 lg CFU After 5 d: ~4.4 lg/after 6 h: ~3.6 lg, after 24 h: 0 lg Aluminum/copper (153)
Mucor spp. 4–5 lg CFU 20–24 d Cotton/polyester/polyethylene/polyurethane (152)
Paecilomyces spp. 4–5 lg CFU <1 d/5 d/4 d/11 d Cotton/polyester/polyethylene/polyurethane (152)
Rhodotorula rubra ~6.1 lg CFU 40 d Glass (156)
~4.8 lg CFU 205 d Textile
Saccharomyces cerevisiae 6 lg CFU After 48 h: 3.9 lg/1.5 lg Plastic/carton (127)
1 CFU Recovery after 72 h at 22°C: 5 CFU/2.1 lg/3.3 lg/4 lg
/5 CFU 2.9 lg
Dry mattress cover/wet mattress cover/dry trilaminate drapes/wet trilaminate drapes/dry bed sheets/wet bed sheets (103)
a

Table modified from reference 71. Pathogens with fomite-borne transmission potential, characterized by an increased nosocomial risk for transmission from inanimate surfaces, are marked in gray; for additional data and details of recultivation and environmental conditions, see the supplemental material (Table C). Legend: CFU = colony forming units, lg = decadic logarithm, min = minute, h = hour, d = day, wk = week, mon = month.

TABLE 6.

Replication capacity of protozoa from inanimate surfacesa

Pathogen Initial inoculum Replication capacity Surface Reference
Acanthamoeba trophozoites morphological group II Large numbers of trophozoites 2–21 years After amoebae differentiated into cysts, agar plates were tightly wrapped with parafilm (159)
Cryptosporidium parvum oocysts (Oo)cysts Survival at 25°C: >60 d/>60 d/>60 d Stainless steel/formica/fabric (160)
Oocysts Recovery at 21°C up to 75 d Water (161)
6 lg/mL oocysts Recultivation rate after 0 h: 76.3%; after 2 h: 3%; after 4 h: 0% Glass slide (162)
7 lg oocysts After 30 min: 4.1 lg; after 60 min: 3.2 lg; after 90 min: <3 lg Stainless steel (163)
≥100 oocysts After 24-h desiccation: no infectivity after 1–4 d Cryptosporidia-laden calf feces (164)
Giardia muris cysts (Oo)cysts Recovery at 25°C: 45 d/21 d/21 d Stainless steel/formica/fabric (160)
Trichomonas vaginalis trophozoites 2–3 lg for human samples; 3–4 lg from culture Recultivation rates after 120 min: 5.1%/30.5%; survival 24 h Textile/plastic (165)
Trophozoites Recultivation rates after 15 min at 26°C: <10% Water (166)
a

Pathogens with fomite-borne transmission potential, characterized by an increased nosocomial risk for transmission from inanimate surfaces, are marked in gray; for additional data and details of recultivation and environmental conditions, see the supplemental material (Table D). Legend: lg = decadic logarithm, min = minute, h = hour, d = day.

TABLE 7.

Replication capacity of viruses after isolation from inanimate surfacesa,b

Pathogen Initial inoculum Replication capacity/residual virus titer Surface Ref.
Predominant contact transmission
 Adenovirus ~7 lg CCID50 >12 wk; after 8 wk: 3.4–5.7 lg Glass/plastic/porcelain/stainless steel (167)
2,000 PFU <49 d; after 14 d: ~8%/~3% Plastic/aluminum foil (168)
~6 lg PFU 15 d/15 d/30 d/>30 d Aluminum/porcelain/latex/paper (169)
 Adenovirus type 3 ~7 lg TCID50 >9 d: 4.2 lg Polystyrene (170)
 Cytomegalovirus 4–6.9 lg PFU 1–2 h/4–8 h Cotton/plexiglass (171)
 Ebola virus 4–6 lg TCID50 At 4°C > 50 d: 2 lg Plastic/glass/stainless steel (172)
7 lg PFU; 6.2 d Paper (173)
7.3 lg PFU >5.9 d: 4 lg Glass/silicone/aluminum (174)
6–7 lg TCID50 14 d/8 d/11 d Tyvek/stainless steel/plastic (175)
7 lg TCID50 >192 h/>192 h/<24 h/>192 h; 3–4 lg Stainless steel/surgical mask/cotton/plastic (176)
 Hendra virus (HeV) ~6.25 lg TCID50 60 min, after 30 min: ~2.7 lg Polystyrene (177)
 Lassa virus 7.1 lg PFU >9.7 d: 4 lg Glass/silicone/aluminum (174)
 Mpox Household setting after disease At least 15 days: ≤2 lg/0 to ≤ 2 lg Porous surfaces/non-porous (178)
 Marburgvirus 4–7 lg TCID50 >50 d: 2 lg Plastic/glass (172)
 Nipah virus (NiV) ~6.25 lg TCID50 After 60 min: ~2.7 lg Polystyrene (177)
 Sindbis virus 7.2 lg PFU >14.6 d: 4 lg Glass/silicone/aluminum (174)
 Vaccinia virus 7 lg CCID50 >4 wk: 2 lg Glass (167)
8 lg CCID50 14 wk: 3 lg/up to 10 wk: 3.5. lg Wool/cotton (179)
8 lg CCID50/mL 1 wk: 4 lg Cotton (180)
2.8 lg TCID50 14 d: <1 lg Gauze bandage (181)
8 lg PFU <56 d: ~4.5 lg Stainless steel (182)
6–6.5 lg KID50 <20 wk: 4.3 lg Glass (183)
Contact transmission, starting from the gastrointestinal tract (+ surrogate viruses)
 Adenovirus type 40 5–5.7 lg IU >7 d: 3.8 lg Paper/porcelain (184)
 Astrovirus, serotype 4 5–5.7 lg IU 60 d/after 7 d: 1.7 lg Paper/porcelain (184)
 Coxsackie virus 6.8 lg CCID50 2 wk: 2 lg Glass (167)
6.5 lg TCID50 <6 wk Petri dish (185)
 Echovirus max. 300 PFU 42 h Cellulose (186)
 Feline calicivirus 9 lg PFU >7 d: 2 lg Laminate/ceramic/stainless steel (187)
7 lg TCID50 90% reduction in viral titers: up to 24 h Computer/brass/telephone (188)
6 lg PFU <15 d/<3 d/<7 d Wool/nylon/glass (189)
    Hepatitis A virus
    (HAV)
6 lg PFU >1 mo Wood/stainless steel (190)
3–4 lg PFU 4 h to >7 d Stainless steel (191)
5–5.7 lg IU After 7 d: ~3.3 lg/~5 lg Paper/porcelain (184)
6.4 lg After 90 d on PVC: 10% of initial loading Stainless steel/PVC (192)
~6 lg PFU >60 d/>60 d/>60 d/>30 d Aluminum/porcelain/latex/paper (169)
 Hepatitis E virus (HEV) ~4 lg FFU After 28 d: ~1 lg/1 lg/0.4 lg/0 lg Plastics/ceramics/stainless steel/wood (193)
3.9 lg FFU D value: 5.95 d Stainless steel (194)
Escherichia virus (MS2 phage) 6 lg PFU D value: 19.8 d/13.2 d Wood/stainless steel (190)
    Murine hepatitis virus and (MHV)
    Transmissible gastroenteritis virus (TGEV)
4–5 lg PFU MHV: after 5 d 3 lg; TGEV: after 3 d 2 lg Stainless steel (195)
 Murine norovirus 4–4.5 lg PFU >120 min except copper; after 120 min:
3.1 lg for stainless steel
Copper 100%/95%/70%/stainless steel (196)
 Poliovirus type 1 4.4 lg PFU >90 min; after 20 min: 2.6 lg Worktop (197)
~6 lg PFU 3 d/1 d/30 d/>30 d Aluminum/porcelain/latex/paper (169)
max. 300 PFU 42 h Cellulose (186)
~12 lg PFU >3 wks on all surfaces; 99% reduction after 5.2 d/7.4 d/5.9 d Steel/cotton/plastic (198)
3–4 lg PFU 12 h Stainless steel (191)
 Poliovirus type 2 8.1 lg PFU After 14 d: >3 lg Glass (167)
5–5.7 lg IU >7 d Paper/porcelain (184)
 Rotavirus ~6 lg PFU >60 d Aluminum/porcelain/latex/paper (169)
3–4 lg PFU <90 min Worktop (197)
7 lg PFU >10 d Glass/smooth plastic/rough plastic (199)
5–5.7 lg IU >7 d Paper/porcelain (184)
 Tulane virus (Rhesus enteric calicivirus) 4.7 lg PFU D value: 18.8 d/13.3 d Acrylic/stainless steel (200)
Respiratory and/or aerogenic transmission (+ surrogate viruses)
 Endemic human coronaviruses 5.7 lg TCID50 HCoV-229E: >12 h, >12 h, >6 h; HCoV-OC43: >3 h, >1 h, >1 h Aluminum/cotton/latex (201)
3 lg PFU 3 d/5 d/≤40 min/120 min/30 min Silicone/PVC, ceramic, glass, steel/brass/70% copper/90% copper (202)
~7 lg TCID50 48 h: 2 lg Polystyrene (170)
 Influenza A virus 3.1 lg TCID50 (A/NC-H1N1); 4.8 lg TCID50 (A/Br-H1N1) 7 d Stainless steel (203)
5.5 lg TCID50 >24 h/>48 h/>24 h/8 h Stainless steel/wood/plastic/cotton (204)
5.3 lg TCID50 ≥60 min/30 min/15 min/<15 min/<15 min Cotton/formica/vinyl/stainless steel/facial tissue (205)
5 lg TCID50 <5 d Petri dish (185)
4–6 lg PFU After 7.3 d/17.7 h/34.3 h 99% reduction Stainless steel/cotton/microfiber (206)
3–4 lg TCID50 48 h/72 h/24 h/24 h/12 h Plastic/stainless steel/magazine/cotton/paper (207)
6 lg PFU 2–9 h Telephone receiver/wood/keyboard/stainless steel/dishcloth (208)
6 lg TCID50 <4 h Stainless steel/plastic (209)
 Influenza B virus 4 lg TCID50 48 h/48 h/8 h/12 h/8 h Plastic/stainless steel/magazine/cotton/paper handkerchief (207)
    Middle East respiratory syndrome coronavirus
    (MERS-CoV)
6 lg TCID50 <72 h Stainless steel/plastic (209)
 Parainfluenza virus 3.2 lg TCID50 4 h Stainless steel/laminate (210)
 Respiratory syncytial virus 5 lg TCID50 8 h; ~2.5 h; ~5.3 h; 1 h; 1 h Laminate/cotton-polyester/rubber/paper/hands (211)
 Rhinovirus type 14 7 lg PFU <25 h; TCID50: 0.55 h Stainless steel (212)
 Rhinovirus type 2 2 lg PFU After 3 d: ~0.6 lg Stainless steel (213)
 SARS-CoV-1 6 lg TCID50 4 d/4 d/4 d/5 d/5 d Wood/glass/paper/metal/textile (214)
7 lg TCID50 28 d: ~2 lg Plastic (215)
3.4 lg TCID50 72 h/48 h/8 h/8 h Plastic/stainless steel/paper/copper (216)
6 lg TCID50/mL 1 h/24 h/2d Paper/cotton/disposable gown (217)
7 lg TCID50 After 13 d: 2.3 lg Plastic (215)
~7 lg TCID50 After 9 d: 2 lg Polystyrene (170)
6 lg TCID50 4 d/4 d/4 d/≥5 d/≥5 d/4 d Plastic/wood/glass/metal/cloth/paper (214)
 SARS-CoV-2 5.5 lg TCID50 D values: ~6 d/~6.9 d/~9.1 d/~6.3 d/~5.6 d/~6.3 d Stainless steel/paper/polymer/glass/cotton/vinyl (218)
7.9 lg TCID50 After 7 d: ~2.7 lg/2 lg/2.8 lg/not detectable/2.3 lg/2.3 lg/1.1 lg/not detectable Stainless steel/face shield/nitrile glove/chemical glove/N95 mask/N100 mask/Tyvek suit/cotton (219)
3.6 lg TCID50 72 h/48 h/24 h/<4 h Plastic/stainless steel/cardboard/copper (216)
7.8 lg TCID50 <3 h/<3 h/<2 d/<2 d/4 d/4 d/<7 d/<7 d/7 d Paper/handkerchief/wood/clothes/
glass/paper/stainless steel/plastic/surgical mask
(220)
6.2 ± 5.9 lg TCID50 13 min at 0.3 W/cm2: 90% reduction Stainless steel (221)
6.5 lg TCID50 <20 min exposed to sunlight Stainless steel (222)
~2.8 lg TCID50 ≤18.6 h Stainless steel/plastic/nitrile (223)
5.23 lg TCID50 2 d: ~1.2 lg Glass (224)
Contact transmission (predominant sexually; also vertically)
 Herpes simplex virus type 1 7.9 TCID50 After 2 h: 6.7 lg Plastic/chrome (225)
After 2 h: 5.2 lg (226)
5.6 lg PFU After 1 d: 4 lg Glass (167)
~7 lg TCID50 After 9 d: 1.9 lg Polystyrene (170)
 Herpes simplex virus type 2 4.2 lg TCID50 4.5 h: 2.9 lg TCID50 Polystyrene (227)
 Human immunodeficiency virus (HIV) Liquid/dry inoculum: 128,000/25,000
cpm/mL reverse transcriptase
>20 d/~10 d Petri dish (228)
 Papillomavirus ~100–434 FFU <7 d Pipe/cotton/microcentrifuge tube (229)
Blood-borne transmission
 Hepatitis B virus (HBV) 0.1 mL HBsAg-positive plasma 1 wk Silanized tube (230)
0.1 mL HBV-positive blood >2 wk Stainless steel/cotton swab (231)
>6 lg TCID50 After 28 d: ~10% reduction PCR tubes (232)
 Hepatitis C virus (HCV) 4–6 lg IE >40 d 24-well plates (233)
~4.75 lg TCID50 After 7 d: ~1.5 lg Stainless steel (234)
a

Table modified from reference 71. Pathogens with fomite-borne transmission potential, characterized by an increased nosocomial risk for transmission from inanimate surfaces, are marked in gray; for additional data and details of recultivation and environmental conditions, see the supplemental material (Table E). Legend: cmp = counts per minute, D value = time in which the virus titer is reduced by 1 lg.

b

Z value (thermal death time) = number of degrees the temperature has to be increased to achieve a 10-fold decrease in decimal reduction time (D-value), ATCC = American Type Culture Collection, BSA = Bovine Serum Albumin, CCID = cell culture infectious dose, CPE = cytopathic effect, d = day, FFU = focus forming units, h = hours, HBsAg = Hepatitis B surface Antigen, HBVcc = HBV derived from cell cultures, IU = infectious units, lg = decadic logarithm, min = minute, mon = month, N/A = not available, PBS = phosphate-buffered saline, PCR = polymerase chain reaction, PFU = plaque forming unit, PPE = personal protection equipment, PVC = polyvinyl chloride, RH = relative humidity, RIA = radioimmunoassay, RT = room temperature, TCID50 = 50% tissue culture infectious dose, US = ultrasound, W = watt, wk = week.

TABLE 8.

Persistence of different A. baumannii strains suspended in water or bovine serum albumin (BSA) and dried on glass at different RHa

Average persistence Strain(s) Conditions (RH 28%–34%, RT)
≤5 d ATCC 9955 Suspended in water
6–10 d ATCC 17978, ATCC 19606, R 0211019
>10–30 d ATCC 17904, 18, 49, 16/48, 16/49, R 447
<10 d ATCC 9955 Suspended in 7% BSA
>10–30 d ATCC 17978, 18, 16/48
>29–60 d ATCC 19606, ATCC 17904, 49, 16/49, R 447, R 0211019
a

Table modified from reference 73.

EVALUABLE PUBLICATIONS

There were 145 publications taken from three previous reviews, with an additional 495 records identified via the databases (Fig. 2). In all, 152 duplicates were removed. The title and abstract of the remaining 343 records were screened, leading to the inclusion of 40 reports. Of these, 32 were excluded during the full-text screening. Four primary studies and four reviews were included. The reference lists of the reviews were screened for other eligible studies which led to the inclusion of another 22 primary studies. Within the scope of the systematic search, a total of 26 primary studies were included. Together with studies from the three initial reviews, a total of 171 publications were included.

Fig 2.

Fig 2

Flow chart (modified from reference 235, published under a Creative Commons license). For more information, visit https://www.prisma-statement.org.

This review does not claim to include all pathogens with the ability to induce outbreaks, for example, Mycobacterium chimera. The priority was to gauge transmission potential from near-patient inanimate surfaces. We did not consider pathogens in other hospital hygiene-relevant settings (e.g., water, air, and food).

Tables 3 to 7 focus on the most important pathogens in the healthcare setting and the most important parameters for transmission potential (temperature, RH, light, surface material). For better clarity, inocula were reported by waiving application conditions. Due to differences in the choice of units used to report results, the initial inoculum (starting point) was converted into a decadic logarithm. For additional data and details of recultivation and expanded environmental conditions, please see supplementary material (Tables A–E). Pathogens with an increased fomite-borne transmission potential were highlighted in gray. For this tentatively introduced classification, we used a simple scoring system: Pathogens are characterized by (i) a high virulence and/or (ii) a long RC and/or (iii) a high potential for nosocomial spread. A pathogen belongs to the fomite-borne risk group if at least two of the three statements are fulfilled. This is to be understood explicitly as a basis for discussion and is summarized illustratively in Fig. 3.

Fig 3.

Fig 3

Introduced classification of pathogens with fomite-borne transmission potential and derived IPC strategies.

Replication capacity of bacteria

Microorganisms responsible for colonized or infected patients may be isolated from the near-patient environment, especially when surface cleaning or disinfection is inadequate. To clarify transmission routes, screening has been carried out primarily for species such as MRSA (236, 237), vancomycin-resistant enterococci (VRE) (236, 238), carbapenem-resistant enterobacteriaceae (CRE) (239, 240), Acinetobacter baumannii complex (241), Clostridioides (C.) difficile (241, 242), and recently for the high pathogenic yeast Candida (C.) auris (243). For species detected in nosocomial outbreaks, or which frequently colonize or infect newly admitted patients, understanding RC is useful because intensified surface cleaning/disinfection within an intervention bundle has proved effective in controlling cross-infection and even outbreaks. This has been proven for VRE (18, 25), C. difficile (16), MRSA (244), Acinetobacter (A.) baumannii (4, 8, 22, 28), CRE (14, 25), and C. auris (243, 245). The acquisition of pathogens from previous patients caused by deficiencies in final disinfection is well known (57, 9, 15, 23, 246) and evaluated in meta-analyses (21, 31). However, none of these studies used genomic surveillance to link isolates from the previous occupant and the new patient admitted into the same room. Recent work suggests that pathogen identity cannot be assumed, but there is a high likelihood of genotypic identity depending on the species (247).

In most reports, RC was studied on dry surfaces using artificial contamination of a standardized surface in a laboratory. Bacteria were prepared in broth, water, or saline and removed from the germ carrier by different rinsing solutions, for example, dist. water, physiol. NaCl, phosphate-buffered salt solution (PBS), or Triton X-100, sometimes in combination with ultrasound (Tables 3 and 4).

After this preparation, members of the Gram-positive genera enterococci (e.g., VRE) and staphylococci (e.g., MRSA) survive for months on dry surfaces. Among streptococci, RC differs depending on the species, that is, for Streptococccus (Str.) pneumoniae <24 h, Str. pyogenes 1–3 d, and Str. salivarius >88 h. Corynebacterium pseudotuberculosis survives 1–4 d on dry plastic surfaces. By contrast, C. diphtheriae, isolated from dust in patient rooms, survives 7–90 d, depending on the species. In daylight, Mycobacterium tuberculosis survives for 2–5 d, but in darkness, recovery is possible for up to 200 d (Table 3).

There are only a few studies where wild-type and antibiotic-resistant representatives of the same species were compared against each other. For enterococci, VRE has higher RC compared with susceptible enterococci. Similarly, methicillin-sensitive S. aureus (MSSA) in dust demonstrated a shorter survival time on surfaces than MRSA (Table 3).

Spores of Bacillus and Clostridioides (C.) spp. survive for >6 months depending on the material. By contrast, the vegetative form of C. difficile drops to the detectable threshold within 15 minutes (min) (Table 3).

An initial comment is that neither Gram-positive nor Gram-negative organisms represent a uniform group regarding recultivation potential from inanimate surfaces (Tables 3 and 4). Some species can survive for a month, such as Escherichia (E.) coli, Klebsiella spp., Pseudomonas aeruginosa, Serratia marcescens, Enterococcus spp., Acinetobacter ssp. and Clostridioides ssp. This is also reflected in infection epidemiology since these pathogens can cause ongoing transmission incidents and outbreaks. The Salmonella genus behaves very differently: Salmonella (S.) typhimurium is still present in garden soil 280 d after contamination (248), S. paratyphi B survives in soil up to 259 d (249), and S. enteritidis for more than 11 months, whereas S. typhi survives only 4 d.

Conversely, Mitscherlich and Marth (250) demonstrate the persistence of Proteus spp. in the environment with 1–2 d. P. morganii, P. rettgeri, P. vulgaris, and P. mirabilis survive in sterile clay loam at 18–20°C species-dependent 35–40 d. The decimal reduction time was about 6 d (251). Shigella flexneri persists for 6 d (252). B. pertussis, H. influenzae, and Vibrio cholerae persist only a few days [(253); Table 3]. Aerosolized H. influenzae is characterized by short survival on glass (0.29 d), wood (0.08 d), and fabric (<1 d) (250, 254).

Replication capacity of fungi

For RC determination, fungi were removed from the germ carrier mostly by dipping or vortex in bouillon or tryptic-soy-broth (TSB), sometimes in combination with ultrasound, and by contact with an agar plate, overlaying with agar or smear (Table 5).

Molds occur ubiquitously in nature, are thermotolerant, and can survive on surfaces for 2 d to >30 d depending on the material (Table 5). Indoor airborne mold measurements underline the survival for several months (255, 256). Molds can multiply at an RH of ≥75% at room temperature (RT), which can lead to mold infestation (257). The species Cladosporium, Aspergillus, and Penicillium are the most frequently detected molds on hospital surfaces (258260). Mucor and Aspergillus (A.) spp. were isolated from room air and dust from an air-conditioning system with a defective filter and were linked with mycotic endocarditis in patients undergoing open heart surgery (261). Moreover, Mucorales (Rhizopus spp.) recovered from linen were associated with a Mucormycosis outbreak (262, 263) and even survived a certified healthcare laundry process (263). Other Mucorales (Mucor spp.) persisted on various materials for weeks (152).

The dermatophytes Epidermophyton (E.) floccosum, Trichophyton (T.) mentagrophytes, and Tricholosporum violaceum survived in skin scales for 10 years at −20°C, while T. rubrum and T. verrucosum could no longer be cultivated under the same conditions (264). Microsporum canis has been detected on hospital surfaces (260). In Germany, in the 1920s, E. floccosum and Microsporum (M.) audouinii dominated as pathogens of human dermatophytoses and T. rubrum was almost insignificant; dermatophyte isolates increased from 41.7% in 1950 to 82.7 % in 1993 so that T. mentagrophytes var. interdigitale was gradually replaced by T. rubrum as the main pathogen of tinea pedis and onychomycosis. With the introduction of griseofulvin in 1958, both M. audouinii and T. schoenleinii were virtually eradicated (265). In the case of tinea pedis, T. rubrum was detectable in 86% of patients and T. mentagrophytes in 81% of patients in house dust (266). Both dermatophyte species could also be detected and cultivated on the bare soles of the feet after leaving public baths. Washing and drying only did not result in complete elimination (267). Since the beginning of the 20th century, the incidence of Microsporum canis infections in Europe, especially in Mediterranean countries and Slovenia, has been increasing sharply, with dogs and cats being the natural reservoirs (268). However, further spread is also possible via combs, brushes, hats, furniture, bedding, etc.

Candida (C.) albicans, the most common nosocomial yeast, can survive up to 4 months on surfaces. RC for C. glabrata (Nakaseomyces glabratus) was described to be similar but shorter for C. parapsilosis (Table 5). In the patient environment, C. glabrata (Nakaseomyces glabratus), C. parapsilosis, C. tropicalis, C. albicans, C. metapsilosis, and C. lusitaniae were detected on dry surfaces in ~3%, on moist surfaces in ~14% (154).

Several recent outbreaks have been caused by the new emerging multidrug-resistant C. auris (269, 270) which differs from other yeasts and dermatophytes in nosocomial spread (271, 272). C. auris is capable of colonizing patients and it can persist in a patient for over a year (245, 273). It can be transmitted through direct contact, for example, hands, but also through indirect contact via fomites, such as medical devices, other devices, and surfaces that directly contact the patient (272, 274, 275). From 2015 to 2017, an outbreak with 70 patients occurred in a neuroscience intensive care unit of the Oxford University Hospitals, United Kingdom. The outbreak was linked to the use of reusable skin-surface axillary temperature probes, suggesting that C. auris persisted in the environment and initiated a large outbreak (276). By now, several outbreaks have been reported from different countries and hospitals reflecting the high relevant transmission capacity of this new pathogen. This is particularly important since this species is highly virulent, reflected by a substantial high proportion of invasive isolates leading to a high blood culture positivity rate in outbreaks. The risk of nosocomial spread through surfaces is represented by a higher RC in in vitro settings. Moreover, C. auris is often resistant to many antifungals which complement a higher risk of colonization and probable outbreak potential, with special regard to pan-resistant strains of C. auris (277). C. auris is now established in 43 countries across five continents (278).

Replication capacity of protozoa

Protozoa are unicellular heterotrophic eukaryotic organisms. They are considered to be a subkingdom of the kingdom Protista, although in the classical system, they were placed in the kingdom Animalia (279). The cultivation techniques for protozoa differ from those for bacteria and fungi, involve highly complex procedures, and depend on the life cycle stage (280, 281). The RC distinguishes between the vegetative stage (trophozoite), and the inactive infectious stage (oocyst or cyst) (Table 6).

The interruption of infection chains is the main strategy in the field of combating protozoonoses. Depending on habitat, hygienic measures for water and sewage and personal hygiene are of particular importance. Against this background, understanding the RC of protozoa relevant to human medicine is of particular interest.

One of the most common causatives for parasitic diarrhea in high-income countries is Giardia (G.) intestinalis. It shows also relevant prevalence in middle- and low-income countries and in the United States, it is described as the most common parasitic enteropathy. Entamoeba histolytica (Amoebiasis) has the most significant effect in low-income countries and has been globally labeled as the third leading cause of death from parasitic infections. Another protozoa that shows increasing prevalence all over the world, especially among patients with AIDS and children under 5 years of age, is the Cryptosporidium spp. (282, 283). However, there are several other protozoa of relevance for the hospital setting. A number of reports have been published recently describing diarrheal outbreaks caused by Cyclospora (Cy.) cayetanensis (284, 285). Another protozoan is Trichomonas vaginalis which belongs to one of the most relevant non-viral venereal diseases—although fomite-borne transmission is relatively rare (286).

G. intestinalis and Cryptosporidium (Cr.) spp. survive in both aquatic and terrestrial environments. Giardia cysts may remain infectious for months in water or in cool damp areas (287). At temperatures below 15°C, Cryptosporidium oocysts can maintain high levels of infectivity in water for at least 24 wks (162, 288290) and up to 120 d in soil (291). The survival of oocysts of Cr. parvum and G. muris was inversely correlated with the storage temperature and porosity of the surface (Table 6). Under various test conditions, the overall trends of the Cryptosporidium oocysts die-off were similar to the one of Giardia cysts (160). Outbreaks of Cryptosporidium spp. and G. intestinalis generally occur via drinking water and food which were inadequately treated to kill or to remove these parasites (292). Other less frequent water-associated outbreaks include Entamoeba (E.) histolytica/E. dispar, Balantidium (Bal.) coli, Cy. cayetanensis, Microsporidium spp., Toxoplasma (T.) gondii, and the free-living Acanthamoeba species. Cryptosporidium spp. can also be transmitted nosocomial via hands and indirectly via surfaces (293). In China, an outbreak of cryptosporidiosis was associated with HAI by G. intestinalis, Enterocytozoon bieneusi, and C. difficile infection. Poor diaper changing and hand hygiene were probably responsible for this multi-pathogen outbreak (294).

Survival of anaerobic Entamoeba spp. in environments is highly dependent on temperature. Survival was determined in feces and soil at 28°C–34°C for 8–10 d, in water and sewage sludge at 0°C–4°C for 60–365 d, in surface water resp. wastewater at 20°C–30°C for 15 d resp. 10 d (295).

Multiple experiments in soils showed that T. gondii oocysts may remain viable for at least 1 year when covered and in cool temperatures (4°C). Under warm climate conditions in dry soils from Kansas, USA, oocysts remained viable for 18 months. In fresh or marine waters, oocysts were shown to be viable for at least 4.5 and 2 years, respectively, reviewed by reference (296). To determine the survival dynamics, 2.5 g of soil is inoculated with 1 mL of suspension containing 2 × 105 oocysts. The proportion of oocysts surviving after 100 d was estimated to be 7.4% under dry conditions and 43.7% under damp conditions (297).

Babesia (B.) spp. are intraerythrocytic protozoan parasites transmitted primarily by tick vectors, rare also congenital, and by blood transfusion (298). Normally, it has its origin in endogenously infected blood donors. A nosocomial transmission in blood products is only indirectly imaginable during the preparation process of blood products in blood banks via hands contaminated from surfaces. Refrigeration decreases the parasite numbers, but parasites survive 31 d at 2–4°C and yield high end-point parasitemia, proofed by inoculation of hamsters (299). B. microti survives in red cells at 4°C in EDTA-coated blood collection tubes for at least 21 d. Blood held at room temperature did not infect any hamsters (300). Under normal blood bank conditions, a 35-day-old red cell unit was caused by transfusion-transmitted babesiosis (TTB) (301). Similarly, TTB case reports implicating cryopreserved red cell units indicate that B. microti can survive indefinitely in the presence of glycerol cryopreservation (302, 303), but in the absence of cryopreservation, the parasite is rapidly killed by pathogen reduction technology, which uses riboflavin (RB) and ultraviolet (UV) light (304). Theoretically, a single parasite is capable of transmitting infection. Experimental studies, however, have shown that 30 organisms infected about 2/5 inoculated hamsters, and 300 organisms infected all animals (305).

Protozoa play a minor role in HAI, but in our increasingly complex healthcare environment with a growing proportion of immunocompromised patients, they should be respected because certain protozoa may cause morbidity and even mortality in both normal and immunocompromised patients (284). Furthermore, climate change with increasing temperatures and heavy rainfall could promote their nosocomial potential in the future. There is also the possibility that HAI could be missed because the incubation period may be days to weeks (wks) and the parasite is endemic. It is likely that nosocomial transmission of protozoa may be an even greater problem in tropical hospitals, where comprehensive hygienic measures are costly or otherwise more difficult to maintain and growth conditions more beneficial for the protozoa. Up to 1% of HAI were caused by parasites depending on geographic region (306), but in this estimation, no distinction was made between protozoa and other endo- or ectoparasites. Jarrin et al. (307) assumed that intestinal parasites can cause diarrhea in 12%–17% of nosocomial epidemics and 1% of endemic outbreaks, especially on surgical wards. Immunosuppressed patients and those with prolonged antibiotic courses are at higher risk. Enteric protozoa, especially Cr. parvum, G. intestinalis, E. histolytica/E. dispar, Bal. coli, Cy. cayetanensis, and Cystoisospora belli (syn. Isospora (I.) belli) are the most common species involved in nosocomial outbreaks (307).

The spread of enteric protozoa in developing countries usually occurs through fecal contamination due to sewage exposure, poor quality of water, and zoonotic exposure but also via transplantation (308310). The 50% infectious dose (ID50) of C. parvum has been estimated at 132 oocysts; with some infections followed by ingestion of 30 oocysts (311). Ingestion of at least 10 to 25 G. intestinalis oocysts can cause infection in humans (312, 313). Infection after ingestion of a single oocyst has been reported (311). The small ID, the fecal-oral route of transmission, and prolonged environmental survival in water allow Cryptosporidium to spread in healthcare facilities as well as child-care centers. Cryptosporidium can be transmitted by hand after contact with contaminated environmental surfaces (314). The cysts are highly resistant to environmental conditions and most of the disinfectants commonly used have low or no antiparasitic activity (314). For Giardia and Cryptosporidium spp., person-to-person transmission is possible (315, 316). For Cryptosporidium spp., transmission is primarily found among children and staff members in nurseries, day-care centers, and schools (317). HAI by direct and indirect person-to-person transmission is documented, causing secondary cases among roommates (315). In an outbreak of giardiasis at two day-care nurseries G. intestinalis appeared to be transmitted from person to person (318). Conversely, ingestion of approximately 200–49,000 oocysts at healthy volunteers did not experience gastroenteritis, and no oocysts were detected in any stool samples over the following 16 wks (319). Therefore, there is minimal risk of nosocomial transmission. Sporulated oocysts of I. belli can survive for years in the environment (320). Although the transmission of protozoa via surfaces in hospitals is negligible for most species, awareness of surface persistence is important for assessing the risk of surfaces as a reservoir for food, water, and hands (Table 6). Cr. parvum oocysts survived in stool on wood of up to 72 h, and differed between stool samples (162). Survival was shorter than in water because other fecal microorganisms such as bacteria may be associated with the shortened survivability (321), and also with the presence of ammonia, which may occur in feces in high concentrations. Ammonia is a significant inactivation agent for oocysts (322, 323). Oocysts have been shown to survive for hours on wet surfaces, including stainless steel, but they resist desiccation and die rapidly on dry surfaces (324).

One multivariate analysis in a group of virgin females with a high prevalence of trichomoniasis showed that the high prevalence was due to non-sexual acquisition of trichomoniasis, mainly through shared bathing water and inconsistent use of soap (325).

Acanthamoeba is a common protozoa that can be found in diverse environments. Their presence has been documented not only in soil and freshwater but also in pools, lakes, brackish water, seawater, heating, ventilating, and air-conditioning filters. Moreover, it has been detected on medical devices, such as gastric wash tubing and dental irrigation units (159). Wearing hydrogel contact lenses was associated with keratitis caused by Acanthamoeba and Fusarium (326), probably due to moist conditions favored by these pathogens. Moreover, the presence of Acanthamoeba, together with Vahlkampfia and Vermamoeba spp., has been verified in the dust of different intensive care wards; on equipment, doors, and in the air-conditioning system (327). With their doubled walls, Acanthamoeba cysts are highly resilient, forming dormant stages that remain viable (and infectious) for several years (328, 329) and in a state of desiccation up to 21 years (Table 6).

Replication capacity of viruses

To determine the RC of viruses, applied material was removed from the germ carrier by scraping or rinsing in a cell culture medium; sometimes combined with vortexing and transfer of the sample usually into cell culture. Recultivability is determined, based on the number of infectious virus particles, by growing the remaining virus particles with subsequent determination of the virus titer. By contrast, molecular biological detection alone does not allow any conclusions regarding infectivity. For hepatitis B virus (HBV), infectivity was proven by the application of the rehydrated inoculum in chimpanzees due to lack of cultivation in cell culture in the past. Nowadays, it can be analyzed in an HBV-susceptible cell culture system using hepatoma cells expressing the Na+- taurocholate co-transporting polypeptide (NTCP)-HBV cell entry factor (232) (Table 7). However, this method is only available in specialized laboratories and cannot be used routinely.

Gastrointestinal transmissible viruses remain infectious on inanimate surfaces. The longest has an average of 1–6 w, followed by blood-borne (average 1–6 w), respiratory (average 1–3 d), and sexually transmitted viruses (2 h to <7 d) (Table 7).

Non-enveloped viruses are more resistant to extreme pH, heat, dryness, disinfectants in general, and some can intrinsically resist certain disinfectants such as the parvovirus or hepatitis A virus (HAV). By contrast, most enveloped viruses such as herpes viruses (e.g., cytomegalovirus), human immunodeficiency virus (HIV), and respiratory syncytial virus (RSV) are less environmentally stable since they possess an outer lipid bilayer membrane. Small viruses, for example, HBV or the members of the picornavirus or parvovirus family, are much more resistant than larger complex viruses, for example, members of herpes or retrovirus families (330). Some non-enveloped viruses, such as enteroviruses belonging to the picorna viridae, are sensitive to drying, for example, dried inoculum of the Coxsackie B4 (CVB4) virus was easier to recover when CVB4 was spiked in media containing any concentration of NaCl instead of protein load (185).

The relevance of surfaces in healthcare facilities as a contamination source for viruses is even more difficult to prove than for bacteria and fungi, surface isolation is more complex. Virus infection can so far only be indirectly deduced by tracking the spread of the virus from the patient and its presence in the patient’s environment, as the ID is not known with a few exceptions. However, in both situations, the risk of infection increases with higher RC. A few examples illustrate the importance of surfaces for the spread of viral infections. After the discharge of patients with norovirus infection, the number of new cases has continued to rise, most likely due to the low ID of norovirus (1 to 10 to 100 virus particles) (331). A large outbreak due to norovirus infections could therefore be controlled by closing the affected departments, implementing extensive disinfection measures, and reducing the exposition risk, that is, from infected healthcare workers (332). However, if recognized at an early stage, most norovirus outbreaks can be controlled easily without these intensified intervention strategies. A retrospective cohort study showed a very low risk of general infection by only 2 of 1,106 exposed patients had acquired the identical norovirus strain from the discharged patient (333). Although direct hand transmission dominates nosocomial transmission of rotaviruses, surfaces are also relevant for spread (334). A simulation experiment on virus inoculated over surfaces using Cauliflower mosaic virus showed that the virus was detectable on 41% of the sampled surfaces within 10 h outside of the isolation unit (335). Whether this amount was sufficient to transmit infection was not investigated. After the emergence of MERS-CoV, although the origin is zoonotic, the risk of further spread via surfaces was investigated. The contamination with viral RNA was detected in the environment of hospitalized ventilated patients despite a strict disinfection regimen and negative pressure ventilation. Due to the RC of up to 9 d and the detection in the patient environment, the authors concluded that careful surface disinfection, especially near the patient, can help with prevention (336). Thus, detecting RNA does not necessarily coincide with infectivity.

Other viruses from the gastrointestinal tract such as Astrovirus, HAV, polio-, and rotavirus can retain their infectivity at RT for quite a long time, with the spectrum varying from several hours to 3 months. HBV belonging to the group of blood-borne or sexually transmitted viruses plays a very high stability with an RC of 50% of more than 22 d at 37°C and a persisting infectivity for up to 9 months at 4°C (232). By contrast, most respiratory viruses retain their infectivity on inanimate surfaces for a few days only (Table 7).

Herpes viruses such as cytomegalovirus are mainly transmitted through contact with infectious body fluids, for example, through breastfeeding, kissing, sexual contact, herpes simplex virus (HSV) type 1, mainly transmitted via contact, and HSV 2, mainly transmitted during sex, have been shown to persist from only a few hours up to days (Table 7).

Mpox virus (MPXV)

Since the summer of 2022, non-travel-associated outbreaks of Mpox have been reported in several non-endemic countries. Human-to-human transmission can occur through close contact with respiratory secretions, infectious skin lesions (such as ruptured blisters) from an infected individual, or recently contaminated objects (e.g., sex toys) and surfaces (337); nosocomial infections have also been documented (338341). The World Health Organization (WHO) recently recommended adopting the term “Mpox” as a synonym for monkeypox (342). Investigations involving the vaccinia virus, which is related to the MPXV, revealed that it can remain “infectious” on surfaces for up to 56 d (68). Studies on textile fibers showed that the vaccinia virus could be recovered from wool fabric after up to 4 wks and from cotton for up to 8 d; textiles contaminated with virus-laden dust even remained infectious for up to 12 wks (179, 180). Adler et al. found that in some patients the virus could be detected in throat swabs by PCR test for up to 3 wks and in one 2018 case even up to 41 d after diagnosis (343). However, it was not determined whether this represented “residual nucleic acid” or infectious virus. Viable virus was identified in two (50%) of four samples selected for viral isolation, including air and surface MPXV samples collected during bedding change in a hospital in UK (344). In another study, there was no statistical difference (P = 0.94) between MPXV-WA PCR positivity of porous (9/10, 90%) vs. nonporous (19/21, 90.5%) surfaces, but there was a significant difference (P < 0.01) between viable virus detected in cultures of porous (6/10, 60%) vs nonporous (1/21, 5%) surfaces. These findings suggest that porous surfaces (e.g., bedding, clothing) may pose a higher risk of MPXV exposure than nonporous surfaces (e.g., metal, plastic). Viable MPXV was detected on household surfaces for at least 15 d (178). Therefore, the Centers for Disease Control and Prevention (CDC) recommend minimizing the spread of virus in households by cleaning and disinfecting laundry, hard and soft surfaces, and carpets and flooring when exposed to an infected person (345).

SARS-CoV-2

SARS-CoV-2 illustrates how infection control measures for a new infectious disease can be established, and continuously adapted at breathtaking speed using hospital hygiene strategies including RC, biocide resistance, and transmission considerations. Like other coronaviruses, SARS-CoV-2 has been detected on surfaces (346) showing a correlation between patient proximity and surface contamination (347). Consequently, the risk of further spread due to RC on surfaces of up to 7 d (Table 7) could be prevented by surface decontamination (348, 349). Even simple wiping with hard water or detergent-based cleaning has proven to be an effective decontamination strategy against SARS-CoV-2 (350) applicable to all materials (Table 7), despite variations in their influence on RC (351). Depending on the exposure time, the recoverable virus quantity decreases almost linearly and becomes negligible on plastic after 72 h, stainless steel after 48 h, cardboard after 24 h, and copper after 4 h (352). Since the ID is unknown, the risk assessment remains open. A case report suggests that the detection of SARS-CoV-2 on household surfaces indicates that transmission is possible if surfaces are recently contaminated by coughing or sneezing and then are touched and transferred to the mouth, nose, or eyes (353). However, in other studies where surface transmission was suspected, respiratory transmission could not be entirely ruled out in this study (354). The infection risk is presumed to be low as small amounts of SARS-CoV-2 RNA were detectable in only 2 of 26 samples from an emergency ward and an infectious disease sub-intensive care ward and these did not cause cytopathic effect in cell culture (355). It is possible that residues from surface disinfectants reduced RC. Conversely, there is a possibility that disinfectant residues could induce tolerance. Similarly, quantitative microbial risk assessment (QMRA) studies indicate that the risk of SARS-CoV-2 infection via surface transmission is low with a probability of less than 1:10,000 for each contact with a contaminated surface (356358). These findings suggest that the transmission of SARS-CoV-2 via surfaces in public areas is negligible (359). In isolation units/rooms for patients with SARS-CoV-2 infection and in units or rooms for suspected patient cases of SARS-CoV-2 infection, surface cleaning and disinfection is indicated based on the observation that SARS-CoV-2 can be detected in the entire patient environment. Moreover, the RC is up to 7 d, although the infectivity of the surfaces is apparently only low. In a retrospective questionnaire-based study, it was shown that even at home the use of protective masks and daily use of chlorine- and ethanol-based disinfectants for surface decontamination and hand antisepsis significantly reduced the risk of infection (360). Santarpia et al. (361) deduced from the data that in cases of suspected or confirmed SARS-CoV-2 infection within the last 24 h in the household, surfaces should also be decontaminated.

Factors influencing the replication and infection capacity of microorganisms, protozoa, and viruses in the environment

Microbiological test conditions

For bacteria, desiccation on the surface after contamination (rapid or slow), RH and temperature during storage, recultivation conditions, and stage of cultivability (VBNC) are of influence on RC (Tables 3 and 4). The origin of the pathogen is also influential. A. baumannii strains isolated from clinical settings were more often resistant to desiccation than ATCC strains (Table 3). As expected, the RC is influenced by the initial bio-inoculum of feces, demonstrated for E. faecalis, MRSA, A. baumannii, C. jejuni (Table 3), E. coli, P. aeruginosa of recovery (Table 4), C. albicans, C. auris, C. krusei (Pichia kudriavzevii), C. parapsilosis, and C. tropicalis (Table 5). Similarly for viruses smaller inocula were associated with shorter RC, for example, for transmissible gastroenteritis virus, mouse hepatitis (195), and SARS-CoV-2. The latter lost infectivity after 2–4 d (216, 220) compared with longer times of 21 d (219) or 7–28 d (218) for larger inocula (Table 7). Finally, the RC depends on the recovery method (Tables 3 to 7).

Surface material

The RC of bacteria, fungi, and viruses was significantly shorter on copper surfaces than on textile materials, plastics, and steel, due to the oligodynamic effect of copper ((362, 363); Table 7). On porous surfaces, for example, coronavirus, influenza virus, avian metapneumovirus, poliovirus type 1, and human enteric adenovirus type 40 (169, 364), survival is longer than on non-porous surfaces (Table 7). One reason may be the lower virus elution during recovery from porous materials (365). A recently published scoping review draws the same conclusion (366). The capillary effect within the cavities and the faster evaporation of the aerosols could also be influential (367).

RH

Gram-positive bacteria tolerate dry conditions better than Gram-negative bacteria due to cell wall properties (368). S. aureus persisted longer at low RH (369), while survival kinetics for E. faecalis were lower at 25% RH than at 0% RH (370). Acinetobacter spp. suspended in distilled water survived significantly longer at room temperature (RT) at RH of 28%–34% and 93%, respectively, compared to 10% RLF, while survival did not differ between 28–34% and 93%, respectively (73). Survival of Gram-positive bacteria was reduced most at RLF of 50%–70%, while death rates of Gram-negative bacteria were highest at RLF of 50%–70% and 70%–90 %, respectively (368).

Enveloped viruses, especially respiratory viruses such as influenza, parainfluenza, corona, respiratory syncytial, measles, and rubella viruses but also herpes simplex and varicella-zoster viruses, retain their RC longer with a low RH of 20%–30% (368). Only cytomegalovirus is isolated more frequently from moist surfaces (371). Non-enveloped viruses such as adenoviruses, enteroviruses, and rhinoviruses are replicable for longer at 70%–90% RH [Table 7, (372)].

Temperature

Constant temperatures >24°C seem to reduce the replication and infection capacity of airborne bacteria, as shown for representatives of Gram-positive, Gram-negative, and intracellular bacteria (368). For 15 yeast species, the survival time increased when the ambient temperature was reduced. Overall, the survivability of the species studied was longest at 4°C and 1% RH and shortest at 37°C and 96% RH (156). The situation is different for the release of bioaerosols indoors. At 25°C, more fungi (mainly Fusarium and Penicillium spp.) were released than at 37 and 15°C, whereby the composition of the mold species differed significantly across these three temperature ranges (373). The viral genome (viral DNA or RNA) shows especially high sensitivity to the surrounding temperature which influences the RC of some viruses. This is mainly due to their impact and affection not only on the viral genome but also on the viral proteins and the whole enzymatic system. Principally, even though higher temperatures also affect DNA integrity, DNA viruses have more stability than RNA viruses. For certain viruses, including astro-, adeno-, polioviruses, herpes simplex, and HAV, low temperatures (4°C) are associated with longer replicative periods (66). For enteric viruses, RC in water increased with increasing temperature >20°C (374, 375). For rota-, poliovirus, and HAV, RC was higher at >80% RH (169). This was confirmed for poliovirus in that stability was significantly greater at 95% RH than at 25% RH (191). For coronaviruses, the influence of RH was different with higher RC at 20% and 80% and comparatively lower RC at 50% (195). For SARS-CoV-2, interfering substances, temperature (20°C or 35°C), and RH were only of moderate influence (Table 7). Morris et al. (376) developed an original prediction model of how temperature and humidity alter RC using a mechanistic quantitative approach that was based on testing the stability of SARS-CoV-2 on an inert surface for a range of temperature and humidity conditions. SARS-CoV-2 remained infectious longest at low temperatures and extreme humidity (up to 85%). The estimated mean half-time of RC was >24 h at 10°C and 40% RH, but ~1.5 h at 27°C and 65% RH. The model uses basic chemistry to explain why the sensitivity of enveloped viruses increases with higher temperatures and has a U-shaped dependence on humidity. The model accurately predicts existing results on the influence of temperature and RLF for five different human coronaviruses. This suggests that common mechanisms may influence the stability of many viruses.

Light conditions

Light, especially sunlight, or lack of it influences the RC. The survival time of C. albicans and Rhodotorula rubra on smooth glass surfaces doubled when they were kept in darkness compared with daylight and extended from 44 to 98 d for C. albicans (156). Under the influence of simulated sunlight, 90% of SARS-CoV-2 applied to the surface in artificial saliva were inactivated every 6.8 min during simulated summer exposure, but every 14.3 min during winter exposure (221). By contrast, no significant decrease was detectable within 1 h in the dark [Table 7; (221)]. The effect of sunlight was also reproducible in aerosol, while RH alone (20–70%) had no influence (377). Irradiation (distance 3 cm) with UVC (dose 1.048 mJ/cm2) completely inactivated SARS-CoV-2 (infectious titer of 5 × 106 TCID50/mL) after 9 min, while UVA (dose 292 mJ/cm2) reduced the titer by only 1 lg after 9 min (378).

Protein, fecal, and urine load

Desiccation in protein-containing media prolongs persistence, for example, for A. baumannii (Table 8), Escherichia (E.) coli (92), Neisseria (N.) meningitidis (379), and yeasts (156). The fecal load had little effect on the RC of HAV and rotaviruses. For adenoviruses, the RC only tended to increase (Table 7).

Biofilm

Several microorganisms form biofilms which is the predominant state of life in nutrient-sufficient habitats. Such life forms lead to more pronounced microorganism adhesion, by which the expression of the so-called sigma factor is triggered. This results in gene activation, making the microorganisms subsequently at least 500 times more tolerable against antimicrobial agents (380) and cold atmospheric plasma (381, 382). Some bacteria such as K. pneumoniae can remain viable for up to 4 wks in a dry biofilm, demanding more profound cleaning approaches (383). This may be due to increased tolerance of the production of extracellular substances such as polysaccharides, proteins, and DNA after attaching to surfaces. In addition to biofilm formation under moist conditions, biofilm formation on dry inanimate surfaces at room humidity should also be considered (384). This poses a challenge due to water retention from the biofilm, along with other nutrients, which protects the microorganism itself from various environmental factors (385, 386). This makes biofilms relevant not only for the natural persistence of microorganisms in their native habitats but also for industrial and medical settings (385387). The RC on inanimate surfaces is prolonged and dependent on environmental aspects, especially humidity. Biofilms have been identified on diverse surfaces in hospitals, that is, on sterile objects, plastic doors, and sanitary areas. Out of these formations, it is possible to cultivate viable bacteria. Available scientific data cannot clarify and elucidate to which extent the risk of transmission and the possibility of cross-transmission is affected by biofilm formation. In the context of multidrug-resistant bacteria, the biofilm could be one additional mechanism for persistence in medical settings (388). Of note, potential intraspecies or interspecies virulence factor exchange may be present in the biofilm (386, 388390).

The current literature regarding associations between viruses and biofilms is scarce. As viruses are strict intracellular pathogens, they may profit from a prolonged persistence in a reservoir host due to the advantages conferred by the biofilm structure but they will not be able to proliferate (391). Biofilms can contain a range of non-enveloped enteric viruses, including caliciviruses, rotavirus spp., astrovirus spp., and hepatitis A virus, alongside other microorganisms such as Gram-negative bacteria and filamentous fungi (392). The virion RC in an extracellular context can be promoted by biofilms, both on fomites and aquatic sediments, allowing viral persistence and spread. Therefore, it is necessary to highlight that both virions and virus-infected eukaryotic cells embedded in biofilms can retain their infectivity. The first in vitro study provides further information that the enveloped virus herpes simplex virus 1 (HSV-1) and the non-enveloped virus coxsackievirus type B5 (CVB5) can be encompassed within fungal Candida albicans biofilms (393). As such viruses stored in biofilms can be depicted as temporary or long-term reservoirs (52). Thus, the viral ability to remain infectious and the potential of fomite-borne transmission can be enhanced by the biofilm, especially due to protection against desiccation and antimicrobial agents (394).

DISCUSSION

The most important difference in this review, compared with the 2006 systematic review (66) on pathogen resilience, is that the course of the RC over time has been calculated based on the quantity of the inoculum on the surface and expressed as log reduction. This has resulted in more accurate values, as well as explaining different values in some cases in the first review. Furthermore, the methodological development of laboratory experiments to determine the RC over the last almost two decades has also influenced overall findings.

In general, good clinical epidemiological evidence for transmission scenarios beyond outbreaks is lacking. However, studies on RC and evidence for persistence on inanimate surfaces in combination with a conspicuous transmission event are available. It is clear that the inanimate environment plays a relevant role in these bacterial transmission pathways in everyday situations (Fig. 1a). Studies using whole-genome sequencing indicate that there is a serious underestimation of transmission events when using standard techniques only (395). These analyses tend to focus on resistant, thus easily recognizable pathogens. However, the quantification of transmission events and thus an appropriate risk assessment are not yet possible.

Beyond the epidemiological evidence, the studies were usually generated under laboratory conditions. This means that not all possible environmental influences in hospital settings can be detected, especially any from antimicrobial residues. In addition, the influence of the simultaneous contamination of hospital surfaces with various nosocomial pathogens, with secretions, excretions, and dirt will also be disregarded. A growing number of studies report that enveloped and non-enveloped viruses can spread in groups in so-called “collective infectious units” (396398). The vehicles mediating collective spread vary widely and include lipid vesicles, protein matrices, diverse forms of aggregation, and binding to the surface of host or non-host cells (396). It seems reasonable that units like this or interference may also exist for bacteria and/or fungi and/or protozoa. Laboratory studies do not reflect the clinical situation and represent probably an one-sided worst-case scenario assessing the upper bound of infection risk. Furthermore, they cannot represent the complexity of real-life scenarios. When assessing factors that influence the RC, it must be considered that the results only apply to the species investigated and cannot be generalized. Even more so, resistant isolates are often analyzed compared with wild-type variants. Sometimes tested microorganisms are poorly characterized so cannot determine the extent of generalizability. Furthermore, it should be noted that data on the RC are often not median values; the maximum was detected and described and these results can, and should, be used as an upper bound approach. Data suggest that no general prediction about RC independent of the genus is possible.

In addition, further influences must be considered. First, the dependence of environmental conditions on the RC has not yet been sufficiently studied under real-life conditions. Second, there is insufficient data on the behavior of wild-type and/or sensitive strains and variants within a species. Third, no data exist, on whether certain virulence or RC determinants are genetically present in isolates that are particularly well adapted to the hospital setting.

In this review, only the risks due to direct or indirect contact transmission from inanimate surfaces were addressed, not the additional risks by potential aerosolization of pathogens from fomites (399401). Therefore, it should be considered that the RC in aerosols can be significantly lower than on surfaces, as has been proven for different variants of the Ebola virus and Marburg virus (402). It is also the case that high inocula results in longer survival times due to the logarithmic death curve (403), which has been proven for various bacterial species (88, 404) and or fungal spores (156) on surfaces. Considering all background factors, data generated under laboratory conditions can only provide a rough orientation. In case of doubt, the less favored situation should be assumed when evaluating the data in Tables 3 to 7.

Despite knowledge of the dependency of replication and infection capacity from factors like pH, temperature, humidity, and others, we cannot easily change these surrounding conditions using their preventive potential. For others, for example, inocula and biofilms, we can use knowledge covering these aspects from common IPC recommendations.

Another viewpoint for the risk assessment of surface contamination is the minimal infectious dose (MID) to trigger infection. The lower the ID, the greater the risk of acquiring an infection and further transmission as nosocomial outbreaks. It should be noted that the ID can be reduced by a viral infection, which often leads to bacterial co- or superinfection, especially in cases of respiratory viral infections (405407). In Table 9, examples of different IDs are summarized, mainly taken from reviews. From the clinical perspective, it must be considered that this dose depends on the site of infection or at least contamination allowing short-term contamination. For respiratory transmissible viruses with a MID of >102 50% tissue culture infectious dose (TCID50), infection by aerosolization from surfaces is unlikely. By contrast, infection is possible via the surface-finger-eye route for keratoconjunctivitis epidemica due to low ID (Table 9) and the surface-finger-nose route, particularly in the case of nasal exposure to respiratory viruses with a MID <101. The same applies to orally transmissible pathogens with a MID of <101 TCID50, CFU resp. oocysts. This is supported by the outbreak potential of pathogens with low MID. For fecal-orally transmissible bacteria and mucorales, transmission from surfaces is unlikely with a MID of <102 CFU. However, it should be noted that MID studies do not usually consider the fact that the pathogens multiply from an initially acquired small number and the infection only manifests after the critical quantity has been reached.

TABLE 9.

Minimal infectious dose of selected pathogens

Infectious dose Application Pathogen Reference
1–100 virus particles, CFU resp. oocysts Oral Noro-, rotavirus, EHEC, ETEC, C. difficile, MRSA, Cr. parvum, G. intestinalis (67, 311, 331, 370, 408412)
6.6 virus particles Inhalative Adenovirus type 4 (331)
10–100 virus particles Oral HAV (413)
30–40 TCID50 Intranasal RSV (331)
6/71 TCID50 Intranasal/oral Coxsackievirus A21 (331)
0.03/>101–104 TCID50 Intranasal/inhalative Rhinovirus, different serotypes (331)
<103 CFU Oral Acinetobacter spp., C. jejuni, Klebsiella spp., VRE (67, 414)
≥103 spores Chorio-allantois-membrane hen egg (equivalent to eye contact) Lichtheimia corymbifera (415)
≥103 CFU Oral Salmonella enteritidis (416)
≥103 TCID50 Oral Echovirus (331)
>103 TCID50 Inhalative Influenza A virus (H3N2) (331)
>103 LD50 Intranasal Congo Basin MPXV (417)
≥104 CFU Conjunctival P. aeruginosa (418)
≥104 to ≥107 TCID50 Inhalative Influenza B virus (331)
≥104 spores Rhizopus spp., A. fumigatus (419, 420)
105 TCID50 Conjunctival RSV (331)
≥105 CFU Intravenous C. albicans, C. auris (421)
≥105 spores Parenteral Rhizomucor pusillus (419)
>105 CFU Oral E. coli, S. aureus (422)
>105 LD50 Intranasal West African MPXV (417)
>106 TCID50 Oral Adenovirus (331)
>106 to >107 TCID50 Inhalative Influenza A virus (H1N1)
>108 CFU/mL Intraperitoneal P. aeruginosa (423)
>1010 CFU/mL S. aureus

The lower the ID and the greater the RC, the greater the risk of acquiring an infection by direct or indirect contact with the surface or by aerosolization from the surface and following respiratory exposure. Likewise, the risk of an outbreak emanating from surfaces increases. In both cases, the ID is likely to have a greater influence. At the same time, the risk of a fomite-borne HAI is influenced by the patient’s immune status. The ID, RC, and immune status must be considered when deciding upon targeted surface disinfection and additional IPC.

Disinfecting surfaces in hospitals is generally accepted as a key component of infection prevention (3235, 72, 424427). However, disinfection can also have an influence on the development of tolerance; it is costly and leads to an ecological footprint. Clearly, every disinfection event requires a clear indication. Disinfection must be implemented in a precise and quality-assured manner since it offers a valuable contribution toward HAI prevention. Regarding environmental protection, probiotic cleaning agents are a promising alternative to chemical disinfection. Surface contamination with pathogens could be reduced by up to 90% more with probiotic products compared with conventional disinfection wipes (428, 429). SARS-CoV-2 was reduced significantly more by probiotic cleaning than by chemical disinfection (430). In non-intensive care units, routine surface disinfection did not prove superior to soap-based or probiotic cleaning in terms of preventing HAI (61). Of course, no evidence-based practical approach for systematic surface or probiotic cleaning in hospitals can be derived from the RC of nosocomial pathogens.

RC and ID influence the implementation of surface decontamination regarding the extent and the selection of the application concentration and exposure time of the disinfectant. In cases of high RC and low ID, it makes sense to use concentrations that are rapidly effective. For final (or terminal) disinfection after patient discharge, all potential pathogen reservoirs must be eradicated with the choice of effective disinfectants. In general, a simple four-step guide for daily decontamination of the occupied bed space can be recommended: Step 1 (LOOK) describes a visual assessment of the area to be cleaned; Step 2 (PLAN) argues why the bed space needs preparation before cleaning; Step 3 (CLEAN) covers surface cleaning/disinfection; and Step 4 (DRY) is the final stage whereby surfaces are allowed to dry. Visible soil should always be removed with detergent and water before using disinfectant (431). Analogous to the 5 moments of hand antisepsis (432), 5 moments of disinfecting surface cleaning can be distinguished: (i) Disinfecting surface cleaning as part of standard precautions (non-targeted disinfection) on near-patient (high-touch) sites during patient care, and targeted disinfection, (i) disinfecting surface cleaning on the work surface before performing aseptic activities, (iii) final disinfecting of surfaces after discharge of patients, (iv) two-step disinfection surface cleaning after visible surface contamination (first cleaning, thereafter disinfection), and (v) disinfection surface cleaning as part of the multi-barrier strategy to control outbreaks (431).

This review can reduce the complexity of disinfection choices depending on the range of pathogen properties. At the same time, it proposes the best possible balance between patient and employee safety, that is, IPC and ecological and economic sustainability. Through a novel classification of pathogens by their fomite-borne potential for transmission—completely independent of the taxonomic approach—a fact-based but also realizable and pragmatic recommendation can be prepared with a view to avoiding transmission. The attempt to classify pathogens by fomite-borne transmission potential should serve only as a first suggestion and should be improved by scientific discussion. In general, further studies should focus beyond the ecological and outbreak assessment—and target real-life settings or near real-life scenarios to emulate endemic settings. There is insufficient evidence regarding the impact of contaminated surfaces in encouraging contact-free transmission risk. Further analysis should cover aspects of ecological sustainability and should weigh up the potential benefit for transmission and infection events against the additional ecological footprint from resource consumption, production, and waste management.

ACKNOWLEDGMENTS

The authors thank Isabella Dresselhaus (Department of Infection Control and Infectious Diseases, University Medical Center Göttingen (UMG), Georg-August University Göttingen, Germany) for her important contribution to this review.

Biographies

graphic file with name cmr.00186-23.f004.gif

Axel Kramer is a medical specialist in hygiene and environmental medicine. From 1990 to 2021, he was the head of the Institute of Hygiene and Environmental Medicine, University Medicine Greifswald and he is still working as a consultant. Since 1990, he has been a founding member of the German Society of Hospital Hygiene (president until 2010); since 1993, he has been a member of the Commission of Hospital Hygiene and Infection Control at the Robert Koch Institute Berlin. From 1994 to 1998, Professor Kramer was vice-dean of the Medical Faculty, at University Greifswald. Since 2006, he has been an Editor-in-Chief of GMS Hygiene and Infection Control. He coordinated several networks, founded by the Federal Ministry of Education and Research: Center of Innovation Competence Plasma—Tissue Interactions (2007–2014); Health Region Baltic Coast—coalition against multi-resistant pathogens (2010–2016); infection prevention of multi-resistant pathogens by UVC irradiation (2019–2021); inactivation of SARS-CoV-2 by UVC light (2021–2024). His work includes 535 research articles, 41 books, 54 patents, and a poetry book “Questioning.”

graphic file with name cmr.00186-23.f005.gif

Franziska Lexow completed her studies in veterinary medicine (University of Veterinary Medicine Hannover) in 2011 and wrote her doctoral thesis on biocompatibility studies for implant materials in middle ear surgery. Moreover, she successfully completed Graduate School in “Biomedical Engineering” funded by the German Research Foundation (Collaborative Research Centres SFB599) (2011–2015). Since 2020, Dr. Lexow has been a scientific associate at the Robert Koch Institute (RKI), Department for Infectious Diseases, Unit 14 Hospital Hygiene, Infection Prevention and Control, and working at the scientific office of the Commission for Hospital Hygiene and Infection Prevention (KRINKO). Her focus topic is the development of recommendations on IPC strategies. So far, she has written six research articles and one conference abstract.

graphic file with name cmr.00186-23.f006.gif

Anna Bludau completed a master’s of Public Health and has been a researcher at the Department of Infection Control and Infectious Diseases at the University Medical Center Göttingen, Germany since 2020. Since 2023, she has been a doctoral student (Dr. of Public Health) at the University of Bielefeld, Germany. Since 2023, she has been a member of the German Society for Hygiene and Microbiology and since 2024 a member of the German Public Health Association. Since 2022, she coordinated three projects in the network university medicine, funded by the German Federal Ministry of Education and Research (genomic pathogen surveillance and translational research—GenSurv; molecular surveillance and infection chain tracing for local public health authorities—MolTraX; genomic pathogen surveillance and translational research plus—GenSurv+). So far, her work includes 10 research articles and 8 conference abstracts.

graphic file with name cmr.00186-23.f007.gif

Antonia Milena Köster has a Bachelor of Arts in Social Work (University of Applied Sciences and Arts Hannover) and is a licensed quality manager with a master’s degree in organization and leadership (Malmö University). She was in charge of the leadership of an elderly care home from 2016 to 2020. Since 2020, she has been a scientific associate at the Department of Infection Control and Infectious Diseases, University Medical Center Göttingen, and working on small- and large-scale research projects, and for the Commission for Hospital Hygiene and Infection Prevention (KRINKO). Her focus topics are hygiene and sustainability. Her scientific work includes three research articles so far.

graphic file with name cmr.00186-23.f008.gif

Martin Misailovski completed his secondary education as a medical laboratory technician at Skopje's Secondary Medical School and graduated with a medical degree from the University "St. Kiril und Metodij" in 2019. He obtained a master's degree in Cardiovascular Science with a focus on Mass Spectrometry from Georg-August University of Göttingen. Currently, he is pursuing a doctorate (Dr. med.) in Infectious diseases and infection control/prevention and working as a medical doctor at the Department for Infectious Diseases and Infection Control, and the Department of Geriatrics. He is an Associate Fellow at the International Organization for Health Professions Education (AMEE). Moreover, he is a member of the German Society for Hygiene and Microbiology and a member of the European Society of Clinical Microbiology and Infectious Diseases.

graphic file with name cmr.00186-23.f009.gif

Ulrike Seifert is a medical specialist in hygiene and environmental medicine as well as in biochemistry. She has venia legendi in immunology since 2019. Since 2016, she has been a professor and head of virology at the Friedrich Loeffler-Institute of Medical Microbiology, University Medicine Greifswald. Since 2005, she has led a research working group with a focus on the “Ubiquitin-Proteasome-System in infection and disease” and is a principal investigator in several Consortia funded by the German Research Foundation (Collaborative Research Centres SFB421, SFB-TR84, SFB-TR36, SFB854, and Research Training Group 2719-PRO). Since 2022, she has been a member of the section Antiseptic Stewardship of the German Society of Hospital Hygiene. So far, her work includes 47 research articles, 5 review articles, 2 case reports, and 9 book chapters.

graphic file with name cmr.00186-23.f010.gif

Maren Eggers is a specialist in virus hygiene and clinical virology. Since 1997, she has been the head of the virology and disinfectant testing department, Labor Prof. Dr. G. Enders MVZ GbR and Lecturer at the Medical Ruprecht-Karls-University Heidelberg. Professor Eggers is a member of CEN/TC216 WG 1 of the European Committees for Standardization (Chemical disinfectants and antiseptics), and responsible for the virucidal task group since 2018 and chairwoman of the Commission for Virus Disinfection of the German Association for the Control of Virus Diseases (DVV) and the German Society for Virology, on the Board of Association for Applied Hygiene (VAH) and a member of the VAH disinfectant commission since 2011. Moreover, she is a member of the virucidal working group at the Robert Koch Institute (RKI). So far, her scientific work includes 62 research articles, 21 books, 4 European standards, and 2 national guidelines for virucidal testing.

graphic file with name cmr.00186-23.f011.gif

William Rutala is the Director and co-founder of the Statewide Program for Infection Control and Epidemiology and a Professor for the Division of Infectious Diseases at the University of North Carolina's School of Medicine. He was the Director of Hospital Epidemiology, Occupational Health and Safety Program at the University of North Carolina Hospitals for 38 years before retiring in May 2017. He is a retired Colonel with the U.S. Army Reserve and is certified in infection control. He has written more than 700 publications (e.g., peer-reviewed articles, books, book chapters) in the fields of disinfection, sterilization, the healthcare environment, and prevention of healthcare-associated infections. Dr. Rutala has been an invited lecturer at over 400 state, national, and international conferences (>40 states, >40 countries). Dr. Rutala earned his BS from Rutgers University, his MS from UT, and both his MPH and PhD in microbiology from the UNC School of Public Health.

graphic file with name cmr.00186-23.f012.gif

Stephanie J. Dancer is a consultant in microbiology & infection control working as a research microbiologist in NHS Lanarkshire and Edinburgh Napier University, Scotland, UK. Professor Dancer edited the Journal of Hospital Infection for over 20 years, five of them as editor-in-chief. She is a member of NHS Scotland Decontamination; UK NICE (infection control & antimicrobial prescribing); UK HTA (screening & diagnostics); ESCMID groups on infection control (ESGNI), MRSA & multi-resistant Gram-negative bacilli; and ECCMID conference committee. Moreover, she advised DEFRA on surface cleaning and hygiene during the COVID-19 pandemic and collaborated with an international group of virologists, physicists, and engineers on the airborne spread of SARS-CoV-2. She wrote several books, book chapters, and over 200 papers in peer-reviewed journals on hospital cleaning, antimicrobial management, IPC, and pathogen transmission. Currently, she is PI for NHS Scotland ASSURE research scheme while balancing editorial duties alongside research and teaching, specifically, environmental control of hospital pathogens.

graphic file with name cmr.00186-23.f013.gif

Simone Scheithauer is a director and W3 Ordinaria of the Department of Infection Control and Infectious Diseases at the University Medical Center Göttingen. She is a specialist in hygiene and environmental medicine, microbiology, virology, and infectious diseases. Professor Scheithauer is an appointed member of the Scientific Advisory Board of Medical Faculty Bielefeld and a member of the Commission for Hospital Hygiene and Infection Prevention at the Robert Koch Institute (RKI). Moreover, she is a member of the Supervisory Board Helmholtz-Center for Infection Research Braunschweig; of the Scientific Advisory Board Public Health Microbiology at the RKI. Since 2022, she has been a Vice-President of the German Society of Hygiene and Microbiology. Professor Scheithauer is a part of the Health and Resilience Expert Panel at the Federal Chancellery. During the last 10 years, she was scientifically involved in 25 (13 in the lead) qualified funded projects. Main research areas: Interventions studies in IPC, Surveillance and resilience, bridging knowledge across disciplines and sectors in the healthcare system and ecological sustainability.

Contributor Information

Axel Kramer, Email: kramer@uni-greifswald.de.

Graeme N. Forrest, Rush University Medical Center, Chicago, Illinois, USA

Pierre Parneix, C.C.L.I.N Sud-Ouest - CHU Pellegrin, Bordeaux, France.

Silvio Brusaferro, Istituto Superiore di Sanità, Rome, Italy.

SUPPLEMENTAL MATERIAL

The following material is available online at https://doi.org/10.1128/cmr.00186-23.

Supplemental Tables A to E. cmr.00186-23-s0001.docx.

Additional data and details of recultivation and expanded environmental conditions.

cmr.00186-23-s0001.docx (323.4KB, docx)
DOI: 10.1128/cmr.00186-23.SuF1

ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.

REFERENCES

  • 1. Gastmeier P. 2020. From 'one size fits all' to personalized infection prevention. J Hosp Infect 104:256–260. doi: 10.1016/j.jhin.2019.12.010 [DOI] [PubMed] [Google Scholar]
  • 2. Carter Y, Barry D. 2011. Tackling C difficile with environmental cleaning. Nurs Times 107:22–25. [PubMed] [Google Scholar]
  • 3. Cassone M, Zhu Z, Mantey J, Gibson KE, Perri MB, Zervos MJ, Snitkin ES, Foxman B, Mody L. 2020. Interplay between patient colonization and environmental contamination with vancomycin-resistant enterococci and their association with patient health outcomes in postacute care. Open Forum Infect Dis 7:fz519. doi: 10.1093/ofid/ofz519 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Chmielarczyk A, Higgins PG, Wojkowska-Mach J, Synowiec E, Zander E, Romaniszyn D, Gosiewski T, Seifert H, Heczko P, Bulanda M. 2012. Control of an outbreak of Acinetobacter baumannii infections using vaporized hydrogen peroxide. J Hosp Infect 81:239–245. doi: 10.1016/j.jhin.2012.05.010 [DOI] [PubMed] [Google Scholar]
  • 5. Cohen B, Cohen CC, Løyland B, Larson EL. 2017. Transmission of health care-associated infections from roommates and prior room occupants: a systematic review. Clin Epidemiol 9:297–310. doi: 10.2147/CLEP.S124382 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Cohen B, Liu J, Cohen AR, Larson E. 2018. Association between healthcare-associated infection and exposure to hospital roommates and previous bed occupants with the same organism. Infect Control Hosp Epidemiol 39:541–546. doi: 10.1017/ice.2018.22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Datta R, Platt R, Yokoe DS, Huang SS. 2011. Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. Arch Intern Med 171:491–494. doi: 10.1001/archinternmed.2011.64 [DOI] [PubMed] [Google Scholar]
  • 8. Doidge M, Allworth AM, Woods M, Marshall P, Terry M, O’Brien K, Goh HM, George N, Nimmo GR, Schembri MA, Lipman J, Paterson DL. 2010. Control of an outbreak of carbapenem-resistant Acinetobacter baumannii in Australia after introduction of environmental cleaning with a commercial oxidizing disinfectant. Infect Control Hosp Epidemiol 31:418–420. doi: 10.1086/651312 [DOI] [PubMed] [Google Scholar]
  • 9. Drees M, Snydman DR, Schmid CH, Barefoot L, Hansjosten K, Vue PM, Cronin M, Nasraway SA, Golan Y. 2008. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis 46:678–685. doi: 10.1086/527394 [DOI] [PubMed] [Google Scholar]
  • 10. Garvey MI, Wilkinson MAC, Bradley CW, Holden KL, Holden E. 2018. Wiping out MRSA: effect of introducing a universal disinfection wipe in a large UK teaching hospital. Antimicrob Resist Infect Control 7:155. doi: 10.1186/s13756-018-0445-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Hacek DM, Ogle AM, Fisher A, Robicsek A, Peterson LR. 2010. Significant impact of terminal room cleaning with bleach on reducing nosocomial Clostridium difficile. Am J Infect Control 38:350–353. doi: 10.1016/j.ajic.2009.11.003 [DOI] [PubMed] [Google Scholar]
  • 12. Hall AJ, Vinjé J, Lopman B, Park GW, Yen C, Gregoricus N, Parashar U. 2011. Updated norovirus outbreak management and disease prevention guidelines. MMWR Recomm Rep 60:1–18. [PubMed] [Google Scholar]
  • 13. Hayden MK, Blom DW, Lyle EA, Moore CG, Weinstein RA. 2008. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant Enterococcus or the colonized patients' environment. Infect Control Hosp Epidemiol 29:149–154. doi: 10.1086/524331 [DOI] [PubMed] [Google Scholar]
  • 14. Hobson RP, MacKenzie FM, Gould IM. 1996. An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland. J Hosp Infect 33:249–262. doi: 10.1016/s0195-6701(96)90011-0 [DOI] [PubMed] [Google Scholar]
  • 15. Huang SS, Datta R, Platt R. 2006. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 166:1945–1951. doi: 10.1001/archinte.166.18.1945 [DOI] [PubMed] [Google Scholar]
  • 16. Kaatz GW, Gitlin SD, Schaberg DR, Wilson KH, Kauffman CA, Seo SM, Fekety R. 1988. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 127:1289–1294. doi: 10.1093/oxfordjournals.aje.a114921 [DOI] [PubMed] [Google Scholar]
  • 17. Knox J, Sullivan SB, Urena J, Miller M, Vavagiakis P, Shi QH, Uhlemann AC, Lowy FD. 2016. Association of environmental contamination in the home with the risk for recurrent community-associated, methicillin-resistant Staphylococcus aureus infection. JAMA Intern Med 176:807–815. doi: 10.1001/jamainternmed.2016.1500 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Kreidl P, Mayr A, Hinterberger G, Berktold M, Knabl L, Fuchs S, Posch W, Eschertzhuber S, Obwegeser A, Lass-Flörl C, Orth-Höller D. 2018. Outbreak report: a nosocomial outbreak of vancomycin resistant enterococci in a solid organ transplant unit. Antimicrob Resist Infect Control 7:86. doi: 10.1186/s13756-018-0374-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Martínez JA, Ruthazer R, Hansjosten K, Barefoot L, Snydman DR. 2003. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 163:1905–1912. doi: 10.1001/archinte.163.16.1905 [DOI] [PubMed] [Google Scholar]
  • 20. Mayfield JL, Leet T, Miller J, Mundy LM. 2000. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 31:995–1000. doi: 10.1086/318149 [DOI] [PubMed] [Google Scholar]
  • 21. Mitchell BG, Dancer SJ, Anderson M, Dehn E. 2015. Risk of organism acquisition from prior room occupants: a systematic review and meta-analysis. J Hosp Infect 91:211–217. doi: 10.1016/j.jhin.2015.08.005 [DOI] [PubMed] [Google Scholar]
  • 22. Neely AN, Maley MP, Warden GD. 1999. Computer keyboards as reservoirs for Acinetobacter baumannii in a burn hospital. Clin Infect Dis 29:1358–1360. doi: 10.1086/313463 [DOI] [PubMed] [Google Scholar]
  • 23. Nseir S, Blazejewski C, Lubret R, Wallet F, Courcol R, Durocher A. 2011. Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit. Clin Microbiol Infect 17:1201–1208. doi: 10.1111/j.1469-0691.2010.03420.x [DOI] [PubMed] [Google Scholar]
  • 24. Orenstein R, Aronhalt KC, McManus JE, Fedraw LA. 2011. A targeted strategy to wipe out Clostridium difficile. Infect Control Hosp Epidemiol 32:1137–1139. doi: 10.1086/662586 [DOI] [PubMed] [Google Scholar]
  • 25. Ross B, Hansen D, Popp W. 2013. Cleaning and disinfection in outbreak control – experiences with different pathogens. Healthcare infection 18:37–41. doi: 10.1071/HI12041 [DOI] [Google Scholar]
  • 26. Rutala WA, Kanamori H, Gergen MF, Knelson LP, Sickbert-Bennett EE, Chen LF, Anderson DJ, Sexton DJ, Weber DJ, and the CDC Prevention Epicenters Program . 2018. Enhanced disinfection leads to reduction of microbial contamination and a decrease in patient colonization and infection. Infect Control Hosp Epidemiol 39:1118–1121. doi: 10.1017/ice.2018.165 [DOI] [PubMed] [Google Scholar]
  • 27. Suleyman G, Alangaden G, Bardossy AC. 2018. The role of environmental contamination in the transmission of nosocomial pathogens and healthcare-associated infections. Curr Infect Dis Rep 20:12. doi: 10.1007/s11908-018-0620-2 [DOI] [PubMed] [Google Scholar]
  • 28. Tankovic J, Legrand P, De Gatines G, Chemineau V, Brun-Buisson C, Duval J. 1994. Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods. J Clin Microbiol 32:2677–2681. doi: 10.1128/jcm.32.11.2677-2681.1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. White LF, Dancer SJ, Robertson C, McDonald J. 2008. Are hygiene standards useful in assessing infection risk? Am J Infect Control 36:381–384. doi: 10.1016/j.ajic.2007.10.015 [DOI] [PubMed] [Google Scholar]
  • 30. Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freeman J. 2003. Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect 54:109–114. doi: 10.1016/s0195-6701(02)00400-0 [DOI] [PubMed] [Google Scholar]
  • 31. Wu Y-L, Yang X-Y, Ding X-X, Li R-J, Pan M-S, Zhao X, Hu X-Q, Zhang J-J, Yang L-Q. 2019. Exposure to infected/colonized roommates and prior room occupants increases the risks of healthcare-associated infections with the same organism. J Hosp Infect 101:231–239. doi: 10.1016/j.jhin.2018.10.014 [DOI] [PubMed] [Google Scholar]
  • 32.Alberta Health Services (AHS) 2019. Suggested surface cleaning/disinfection guidelines for GI/ILI/VLI outbreaks in child care facilities
  • 33. Rutala WA, Weber DJ, Centers for Disease Control and Prevention (CDC), Healthcare Infection Control Practices Advisory Committee (HICPAC) . 2008. Guideline for disinfection and sterilization in healthcare facilities, 2008. CDC, Atlanta, GA. [Google Scholar]
  • 34. Ontario Agency for Health Protection and Promotion (Public Health Ontario), Provincial Infectious Diseases Advisory Committee (PIDAC) . 2018. Response to Schmidt et al.: antimicrobial surfaces - huge potential, significant uncertainty. 3rd ed. Queen’s Printer for Ontario. [Google Scholar]
  • 35. Sehulster LM, Chinn RYW, Arduino MJ, Carpenter J, Donlan R, Ashford D, Besser R, Fields B, McNeil MM, Whitney C, Wong S, Juranek D, Cleveland J. 2004. Guidelines for environmental infection control in health-care facilities. In Recommendations from CDC and the healthcare Infection control practices advisory committee (HICPAC). American Society for Healthcare Engineering/American Hospital Association, Chicago IL. [Google Scholar]
  • 36. Kampf G, Dietze B, Grosse-Siestrup C, Wendt C, Martiny H. 1998. Microbicidal activity of a new silver-containing polymer, SPI-ARGENT II. Antimicrob Agents Chemother 42:2440–2442. doi: 10.1128/AAC.42.9.2440 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Goldman E. 2020. Exaggerated risk of transmission of COVID-19 by fomites. Lancet Infect Dis 20:892–893. doi: 10.1016/S1473-3099(20)30561-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Stein C, Vincze S, Kipp F, Makarewicz O, Al Dahouk S, Pletz MW. 2019. Carbapenem-resistant Klebsiella pneumoniae with low chlorhexidine susceptibility. Lancet Infect Dis 19:932–933. doi: 10.1016/S1473-3099(19)30427-X [DOI] [PubMed] [Google Scholar]
  • 39. Wand ME, Bock LJ, Bonney LC, Sutton JM. 2017. Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine. Antimicrob Agents Chemother 61:e01162-16. doi: 10.1128/AAC.01162-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Bhardwaj P, Hans A, Ruikar K, Guan Z, Palmer KL. 2018. Reduced chlorhexidine and daptomycin susceptibility in vancomycin-resistant Enterococcus faecium after serial chlorhexidine exposure. Antimicrob Agents Chemother 62:e01235-17. doi: 10.1128/AAC.01235-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Dumas O, Varraso R, Boggs KM, Quinot C, Zock JP, Henneberger PK, Speizer FE, Le Moual N, Camargo CA. 2019. Association of occupational exposure to disinfectants with incidence of chronic obstructive pulmonary disease among US female nurses. JAMA Netw Open 2:e1913563. doi: 10.1001/jamanetworkopen.2019.13563 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Hashemi F, Hoepner L, Hamidinejad FS, Haluza D, Afrashteh S, Abbasi A, Omeragić E, Imamović B, Rasheed NA, Taher TMJ, et al. 2023. A comprehensive health effects assessment of the use of sanitizers and disinfectants during COVID-19 pandemic: a global survey. Environ Sci Pollut Res Int 30:72368–72388. doi: 10.1007/s11356-023-27197-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Hrubec TC, Seguin RP, Xu L, Cortopassi GA, Datta S, Hanlon AL, Lozano AJ, McDonald VA, Healy CA, Anderson TC, Musse NA, Williams RT. 2021. Altered toxicological endpoints in humans from common quaternary ammonium compound disinfectant exposure. Toxicol Rep 8:646–656. doi: 10.1016/j.toxrep.2021.03.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Romero Starke K, Friedrich S, Schubert M, Kämpf D, Girbig M, Pretzsch A, Nienhaus A, Seidler A. 2021. Are healthcare workers at an increased risk for obstructive respiratory diseases due to cleaning and disinfection agents? A systematic review and meta-analysis. Int J Environ Res Public Health 18:5159. doi: 10.3390/ijerph18105159 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Dancer SJ. 2023. Hospital cleaning: past, present, and future. Antimicrob Resist Infect Control 12:80. doi: 10.1186/s13756-023-01275-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Von Sprockhoff H. 1979. Überlebensfähigkeit bestimmter krankheitserreger unter umwelteinflüssen. Deutsche Tierärztliche Wochenschrift 86:33–36. [PubMed] [Google Scholar]
  • 47. Egen S. 2000. Untersuchungen zur tenazität von Campylobacter jejuni. einfluss von trägermaterial, relativer luftfeuchte und temperatur auf zwei ausgewählte stämme Dissertation, University of Veterinary Medicine Hannover, Hannover [Google Scholar]
  • 48. Cambridge dictionary. 2023. Available from: https://dictionary.cambridge.org
  • 49. Merriam-webster dictionary. 2023. Available from: https://www.merriam-webster.com/dictionary/tenacity
  • 50. Roszak DB, Colwell RR. 1987. Survival strategies of bacteria in the natural environment. Microbiol Rev 51:365–379. doi: 10.1128/mr.51.3.365-379.1987 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Stewart PS. 2015. Antimicrobial tolerance in biofilms. Microbiol Spectr 3. doi: 10.1128/microbiolspec.MB-0010-2014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Wingender J, Flemming HC. 2011. Biofilms in drinking water and their role as reservoir for pathogens. Int J Hyg Environ Health 214:417–423. doi: 10.1016/j.ijheh.2011.05.009 [DOI] [PubMed] [Google Scholar]
  • 53. Yan J, Bassler BL. 2019. Surviving as a community: antibiotic tolerance and persistence in bacterial biofilms. Cell Host Microbe 26:15–21. doi: 10.1016/j.chom.2019.06.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Li L, Mendis N, Trigui H, Oliver JD, Faucher SP. 2014. The importance of the viable but non-culturable state in human bacterial pathogens. Front Microbiol 5:258. doi: 10.3389/fmicb.2014.00258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Wideman NE, Oliver JD, Crandall PG, Jarvis NA. 2021. Detection and potential virulence of viable but non-culturable (VBNC) Listeria monocytogenes: a review. Microorganisms 9:194. doi: 10.3390/microorganisms9010194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Lambrecht E, Baré J, Chavatte N, Bert W, Sabbe K, Houf K. 2015. Protozoan cysts act as a survival niche and protective shelter for foodborne pathogenic bacteria. Appl Environ Microbiol 81:5604–5612. doi: 10.1128/AEM.01031-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Pennycook BR, Vesela E, Peripolli S, Singh T, Barr AR, Bertoli C, de Bruin RAM. 2020. E2F-dependent transcription determines replication capacity and S phase length. Nat Commun 11:3503. doi: 10.1038/s41467-020-17146-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Barbour JD, Wrin T, Grant RM, Martin JN, Segal MR, Petropoulos CJ, Deeks SG. 2002. Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults. J Virol 76:11104–11112. doi: 10.1128/jvi.76.21.11104-11112.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Hu X, Waigi MG, Yang B, Gao Y. 2022. Impact of plastic particles on the horizontal transfer of antibiotic resistance genes to bacterium: dependent on particle sizes and antibiotic resistance gene vector replication capacities. Environ Sci Technol 56:14948–14959. doi: 10.1021/acs.est.2c00745 [DOI] [PubMed] [Google Scholar]
  • 60. Selhorst P, Combrinck C, Ndabambi N, Ismail SD, Abrahams MR, Lacerda M, Samsunder N, Garrett N, Abdool Karim Q, Abdool Karim SS, Williamson C. 2017. Replication capacity of viruses from acute infection drives HIV-1 disease progression. J Virol 91:e01806-16. doi: 10.1128/JVI.01806-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Leistner R, Kohlmorgen B, Brodzinski A, Schwab F, Lemke E, Zakonsky G, Gastmeier P. 2023. Environmental cleaning to prevent hospital-acquired infections on non-intensive care units: a pragmatic, single-centre, cluster randomized controlled, crossover trial comparing soap-based, disinfection and probiotic cleaning. EClinicalMedicine 59:101958. doi: 10.1016/j.eclinm.2023.101958 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Walther BA, Ewald PW. 2004. Pathogen survival in the external environment and the evolution of virulence. Biol Rev Camb Philos Soc 79:849–869. doi: 10.1017/s1464793104006475 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Dennis PJ, Lee JV. 1988. Differences in aerosol survival between pathogenic and non-pathogenic strains of Legionella pneumophila serogroup 1. J Appl Bacteriol 65:135–141. doi: 10.1111/j.1365-2672.1988.tb01501.x [DOI] [PubMed] [Google Scholar]
  • 64. Mitchell BG, McDonagh J, Dancer SJ, Ford S, Sim J, Thottiyil Sultanmuhammed Abdul Khadar B, Russo PL, Maillard JY, Rawson H, Browne K, Kiernan M. 2023. Risk of organism acquisition from prior room occupants: an updated systematic review. Infect Dis Health 28:290–297. doi: 10.1016/j.idh.2023.06.001 [DOI] [PubMed] [Google Scholar]
  • 65. Otter JA, Yezli S, Salkeld JAG, French GL. 2013. Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am J Infect Control 41:S6–S11. doi: 10.1016/j.ajic.2012.12.004 [DOI] [PubMed] [Google Scholar]
  • 66. Kramer A, Schwebke I, Kampf G. 2006. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 6:130. doi: 10.1186/1471-2334-6-130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Dancer SJ. 2014. Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination. Clin Microbiol Rev 27:665–690. doi: 10.1128/CMR.00020-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Wißmann JE, Kirchhoff L, Brüggemann Y, Todt D, Steinmann J, Steinmann E. 2021. Persistence of pathogens on inanimate surfaces: a narrative review. Microorganisms 9:343. doi: 10.3390/microorganisms9020343 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Nordhausen T, Hirt J. 2019. RefHunter. Manual zur literaturrecherche in fachdatenbanken. Version 3.0. Martin‐Luther‐Universität Halle‐Wittenberg & FHS St.Gallen, Hrsg., Halle (Saale). [Google Scholar]
  • 70. Lettau LA. 1991. Nosocomial transmission and infection control aspects of parasitic and ectoparasitic diseases. Part III. Ectoparasites/summary and conclusions. Infect Control Hosp Epidemiol 12:179–185. doi: 10.1086/646313 [DOI] [PubMed] [Google Scholar]
  • 71. Kommission für Krankenhaushygiene und Infektionsprävention (KRINKO . 2022. Informativer anhang zur empfehlung „anforderungen an die hygiene bei der reinigung und desinfektion von flächen“ der kommission für krankenhaushygiene und infektionsprävention (KRINKO) beim Robert Koch-Institut. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 65:1074–1115. doi: 10.1007/s00103-022-03576-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Hygiene requirements for cleaning and disinfection of surfaces: recommendation of the Commission for Hospital Hygiene and Infection Prevention (KRINKO) at the Robert Koch Institute. 2024. GMS Hyg Infect Control 19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Jawad A, Heritage J, Snelling AM, Gascoyne-Binzi DM, Hawkey PM. 1996. Influence of relative humidity and suspending menstrua on survival of Acinetobacter spp. on dry surfaces. J Clin Microbiol 34:2881–2887. doi: 10.1128/jcm.34.12.2881-2887.1996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Wood JP, Meyer KM, Kelly TJ, Choi YW, Rogers JV, Riggs KB, Willenberg ZJ. 2015. Environmental persistence of Bacillus anthracis and Bacillus subtilis spores. PLoS One 10:e0138083. doi: 10.1371/journal.pone.0138083 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75. Zeidler S, Müller V. 2019. The role of compatible solutes in desiccation resistance of Acinetobacter baumannii. Microbiologyopen 8:e00740. doi: 10.1002/mbo3.740 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Shimoda T, Okubo T, Enoeda Y, Yano R, Nakamura S, Thapa J, Yamaguchi H. 2019. Effect of thermal control of dry fomites on regulating the survival of human pathogenic bacteria responsible for nosocomial infections. PLoS One 14:e0226952. doi: 10.1371/journal.pone.0226952 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Kim KH, Fekety R, Batts DH, Brown D, Cudmore M, Silva J, Waters D. 1981. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 143:42–50. doi: 10.1093/infdis/143.1.42 [DOI] [PubMed] [Google Scholar]
  • 78. Otter JA, French GL. 2009. Survival of nosocomial bacteria and spores on surfaces and inactivation by hydrogen peroxide vapor. J Clin Microbiol 47:205–207. doi: 10.1128/JCM.02004-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Jump RLP, Pultz MJ, Donskey CJ. 2007. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob Agents Chemother 51:2883–2887. doi: 10.1128/AAC.01443-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Ross PW, Lough H. 1978. Survival of upper respiratory tract bacteria on cotton-wool swabs. J Clin Pathol 31:430–433. doi: 10.1136/jcp.31.5.430 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Crosbie WE, Wright HD. 1941. Diphtheria bacilli in floor dust. The Lancet 237:656–659. doi: 10.1016/S0140-6736(00)61019-X [DOI] [Google Scholar]
  • 82. Augustine JL, Renshaw HW. 1986. Survival of Corynebacterium pseudotuberculosis in axenic purulent exudate on common barnyard fomites. Am J Vet Res 47:713–715. [PubMed] [Google Scholar]
  • 83. Alibi S, Ramos-Vivas J, Ben Selma W, Ben Mansour H, Boukadida J, Navas J. 2021. Virulence of clinically relevant multidrug resistant Corynebacterium striatum strains and their ability to adhere to human epithelial cells and inert surfaces. Microb Pathog 155:104887. doi: 10.1016/j.micpath.2021.104887 [DOI] [PubMed] [Google Scholar]
  • 84. Koca O, Altoparlak U, Ayyildiz A, Kaynar H. 2012. Persistence of nosocomial pathogens on various fabrics. Eurasian J Med 44:28–31. doi: 10.5152/eajm.2012.06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85. Katzenberger RH, Rösel A, Vonberg R-P. 2021. Bacterial survival on inanimate surfaces: a field study. BMC Res Notes 14:97. doi: 10.1186/s13104-021-05492-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Wendt C, Wiesenthal B, Dietz E, Rüden H. 1998. Survival of vancomycin-resistant and vancomycin-susceptible enterococci on dry surfaces. J Clin Microbiol 36:3734–3736. doi: 10.1128/JCM.36.12.3734-3736.1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87. Wendt C, Dietze B, Dietz E, Rüden H. 1997. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 35:1394–1397. doi: 10.1128/jcm.35.6.1394-1397.1997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Neely AN, Maley MP. 2000. Survival of enterococci and staphylococci on hospital fabrics and plastic. J Clin Microbiol 38:724–726. doi: 10.1128/JCM.38.2.724-726.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Hanczvikkel A, Tóth Á. 2018. Quantitative study about the role of environmental conditions in the survival capability of multidrug-resistant bacteria. J Infect Public Health 11:801–806. doi: 10.1016/j.jiph.2018.05.001 [DOI] [PubMed] [Google Scholar]
  • 90. Fijan S, Pahor D, Šostar Turk S. 2017. Survival of Enterococcus faecium, Staphylococcus aureus and Pseudomonas aeruginosa on cotton. Text Res J 87:1711–1721. [Google Scholar]
  • 91. Esteves DC, Pereira VC, Souza JM, Keller R, Simões RD, Winkelstroter Eller LK, Rodrigues MVP. 2016. Influence of biological fluids in bacterial viability on different hospital surfaces and fomites. Am J Infect Control 44:311–314. doi: 10.1016/j.ajic.2015.09.033 [DOI] [PubMed] [Google Scholar]
  • 92. Hirai Y. 1991. Survival of bacteria under dry conditions; from a viewpoint of nosocomial infection. J Hosp Infect 19:191–200. doi: 10.1016/0195-6701(91)90223-u [DOI] [PubMed] [Google Scholar]
  • 93. Lankford MG, Collins S, Youngberg L, Rooney DM, Warren JR, Noskin GA. 2006. Assessment of materials commonly utilized in health care: implications for bacterial survival and transmission. Am J Infect Control 34:258–263. doi: 10.1016/j.ajic.2005.10.008 [DOI] [PubMed] [Google Scholar]
  • 94. Rose LJ, Houston H, Martinez-Smith M, Lyons AK, Whitworth C, Reddy SC, Noble-Wang J. 2022. Factors influencing environmental sampling recovery of healthcare pathogens from non-porous surfaces with cellulose sponges. PLoS One 17:e0261588. doi: 10.1371/journal.pone.0261588 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95. Bale MJ, Bennett PM, Hinton M, Beringer JE. 1990. The survival of genetically engineered microorganisms and bacteria on inanimate surfaces and in animals. In Bacterial Genetics in Natural Environments [Google Scholar]
  • 96. Smith CR. 1942. Survival of Tubercle Bacilli. Am Rev Tuberc 45:334–345. [Google Scholar]
  • 97. Zarpellon MN, Gales AC, Sasaki AL, Selhorst GJ, Menegucci TC, Cardoso CL, Garcia LB, Tognim MCB. 2015. Survival of vancomycin-intermediate Staphylococcus aureus on hospital surfaces. J Hosp Infect 90:347–350. doi: 10.1016/j.jhin.2015.04.005 [DOI] [PubMed] [Google Scholar]
  • 98. Webster C, Towner KJ, Humphreys H. 2000. Survival of Acinetobacter on three clinically related inanimate surfaces. Infect Control Hosp Epidemiol 21:246. doi: 10.1086/503214 [DOI] [PubMed] [Google Scholar]
  • 99. Dickgiesser N. 1978. Untersuchungen über das Verhalten grampositiver und gramnegativer Bakterien in trockenem und feuchtem Milieu. Zentralblatt für Bakteriologie und Hygiene, I Abt Orig B 167:48–62. [PubMed] [Google Scholar]
  • 100. Gundermann K. 1972. Untersuchungen zur Lebensdauer von Bakterienstämmen im Staub unter dem Einfluß unterschiedlicher Luftfeuchtigkeit. Zentralblatt für Bakteriologie und Hygiene, I Abt Orig B 156:422–429. [PubMed] [Google Scholar]
  • 101. Wagenvoort JH, Penders RJ. 1997. Long-term in-vitro survival of an epidemic MRSA phage-group III-29 strain. J Hosp Infect 35:322–325. doi: 10.1016/s0195-6701(97)90229-2 [DOI] [PubMed] [Google Scholar]
  • 102. Huang R, Mehta S, Weed D, Price CS. 2006. Methicillin-resistant Staphylococcus aureus survival on hospital fomites. Infect Control Hosp Epidemiol 27:1267–1269. doi: 10.1086/507965 [DOI] [PubMed] [Google Scholar]
  • 103. Carraro V, Sanna A, Pinna A, Carrucciu G, Succa S, Marras L, Bertolino G, Coroneo V. 2021. Evaluation of microbial growth in hospital textiles through challenge test, p 19–34. In Donelli G (ed), Advances in microbiology, infectious diseases and public health. Vol. 15. Springer International Publishing, Cham. [DOI] [PubMed] [Google Scholar]
  • 104. Riley K, Williams J, Owen L, Shen J, Davies A, Laird K. 2017. The effect of low-temperature laundering and detergents on the survival of Escherichia coli and Staphylococcus aureus on textiles used in healthcare uniforms. J Appl Microbiol 123:280–286. doi: 10.1111/jam.13485 [DOI] [PubMed] [Google Scholar]
  • 105. Jenkins RO, Sherburn RE. 2005. Growth and survival of bacteria implicated in sudden infant death syndrome on cot mattress materials. J Appl Microbiol 99:573–579. doi: 10.1111/j.1365-2672.2005.02620.x [DOI] [PubMed] [Google Scholar]
  • 106. Chaibenjawong P, Foster SJ. 2011. Desiccation tolerance in Staphylococcus aureus. Arch Microbiol 193:125–135. doi: 10.1007/s00203-010-0653-x [DOI] [PubMed] [Google Scholar]
  • 107. Noyce JO, Michels H, Keevil CW. 2006. Potential use of copper surfaces to reduce survival of epidemic meticillin-resistant Staphylococcus aureus in the healthcare environment. J Hosp Infect 63:289–297. doi: 10.1016/j.jhin.2005.12.008 [DOI] [PubMed] [Google Scholar]
  • 108. Oie S, Kamiya A. 1996. Survival of methicillin-resistant Staphylococcus aureus (MRSA) on naturally contaminated dry mops. J Hosp Infect 34:145–149. doi: 10.1016/s0195-6701(96)90140-1 [DOI] [PubMed] [Google Scholar]
  • 109. Wagenvoort JH, Sluijsmans W, Penders RJ. 2000. Better environmental survival of outbreak vs. sporadic MRSA isolates. J Hosp Infect 45:231–234. doi: 10.1053/jhin.2000.0757 [DOI] [PubMed] [Google Scholar]
  • 110. Giannouli M, Antunes LCS, Marchetti V, Triassi M, Visca P, Zarrilli R. 2013. Virulence-related traits of epidemic Acinetobacter baumannii strains belonging to the international clonal lineages I-III and to the emerging genotypes ST25 and ST78. BMC Infect Dis 13:282. doi: 10.1186/1471-2334-13-282 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111. Desai R, Pannaraj PS, Agopian J, Sugar CA, Liu GY, Miller LG. 2011. Survival and transmission of community-associated methicillin-resistant Staphylococcus aureus from fomites. Am J Infect Control 39:219–225. doi: 10.1016/j.ajic.2010.07.005 [DOI] [PubMed] [Google Scholar]
  • 112. Domon H, Uehara Y, Oda M, Seo H, Kubota N, Terao Y. 2016. Poor survival of Methicillin-resistant Staphylococcus aureus on inanimate objects in the public spaces. Microbiologyopen 5:39–46. doi: 10.1002/mbo3.308 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 113. Ingham SC, Wadhera RK, Chu CH, DeVita MD. 2006. Survival of Streptococcus pyogenes on foods and food contact surfaces. J Food Prot 69:1159–1163. doi: 10.4315/0362-028x-69.5.1159 [DOI] [PubMed] [Google Scholar]
  • 114. Marks LR, Reddinger RM, Hakansson AP. 2014. Biofilm formation enhances fomite survival of Streptococcus pneumoniae and Streptococcus pyogenes. Infect Immun 82:1141–1146. doi: 10.1128/IAI.01310-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115. Tagg JR, Ragland NL. 1991. Applications of BLIS typing to studies of the survival on surfaces of salivary streptococci and staphylococci. J Appl Bacteriol 71:339–342. doi: 10.1111/j.1365-2672.1991.tb03797.x [DOI] [PubMed] [Google Scholar]
  • 116. Espinal P, Martí S, Vila J. 2012. Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J Hosp Infect 80:56–60. doi: 10.1016/j.jhin.2011.08.013 [DOI] [PubMed] [Google Scholar]
  • 117. Jawad A, Snelling AM, Heritage J, Hawkey PM. 1998. Exceptional desiccation tolerance of Acinetobacter radioresistens. J Hosp Infect 39:235–240. doi: 10.1016/s0195-6701(98)90263-8 [DOI] [PubMed] [Google Scholar]
  • 118. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. 1998. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 36:1938–1941. doi: 10.1128/JCM.36.7.1938-1941.1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119. Antunes LCS, Imperi F, Carattoli A, Visca P. 2011. Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS One 6:e22674. doi: 10.1371/journal.pone.0022674 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120. Farrow JM, Wells G, Pesci EC. 2018. Desiccation tolerance in Acinetobacter baumannii is mediated by the two-component response regulator BfmR. PLoS ONE 13:e0205638. doi: 10.1371/journal.pone.0205638 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121. Chapartegui-González I, Lázaro-Díez M, Bravo Z, Navas J, Icardo JM, Ramos-Vivas J. 2018. Acinetobacter baumannii maintains its virulence after long-time starvation. PLoS One 13:e0201961. doi: 10.1371/journal.pone.0201961 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122. Musa EK, Desai N, Casewell MW. 1990. The survival of Acinetobacter calcoaceticus inoculated on fingertips and on formica. J Hosp Infect 15:219–227. doi: 10.1016/0195-6701(90)90029-n [DOI] [PubMed] [Google Scholar]
  • 123. Ocklitz HW, Milleck H. 1967. Die Überlebenszeit von Pertussisbakterien ausserhalb des Kranken. Zentralblatt für Bakteriologie, Parasitenkunde, Infektionskrankheiten und Hygiene Abt 1 Orig 203:79–91. [PubMed] [Google Scholar]
  • 124. Oosterom J, DE Wilde GJA, DE Boer E, DE Blaauw LH, Karman H. 1983. Survival of Campylobacter jejuni during poultry processing and pig slaughtering. J Food Prot 46:702–706. doi: 10.4315/0362-028X-46.8.702 [DOI] [PubMed] [Google Scholar]
  • 125. Boucher SN, Chamberlain AH, Adams MR. 1998. Enhanced survival of Campylobacter jejuni in association with wood. J Food Prot 61:26–30. doi: 10.4315/0362-028x-61.1.26 [DOI] [PubMed] [Google Scholar]
  • 126. De Cesare A, Sheldon BW, Smith KS, Jaykus L-A. 2003. Survival and persistence of Campylobacter and Salmonella species under various organic loads on food contact surfaces. J Food Prot 66:1587–1594. doi: 10.4315/0362-028x-66.9.1587 [DOI] [PubMed] [Google Scholar]
  • 127. Siroli L, Patrignani F, Serrazanetti DI, Chiavari C, Benevelli M, Grazia L, Lanciotti R. 2017. Survival of spoilage and pathogenic microorganisms on cardboard and plastic packaging materials. Front Microbiol 8:2606. doi: 10.3389/fmicb.2017.02606 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128. Hokunan H, Koyama K, Hasegawa M, Kawamura S, Koseki S. 2016. Survival kinetics of Salmonella enterica and enterohemorrhagic Escherichia coli on a plastic surface at low relative humidity and on low-water activity foods. J Food Prot 79:1680–1692. doi: 10.4315/0362-028X.JFP-16-081 [DOI] [PubMed] [Google Scholar]
  • 129. Williams AP, Avery LM, Killham K, Jones DL. 2005. Persistence of Escherichia coli O157 on farm surfaces under different environmental conditions. J Appl Microbiol 98:1075–1083. doi: 10.1111/j.1365-2672.2004.02530.x [DOI] [PubMed] [Google Scholar]
  • 130. Ak NO, Cliver DO, Kaspar CW. 1994. Decontamination of plastic and wooden cutting boards for kitchen use. J Food Prot 57:23–30. doi: 10.4315/0362-028X-57.1.23 [DOI] [PubMed] [Google Scholar]
  • 131. Abrishami SH, Tall BD, Bruursema TJ, Epstein PS, Shah DB. 1994. Bacterial adherence and viability on cutting board surfaces. J Food Saf 14:153–172. doi: 10.1111/j.1745-4565.1994.tb00591.x [DOI] [Google Scholar]
  • 132. Wells WF, Stone WR. 1934. On air-borne infection: study iii. Viability of droplet nuclei infection. Am J Epidemiol 20:619–627. doi: 10.1093/oxfordjournals.aje.a118098 [DOI] [Google Scholar]
  • 133. Böhmler G, Gerwert J, Scupin E, Sinell HJ. 1996. Zur Epidemiologie der Helicobacteriose des Menschen; Untersuchungen zur Überlebensfähigkeit des Erregers in Lebensmitteln. Dtsch Tierarztl Wochenschr 103:438–443. [PubMed] [Google Scholar]
  • 134. Helke DM, Wong ACL. 1994. Survival and growth characteristics of Listeria monocytogenes and Salmonella typhimurium on stainless steel and buna-N rubber. J Food Prot 57:963–968. doi: 10.4315/0362-028X-57.11.963 [DOI] [PubMed] [Google Scholar]
  • 135. Hansen LT, Vogel BF. 2011. Desiccation of adhering and biofilm Listeria monocytogenes on stainless steel: survival and transfer to salmon products. Int J Food Microbiol 146:88–93. doi: 10.1016/j.ijfoodmicro.2011.01.032 [DOI] [PubMed] [Google Scholar]
  • 136. Vogel BF, Hansen LT, Mordhorst H, Gram L. 2010. The survival of Listeria monocytogenes during long term desiccation is facilitated by sodium chloride and organic material. Int J Food Microbiol 140:192–200. doi: 10.1016/j.ijfoodmicro.2010.03.035 [DOI] [PubMed] [Google Scholar]
  • 137. Daneshvar Alavi HE, Truelstrup Hansen L. 2013. Kinetics of biofilm formation and desiccation survival of Listeria monocytogenes in single and dual species biofilms with Pseudomonas fluorescens, Serratia proteamaculans or Shewanella baltica on food-grade stainless steel surfaces. Biofouling 29:1253–1268. doi: 10.1080/08927014.2013.835805 [DOI] [PubMed] [Google Scholar]
  • 138. Pérez JL, Gómez E, Sauca G. 1990. Survival of gonococci from urethral discharge on fomites. Eur J Clin Microbiol Infect Dis 9:54–55. doi: 10.1007/BF01969538 [DOI] [PubMed] [Google Scholar]
  • 139. Elmros T. 1977. Survival of Neisseria gonorrhoeae on surfaces. Acta Derm Venereol 57:177–180. [PubMed] [Google Scholar]
  • 140. Panagea S, Winstanley C, Walshaw MJ, Ledson MJ, Hart CA. 2005. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. J Hosp Infect 59:102–107. doi: 10.1016/j.jhin.2004.09.018 [DOI] [PubMed] [Google Scholar]
  • 141. Abdelhamid AG, Yousef AE. 2019. The microbial lipopeptide paenibacterin disrupts desiccation resistance in Salmonella enterica serovars Tennessee and Eimsbuettel. Appl Environ Microbiol 85:e00739-19. doi: 10.1128/AEM.00739-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142. Finn S, Händler K, Condell O, Colgan A, Cooney S, McClure P, Amézquita A, Hinton JCD, Fanning S. 2013. ProP is required for the survival of desiccated Salmonella enterica serovar typhimurium cells on a stainless steel surface. Appl Environ Microbiol 79:4376–4384. doi: 10.1128/AEM.00515-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 143. Ramachandran G, Aheto K, Shirtliff ME, Tennant SM. 2016. Poor biofilm-forming ability and long-term survival of invasive Salmonella Typhimurium ST313. Pathog Dis 74:ftw049. doi: 10.1093/femspd/ftw049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 144. Robertson MH. 1972. Survival of S. typhimurium in floor dust — A possible reservoir of infection in institutions. Public Health 87:39–45. doi: 10.1016/s0033-3506(72)80034-9 [DOI] [PubMed] [Google Scholar]
  • 145. Margas E, Meneses N, Conde-Petit B, Dodd CER, Holah J. 2014. Survival and death kinetics of Salmonella strains at low relative humidity, attached to stainless steel surfaces. Int J Food Microbiol 187:33–40. doi: 10.1016/j.ijfoodmicro.2014.06.027 [DOI] [PubMed] [Google Scholar]
  • 146. Dawson P, Han I, Cox M, Black C, Simmons L. 2007. Residence time and food contact time effects on transfer of Salmonella Typhimurium from tile, wood and carpet: testing the five-second rule. J Appl Microbiol 102:945–953. doi: 10.1111/j.1365-2672.2006.03171.x [DOI] [PubMed] [Google Scholar]
  • 147. Islam MS, Hossain MA, Khan SI, Khan MN, Sack RB, Albert MJ, Huq A, Colwell RR. 2001. Survival of Shigella dysenteriae type 1 on fomites. J Health Popul Nutr 19:177–182. [PubMed] [Google Scholar]
  • 148. Nakamura M. 1962. The survival of Shigella sonnei on cotton, glass, wood, paper, and metal at various temperatures. J Hyg (Lond) 60:35–39. doi: 10.1017/s0022172400039280 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 149. Nass W. 1977. Zur Überlebensdauer von Shigellen auf Plastwerkstoffen. Z ges Hyg 23:395–397. [PubMed] [Google Scholar]
  • 150. Barua D. 1970. Survival of cholera vibrios in food, water and fomites. Public Health Pap 40:29–31. [PubMed] [Google Scholar]
  • 151. Farhana I, Hossain ZZ, Tulsiani SM, Jensen PKM, Begum A. 2016. Survival of Vibrio cholerae O1 on fomites. World J Microbiol Biotechnol 32:146. doi: 10.1007/s11274-016-2100-x [DOI] [PubMed] [Google Scholar]
  • 152. Neely AN, Orloff MM. 2001. Survival of some medically important fungi on hospital fabrics and plastics. J Clin Microbiol 39:3360–3361. doi: 10.1128/JCM.39.9.3360-3361.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 153. Weaver L, Michels HT, Keevil CW. 2010. Potential for preventing spread of fungi in air-conditioning systems constructed using copper instead of aluminium. Lett Appl Microbiol 50:18–23. doi: 10.1111/j.1472-765X.2009.02753.x [DOI] [PubMed] [Google Scholar]
  • 154. Piedrahita CT, Cadnum JL, Jencson AL, Shaikh AA, Ghannoum MA, Donskey CJ. 2017. Environmental surfaces in healthcare facilities are a potential source for transmission of Candida auris and other Candida species. Infect Control Hosp Epidemiol 38:1107–1109. doi: 10.1017/ice.2017.127 [DOI] [PubMed] [Google Scholar]
  • 155. Traoré O, Springthorpe VS, Sattar SA. 2002. A quantitative study of the survival of two species of Candida on porous and non-porous environmental surfaces and hands. J Appl Microbiol 92:549–555. doi: 10.1046/j.1365-2672.2002.01560.x [DOI] [PubMed] [Google Scholar]
  • 156. Blaschke-Hellmessen R, Kreuz M, Sprung M. 1985. Umweltresistenz und natürliche Keimreservoire medizinisch bedeutsamer Sproßpilze. Z gesamte Hyg 31:712–715. [PubMed] [Google Scholar]
  • 157. Welsh RM, Bentz ML, Shams A, Houston H, Lyons A, Rose LJ, Litvintseva AP. 2017. Survival, persistence, and isolation of the emerging multidrug-resistant pathogenic yeast Candida auris on a plastic health care surface. J Clin Microbiol 55:2996–3005. doi: 10.1128/JCM.00921-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158. Short B, Brown J, Delaney C, Sherry L, Williams C, Ramage G, Kean R. 2019. Candida auris exhibits resilient biofilm characteristics in vitro: implications for environmental persistence. J Hosp Infect 103:92–96. doi: 10.1016/j.jhin.2019.06.006 [DOI] [PubMed] [Google Scholar]
  • 159. Sriram R, Shoff M, Booton G, Fuerst P, Visvesvara GS. 2008. Survival of Acanthamoeba cysts after desiccation for more than 20 years. J Clin Microbiol 46:4045–4048. doi: 10.1128/JCM.01903-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 160. Alum A, Absar IM, Asaad H, Rubino JR, Ijaz MK. 2014. Impact of environmental conditions on the survival of cryptosporidium and giardia on environmental surfaces. Interdiscip Perspect Infect Dis 2014:210385. doi: 10.1155/2014/210385 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 161. Chauret CP, Radziminski CZ, Lepuil M, Creason R, Andrews RC. 2001. Chlorine dioxide inactivation of Cryptosporidium parvum oocysts and bacterial spore indicators. Appl Environ Microbiol 67:2993–3001. doi: 10.1128/AEM.67.7.2993-3001.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 162. Robertson LJ, Campbell AT, Smith HV. 1992. Survival of Cryptosporidium parvum oocysts under various environmental pressures. Appl Environ Microbiol 58:3494–3500. doi: 10.1128/aem.58.11.3494-3500.1992 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 163. Barbee SL, Weber DJ, Sobsey MD, Rutala WA. 1999. Inactivation of Cryptosporidium parvum oocyst infectivity by disinfection and sterilization processes. Gastrointest Endosc 49:605–611. doi: 10.1016/s0016-5107(99)70389-5 [DOI] [PubMed] [Google Scholar]
  • 164. Anderson BC. 1986. Effect of drying on the infectivity of cryptosporidia-laden calf feces for 3- to 7-day-old mice. Am J Vet Res 47:2272–2273. [PubMed] [Google Scholar]
  • 165. Hued NI, Casero RD. 2003. Survival of Trichomonas vaginalis in the environmental media. Rev Argent Microbiol 35:113–115. [PubMed] [Google Scholar]
  • 166. Ryu J, Lee MH, Park H, Kang JH, Min DY. 2002. Survival of Trichomonas vaginalis exposed on various environmental conditions. Korean J Infect Dis 34:373–379. [Google Scholar]
  • 167. Mahl MC, Sadler C. 1975. Virus survival on inanimate surfaces. Can J Microbiol 21:819–823. doi: 10.1139/m75-121 [DOI] [PubMed] [Google Scholar]
  • 168. Gordon YJ, Gordon RY, Romanowski E, Araullo-Cruz TP. 1993. Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. Ophthalmology 100:1835–1839. doi: 10.1016/s0161-6420(93)31389-8 [DOI] [PubMed] [Google Scholar]
  • 169. Abad FX, Pintó RM, Bosch A. 1994. Survival of enteric viruses on environmental fomites. Appl Environ Microbiol 60:3704–3710. doi: 10.1128/aem.60.10.3704-3710.1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 170. Rabenau HF, Cinatl J, Morgenstern B, Bauer G, Preiser W, Doerr HW. 2005. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol 194:1–6. doi: 10.1007/s00430-004-0219-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 171. Faix RG. 1985. Survival of cytomegalovirus on environmental surfaces. J Pediatr 106:649–652. doi: 10.1016/s0022-3476(85)80096-2 [DOI] [PubMed] [Google Scholar]
  • 172. Piercy TJ, Smither SJ, Steward JA, Eastaugh L, Lever MS. 2010. The survival of filoviruses in liquids, on solid substrates and in a dynamic aerosol. J Appl Microbiol 109:1531–1539. doi: 10.1111/j.1365-2672.2010.04778.x [DOI] [PubMed] [Google Scholar]
  • 173. Westhoff Smith D, Hill-Batorski L, N’jai A, Eisfeld AJ, Neumann G, Halfmann P, Kawaoka Y. 2016. Ebola virus stability under hospital and environmental conditions. J Infect Dis 214:S142–S144. doi: 10.1093/infdis/jiw167 [DOI] [PubMed] [Google Scholar]
  • 174. Sagripanti JL, Rom AM, Holland LE. 2010. Persistence in darkness of virulent alphaviruses, Ebola virus, and Lassa virus deposited on solid surfaces. Arch Virol 155:2035–2039. doi: 10.1007/s00705-010-0791-0 [DOI] [PubMed] [Google Scholar]
  • 175. Fischer R, Judson S, Miazgowicz K, Bushmaker T, Prescott J, Munster VJ. 2015. Ebola virus stability on surfaces and in fluids in simulated outbreak environments. Emerg Infect Dis 21:1243–1246. doi: 10.3201/eid2107.150253 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 176. Cook BWM, Cutts TA, Nikiforuk AM, Poliquin PG, Court DA, Strong JE, Theriault SS. 2015. Evaluating environmental persistence and disinfection of the Ebola virus Makona variant. Viruses 7:1975–1986. doi: 10.3390/v7041975 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 177. Fogarty R, Halpin K, Hyatt AD, Daszak P, Mungall BA. 2008. Henipavirus susceptibility to environmental variables. Virus Res 132:140–144. doi: 10.1016/j.virusres.2007.11.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 178. Morgan CN, Whitehill F, Doty JB, Schulte J, Matheny A, Stringer J, Delaney LJ, Esparza R, Rao AK, McCollum AM. 2022. Environmental persistence of monkeypox virus on surfaces in household of person with travel-associated infection, Dallas, Texas, USA, 2021. Emerg Infect Dis 28:1982–1989. doi: 10.3201/eid2810.221047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 179. Sidwell RW, Dixon GJ, McNeil E. 1966. Quantitative studies on fabrics as disseminators of viruses. I. Persistence of vaccinia virus on cotton and wool fabrics. Appl Microbiol 14:55–59. doi: 10.1128/am.14.1.55-59.1966 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 180. Sidwell RW, Dixon GJ, McNeil E. 1967. Quantitative studies on fabrics as disseminators of viruses. 3. Persistence of vaccinia virus on fabrics impregnated with a virucidal agent. Appl Microbiol 15:921–927. doi: 10.1128/am.15.4.921-927.1967 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 181. Essbauer S, Meyer H, Porsch-Ozcürümez M, Pfeffer M. 2007. Long-lasting stability of vaccinia virus (orthopoxvirus) in food and environmental samples. Zoonoses Public Health 54:118–124. doi: 10.1111/j.1863-2378.2007.01035.x [DOI] [PubMed] [Google Scholar]
  • 182. Wood JP, Choi YW, Wendling MQ, Rogers JV, Chappie DJ. 2013. Environmental persistence of vaccinia virus on materials. Lett Appl Microbiol 57:399–404. doi: 10.1111/lam.12126 [DOI] [PubMed] [Google Scholar]
  • 183. Mahnel H. 1987. Experimentelle Ergebnisse über die Stabilität von Pockenviren unter Labor- und Umweltbedingungen. J Vet Med B 34:449–464. doi: 10.1111/j.1439-0450.1987.tb00419.x [DOI] [PubMed] [Google Scholar]
  • 184. Abad FX, Villena C, Guix S, Caballero S, Pintó RM, Bosch A. 2001. Potential role of fomites in the vehicular transmission of human astroviruses. Appl Environ Microbiol 67:3904–3907. doi: 10.1128/AEM.67.9.3904-3907.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 185. Firquet S, Beaujard S, Lobert PE, Sané F, Caloone D, Izard D, Hober D. 2015. Survival of enveloped and non-enveloped viruses on inanimate surfaces. Microbes Environ 30:140–144. doi: 10.1264/jsme2.ME14145 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 186. Mocé-Llivina L, Papageorgiou GT, Jofre J. 2006. A membrane-based quantitative carrier test to assess the virucidal activity of disinfectants and persistence of viruses on porous fomites. J Virol Methods 135:49–55. doi: 10.1016/j.jviromet.2006.01.021 [DOI] [PubMed] [Google Scholar]
  • 187. D’Souza DH, Sair A, Williams K, Papafragkou E, Jean J, Moore C, Jaykus L. 2006. Persistence of caliciviruses on environmental surfaces and their transfer to food. Int J Food Microbiol 108:84–91. doi: 10.1016/j.ijfoodmicro.2005.10.024 [DOI] [PubMed] [Google Scholar]
  • 188. Clay S, Maherchandani S, Malik YS, Goyal SM. 2006. Survival on uncommon fomites of feline calicivirus, a surrogate of noroviruses. Am J Infect Control 34:41–43. doi: 10.1016/j.ajic.2005.05.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 189. Buckley D, Fraser A, Huang G, Jiang X. 2017. Recovery optimization and survival of the human norovirus surrogates feline calicivirus and murine norovirus on carpet. Appl Environ Microbiol 83:e01336-17. doi: 10.1128/AEM.01336-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 190. Kim SJ, Si J, Lee JE, Ko G. 2012. Temperature and humidity influences on inactivation kinetics of enteric viruses on surfaces. Environ Sci Technol 46:13303–13310. doi: 10.1021/es3032105 [DOI] [PubMed] [Google Scholar]
  • 191. Mbithi JN, Springthorpe VS, Sattar SA. 1991. Effect of relative humidity and air temperature on survival of hepatitis A virus on environmental surfaces. Appl Environ Microbiol 57:1394–1399. doi: 10.1128/aem.57.5.1394-1399.1991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 192. Trudel-Ferland M, Jubinville E, Jean J. 2021. Persistence of hepatitis A virus RNA in water, on non-porous surfaces, and on blueberries. Front Microbiol 12:618352. doi: 10.3389/fmicb.2021.618352 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 193. Wolff A, Günther T, Johne R. 2022. Stability of hepatitis E virus after drying on different surfaces. Food Environ Virol 14:138–148. doi: 10.1007/s12560-022-09510-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 194. Wißmann JE, Brüggemann Y, Todt D, Steinmann J, Steinmann E. 2023. Survival and inactivation of hepatitis E virus on inanimate surfaces. J Hosp Infect 134:57–62. doi: 10.1016/j.jhin.2023.01.013 [DOI] [PubMed] [Google Scholar]
  • 195. Casanova LM, Jeon S, Rutala WA, Weber DJ, Sobsey MD. 2010. Effects of air temperature and relative humidity on coronavirus survival on surfaces. Appl Environ Microbiol 76:2712–2717. doi: 10.1128/AEM.02291-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 196. Warnes SL, Keevil CW. 2013. Inactivation of norovirus on dry copper alloy surfaces. PLoS One 8:e75017. doi: 10.1371/journal.pone.0075017 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 197. Keswick BH, Pickering LK, DuPont HL, Woodward WE. 1983. Survival and detection of rotaviruses on environmental surfaces in day care centers. Appl Environ Microbiol 46:813–816. doi: 10.1128/aem.46.4.813-816.1983 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 198. Tamrakar SB, Henley J, Gurian PL, Gerba CP, Mitchell J, Enger K, Rose JB. 2017. Persistence analysis of poliovirus on three different types of fomites. J Appl Microbiol 122:522–530. doi: 10.1111/jam.13299 [DOI] [PubMed] [Google Scholar]
  • 199. Sattar SA, Lloyd-Evans N, Springthorpe VS, Nair RC. 1986. Institutional outbreaks of rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus transmission. J Hyg (Lond) 96:277–289. doi: 10.1017/s0022172400066055 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 200. Arthur SE, Gibson KE. 2016. Environmental persistence of Tulane virus - a surrogate for human norovirus. Can J Microbiol 62:449–454. doi: 10.1139/cjm-2015-0756 [DOI] [PubMed] [Google Scholar]
  • 201. Sizun J, Yu MWN, Talbot PJ. 2000. Survival of human coronaviruses 229E and OC43 in suspension and after drying onsurfaces: a possible source of hospital-acquired infections. J Hosp Infect 46:55–60. doi: 10.1053/jhin.2000.0795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 202. Warnes SL, Little ZR, Keevil CW. 2015. Human coronavirus 229E remains infectious on common touch surface materials. mBio 6:e01697-15. doi: 10.1128/mBio.01697-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 203. Perry KA, Coulliette AD, Rose LJ, Shams AM, Edwards JR, Noble-Wang JA. 2016. Persistence of influenza A (H1N1) virus on stainless steel surfaces. Appl Environ Microbiol 82:3239–3245. doi: 10.1128/AEM.04046-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 204. Oxford J, Berezin EN, Courvalin P, Dwyer DE, Exner M, Jana LA, Kaku M, Lee C, Letlape K, Low DE, Madani TA, Rubino JR, Saini N, Schoub BD, Signorelli C, Tierno PM, Zhong X. 2014. The survival of influenza A(H1N1)pdm09 virus on 4 household surfaces. Am J Infect Control 42:423–425. doi: 10.1016/j.ajic.2013.10.016 [DOI] [PubMed] [Google Scholar]
  • 205. Mukherjee DV, Cohen B, Bovino ME, Desai S, Whittier S, Larson EL. 2012. Survival of influenza virus on hands and fomites in community and laboratory settings. Am J Infect Control 40:590–594. doi: 10.1016/j.ajic.2011.09.006 [DOI] [PubMed] [Google Scholar]
  • 206. Thompson KA, Bennett AM. 2017. Persistence of influenza on surfaces. J Hosp Infect 95:194–199. doi: 10.1016/j.jhin.2016.12.003 [DOI] [PubMed] [Google Scholar]
  • 207. Bean B, Moore BM, Sterner B, Peterson LR, Gerding DN, Balfour HH. 1982. Survival of influenza viruses on environmental surfaces. J Infect Dis 146:47–51. doi: 10.1093/infdis/146.1.47 [DOI] [PubMed] [Google Scholar]
  • 208. Greatorex JS, Digard P, Curran MD, Moynihan R, Wensley H, Wreghitt T, Varsani H, Garcia F, Enstone J, Nguyen-Van-Tam JS. 2011. Survival of influenza A(H1N1) on materials found in households: implications for infection control. PLoS One 6:e27932. doi: 10.1371/journal.pone.0027932 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 209. van Doremalen N, Bushmaker T, Munster VJ. 2013. Stability of Middle East respiratory syndrome coronavirus (MERS-CoV) under different environmental conditions. Euro Surveill 18:20590. doi: 10.2807/1560-7917.es2013.18.38.20590 [DOI] [PubMed] [Google Scholar]
  • 210. Brady MT, Evans J, Cuartas J. 1990. Survival and disinfection of parainfluenza viruses on environmental surfaces. Am J Infect Control 18:18–23. doi: 10.1016/0196-6553(90)90206-8 [DOI] [PubMed] [Google Scholar]
  • 211. Hall CB, Douglas RG Jr, Geiman JM. 1980. Possible transmission by fomites of respiratory syncytial virus. J Infect Dis 141:98–102. doi: 10.1093/infdis/141.1.98 [DOI] [PubMed] [Google Scholar]
  • 212. Sattar SA, Karim YG, Springthorpe VS, Johnson-Lussenburg CM. 1987. Survival of human rhinovirus type 14 dried onto nonporous inanimate surfaces: effect of relative humidity and suspending medium. Can J Microbiol 33:802–806. doi: 10.1139/m87-136 [DOI] [PubMed] [Google Scholar]
  • 213. Reed SE. 1975. An investigation of the possible transmission of rhinovirus colds through indirect contact. J. Hyg 75:249–258. doi: 10.1017/S0022172400047288 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 214. Duan SM, Zhao XS, Wen RF, Huang JJ, Pi GH, Zhang SX, Han J, Bi SL, Ruan L, Dong XP, Team SR. 2003. Stability of SARS coronavirus in human specimens and environment and its sensitivity to heating and UV irradiation. Biomed Environ Sci 16:246–255. [PubMed] [Google Scholar]
  • 215. Chan KH, Peiris JSM, Lam SY, Poon LLM, Yuen KY, Seto WH. 2011. The effects of temperature and relative humidity on the viability of the SARS coronavirus. Adv Virol 2011:734690. doi: 10.1155/2011/734690 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 216. van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ. 2020. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med 382:1564–1567. doi: 10.1056/NEJMc2004973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 217. Lai MYY, Cheng PKC, Lim WWL. 2005. Survival of severe acute respiratory syndrome coronavirus. Clin Infect Dis 41:e67–71. doi: 10.1086/433186 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 218. Riddell S, Goldie S, Hill A, Eagles D, Drew TW. 2020. The effect of temperature on persistence of SARS-CoV-2 on common surfaces. Virol J 17:145. doi: 10.1186/s12985-020-01418-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 219. Kasloff SB, Leung A, Strong JE, Funk D, Cutts T. 2021. Stability of SARS-CoV-2 on critical personal protective equipment. Sci Rep 11:984. doi: 10.1038/s41598-020-80098-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 220. Chin AWH, Chu JTS, Perera MRA, Hui KPY, Yen HL, Chan MCW, Peiris M, Poon LLM. 2020. Stability of SARS-CoV-2 in different environmental conditions. Lancet Microbe 1:e10. doi: 10.1016/S2666-5247(20)30003-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 221. Ratnesar-Shumate S, Williams G, Green B, Krause M, Holland B, Wood S, Bohannon J, Boydston J, Freeburger D, Hooper I, Beck K, Yeager J, Altamura LA, Biryukov J, Yolitz J, Schuit M, Wahl V, Hevey M, Dabisch P. 2020. Simulated sunlight rapidly inactivates SARS-CoV-2 on surfaces. J Infect Dis 222:214–222. doi: 10.1093/infdis/jiaa274 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 222. Raiteux J, Eschlimann M, Marangon A, Rogée S, Dadvisard M, Taysse L, Larigauderie G. 2021. Inactivation of SARS-CoV-2 by simulated sunlight on contaminated surfaces. Microbiol Spectr 9:e0033321. doi: 10.1128/spectrum.00333-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 223. Biryukov J, Boydston JA, Dunning RA, Yeager JJ, Wood S, Reese AL, Ferris A, Miller D, Weaver W, Zeitouni NE, Phillips A, Freeburger D, Hooper I, Ratnesar-Shumate S, Yolitz J, Krause M, Williams G, Dawson DG, Herzog A, Dabisch P, Wahl V, Hevey MC, Altamura LA. 2020. Increasing temperature and relative humidity accelerates inactivation of SARS-CoV-2 on surfaces. mSphere 5:e00441-20. doi: 10.1128/mSphere.00441-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 224. Jang H, Ross TM. 2020. Dried SARS-CoV-2 virus maintains infectivity to Vero E6 cells for up to 48 h. Vet Microbiol 251:108907. doi: 10.1016/j.vetmic.2020.108907 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 225. Bardell D. 1990. Survival of herpes simplex virus type 1 on some frequently touched objects in the home and public buildings. Microbios 63:145–150. [PubMed] [Google Scholar]
  • 226. Bardell D. 1993. Survival of herpes simplex virus type 1 in saliva and tap water contaminating some common objects. Microbios 74:81–87. [PubMed] [Google Scholar]
  • 227. Nerurkar LS, West F, May M, Madden DL, Sever JL. 1983. Survival of herpes simplex virus in water specimens collected from hot tubs in spa facilities and on plastic surfaces. JAMA 250:3081–3083. doi: 10.1001/jama.1983.03340220049032 [DOI] [PubMed] [Google Scholar]
  • 228. Barre-Sinoussi F, Nugeyre MT, Chermann JC. 1985. Resistance of AIDS virus at room temperature. Lancet 326:721–722. doi: 10.1016/S0140-6736(85)92955-1 [DOI] [PubMed] [Google Scholar]
  • 229. Roden RB, Lowy DR, Schiller JT. 1997. Papillomavirus is resistant to desiccation. J Infect Dis 176:1076–1079. doi: 10.1086/516515 [DOI] [PubMed] [Google Scholar]
  • 230. Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. 1981. Survival of hepatitis B virus after drying and storage for one week. Lancet 317:550–551. doi: 10.1016/S0140-6736(81)92877-4 [DOI] [PubMed] [Google Scholar]
  • 231. Favero MS, Bond WW, Petersen NJ, Berquist KR, Maynard JE. 1974. Detection methods for study of the stability of hepatitis B antigen on surfaces. J Infect Dis 129:210–212. doi: 10.1093/infdis/129.2.210 [DOI] [PubMed] [Google Scholar]
  • 232. Than TT, Jo E, Todt D, Nguyen PH, Steinmann J, Steinmann E, Windisch MP. 2019. High environmental stability of Hepatitis B virus and inactivation requirements for chemical biocides. J Infect Dis 219:1044–1048. doi: 10.1093/infdis/jiy620 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 233. Paintsil E, Binka M, Patel A, Lindenbach BD, Heimer R. 2014. Hepatitis C virus maintains infectivity for weeks after drying on inanimate surfaces at room temperature: implications for risks of transmission. J Infect Dis 209:1205–1211. doi: 10.1093/infdis/jit648 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 234. Doerrbecker J, Friesland M, Ciesek S, Erichsen TJ, Mateu-Gelabert P, Steinmann J, Steinmann J, Pietschmann T, Steinmann E. 2011. Inactivation and survival of hepatitis C virus on inanimate surfaces. J Infect Dis 204:1830–1838. doi: 10.1093/infdis/jir535 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 235. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. 2021. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 236. Knelson LP, Williams DA, Gergen MF, Rutala WA, Weber DJ, Sexton DJ, Anderson DJ, Disease C, Prevention Epicenters P. 2014. A comparison of environmental contamination by patients infected or colonized with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a multicenter study. Infect Control Hosp Epidemiol 35:872–875. doi: 10.1086/676861 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 237. Lin D, Ou Q, Lin J, Peng Y, Yao Z. 2017. A meta-analysis of the rates of Staphylococcus aureus and methicillin-resistant S aureus contamination on the surfaces of environmental objects that health care workers frequently touch. Am J Infect Control 45:421–429. doi: 10.1016/j.ajic.2016.11.004 [DOI] [PubMed] [Google Scholar]
  • 238. Bonten MJ, Hayden MK, Nathan C, van Voorhis J, Matushek M, Slaughter S, Rice T, Weinstein RA. 1996. Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci. Lancet 348:1615–1619. doi: 10.1016/S0140-6736(96)02331-8 [DOI] [PubMed] [Google Scholar]
  • 239. Lerner A, Adler A, Abu-Hanna J, Meitus I, Navon-Venezia S, Carmeli Y. 2013. Environmental contamination by carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 51:177–181. doi: 10.1128/JCM.01992-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 240. Weber DJ, Rutala WA, Kanamori H, Gergen MF, Sickbert-Bennett EE. 2015. Carbapenem-resistant Enterobacteriaceae: frequency of hospital room contamination and survival on various inoculated surfaces. Infect Control Hosp Epidemiol 36:590–593. doi: 10.1017/ice.2015.17 [DOI] [PubMed] [Google Scholar]
  • 241. Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. 2010. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 38:S25–S33. doi: 10.1016/j.ajic.2010.04.196 [DOI] [PubMed] [Google Scholar]
  • 242. Sitzlar B, Deshpande A, Fertelli D, Kundrapu S, Sethi AK, Donskey CJ. 2013. An environmental disinfection odyssey: evaluation of sequential interventions to improve disinfection of Clostridium difficile isolation rooms. Infect Control Hosp Epidemiol 34:459–465. doi: 10.1086/670217 [DOI] [PubMed] [Google Scholar]
  • 243. Ahmad S, Asadzadeh M. 2023. Strategies to prevent transmission of Candida auris in healthcare settings. Curr Fungal Infect Rep 17:36–48. doi: 10.1007/s12281-023-00451-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 244. Rampling A, Wiseman S, Davis L, Hyett AP, Walbridge AN, Payne GC, Cornaby AJ. 2001. Evidence that hospital hygiene is important in the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 49:109–116. doi: 10.1053/jhin.2001.1013 [DOI] [PubMed] [Google Scholar]
  • 245. Aldejohann AM, Wiese-Posselt M, Gastmeier P, Kurzai O. 2022. Expert recommendations for prevention and management of Candida auris transmission. Mycoses 65:590–598. doi: 10.1111/myc.13445 [DOI] [PubMed] [Google Scholar]
  • 246. Shaughnessy MK, Micielli RL, DePestel DD, Arndt J, Strachan CL, Welch KB, Chenoweth CE. 2011. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 32:201–206. doi: 10.1086/658669 [DOI] [PubMed] [Google Scholar]
  • 247. Miles-Jay A, Snitkin ES, Lin MY, Shimasaki T, Schoeny M, Fukuda C, Dangana T, Moore N, Sansom SE, Yelin RD, Bell P, Rao K, Keidan M, Standke A, Bassis C, Hayden MK, Young VB. 2023. Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit. Nat Med 29:2526–2534. doi: 10.1038/s41591-023-02549-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 248. Mair NS, Ross AI. 1960. Survival of Salm. Typhimurium in the soil. Mon Bull Minist Health Public Health Lab Serv 19:39–41. [PubMed] [Google Scholar]
  • 249. Thomas KL. 1967. Survival of Salmonella paratyphi B, phage type 1 var. 6, in soil. Mon Bull Minist Health Public Health Lab Serv 26:39–45. [PubMed] [Google Scholar]
  • 250. Mitscherlich E, Marth EH. 1984. Microbial survival in the environment. 1st ed. Springer, Berlin, Heidelberg. [Google Scholar]
  • 251. Papaconstantinou AT, Leonardopoulos JG, Papavassiliou JT. 1981. Survival of proteus and providentia strains in soil. Zbl Bakteriol Mikrobiol Hyg I Abt 2:362–364. doi: 10.1016/S0721-9571(81)80030-0 [DOI] [Google Scholar]
  • 252. Papavassiliou J, Leonardopoulos J. 1987. Survival of enterobacteria in two different types of sterile soil. Microb Ecol [Google Scholar]
  • 253. Kramer A, Assadian O. 2014. Survival of microorganisms on inanimate surfaces. In Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections [Google Scholar]
  • 254. Burrows W. 1968. Textbook of microbiology. 19 ed. Saunders, Philadelphia. [Google Scholar]
  • 255. Baudisch C, Assadian O, Kramer A. 2009. Concentration of the genera Aspergillus, Eurotium and Penicillium in 63-microm house dust fraction as a method to predict hidden moisture damage in homes. BMC Public Health 9:247. doi: 10.1186/1471-2458-9-247 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 256. Baudisch C, Assadian O, Kramer A. 2009. Evaluation of errors and limits of the 63-microuse-dust-fraction method, a surrogate to predict hidden moisture damage. BMC Res Notes 2:218. doi: 10.1186/1756-0500-2-218 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 257. Johansson P, Ekstrand-Tobin A, Svensson T, Bok G. 2012. Laboratory study to determine the critical moisture level for mould growth on building materials. Int Biodeter Biodegr 73:23–32. doi: 10.1016/j.ibiod.2012.05.014 [DOI] [Google Scholar]
  • 258. Faure O, Fricker-Hidalgo H, Lebeau B, Mallaret MR, Ambroise-Thomas P, Grillot R. 2002. Eight-year surveillance of environmental fungal contamination in hospital operating rooms and haematological units. J Hosp Infect 50:155–160. doi: 10.1053/jhin.2001.1148 [DOI] [PubMed] [Google Scholar]
  • 259. Santos PE, Córdoba S, Carrillo-Muñoz A, Rodero L, Rubeglio E, Soria M. 2010. Epidemiology of fungaemia in a paediatric hospital of high complexity. Rev Iberoam Micol 27:200–202. doi: 10.1016/j.riam.2010.07.002 [DOI] [PubMed] [Google Scholar]
  • 260. Rafiei N, Eftekhar B, Rafiei A, Borujeni MP, Zarrin M. 2012. Fungal and bacterial contamination on indoor surfaces of a hospital in Mexico. Jundishapur J Microbiol 5:460–464. doi: 10.5812/jjm.2625 [DOI] [Google Scholar]
  • 261. Mishra B, Mandal A, Kumar N. 1992. Mycotic prosthetic-valve endocarditis. J Hosp Infect 20:122–125. doi: 10.1016/0195-6701(92)90115-3 [DOI] [PubMed] [Google Scholar]
  • 262. Duffy J, Harris J, Gade L, Sehulster L, Newhouse E, O’Connell H, Noble-Wang J, Rao C, Balajee SA, Chiller T. 2014. Mucormycosis outbreak associated with hospital linens. Pediatr Infect Dis J 33:472–476. doi: 10.1097/INF.0000000000000261 [DOI] [PubMed] [Google Scholar]
  • 263. Sundermann AJ, Clancy CJ, Pasculle AW, Liu G, Cumbie RB, Driscoll E, Ayres A, Donahue L, Pergam SA, Abbo L, et al. 2019. How clean Is the linen at my hospital? The Mucorales on unclean linen discovery study of large United States transplant and cancer centers. Clin Infect Dis 68:850–853. doi: 10.1093/cid/ciy669 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 264. Hosseinpour L, Zareei M, Boroujeni ZB, Yaghoubi R, Hashemi S. 2017. Survival of dermatophytes in skin scales after 10 years storage. Infect Epidemiol Microbiol 3:96–99. [Google Scholar]
  • 265. Seebacher C, Bouchara JP, Mignon B. 2008. Updates on the epidemiology of dermatophyte infections. Mycopathologia 166:335–352. doi: 10.1007/s11046-008-9100-9 [DOI] [PubMed] [Google Scholar]
  • 266. Sugimoto R, Katoh T, Nishioka K. 1995. Isolation of dermatophytes from house dust on a medium containing gentamicin and flucytosine. Mycoses 38:405–410. doi: 10.1111/j.1439-0507.1995.tb00072.x [DOI] [PubMed] [Google Scholar]
  • 267. Watanabe K, Taniguchi H, Katoh T. 2000. Adhesion of dermatophytes to healthy feet and its simple treatment. Mycoses 43:45–50. doi: 10.1046/j.1439-0507.2000.00546.x [DOI] [PubMed] [Google Scholar]
  • 268. Roberts DT. 1992. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Br J Dermatol 126:23–27. doi: 10.1111/j.1365-2133.1992.tb00005.x [DOI] [PubMed] [Google Scholar]
  • 269. Ruiz-Gaitán A, Moret AM, Tasias-Pitarch M, Aleixandre-López AI, Martínez-Morel H, Calabuig E, Salavert-Lletí M, Ramírez P, López-Hontangas JL, Hagen F, Meis JF, Mollar-Maseres J, Pemán J. 2018. An outbreak due to Candida auris with prolonged colonisation and candidaemia in a tertiary care European hospital. Mycoses 61:498–505. doi: 10.1111/myc.12781 [DOI] [PubMed] [Google Scholar]
  • 270. Chow NA, Gade L, Tsay SV, Forsberg K, Greenko JA, Southwick KL, Barrett PM, Kerins JL, Lockhart SR, Chiller TM, Litvintseva AP, US Candida auris Investigation Team . 2018. Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey. Lancet Infect Dis 18:1377–1384. doi: 10.1016/S1473-3099(18)30597-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 271. Caliman Sato M, Izu Nakamura Pietro EC, Marques da Costa Alves L, Kramer A, da Silva Santos PS. 2023. Candida auris: a novel emerging nosocomial pathogen – properties, epidemiological situation and infection control. GMS Hyg Infect Control 18:Doc18. doi: 10.3205/dgkh000444 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 272. Meis JF, Chowdhary A. 2018. Candida auris: a global fungal public health threat. Lancet Infect Dis 18:1298–1299. doi: 10.1016/S1473-3099(18)30609-1 [DOI] [PubMed] [Google Scholar]
  • 273. Centers for Disease Control and Prevention (CDC) . 2023. Surveillance for Candida auris. Available from: https://www.cdc.gov/fungal/candida-auris/health-professionals.html
  • 274. Tsay S, Welsh RM, Adams EH, Chow NA, Gade L, Berkow EL, Poirot E, Lutterloh E, Quinn M, Chaturvedi S, et al. 2017. Notes from the field: ongoing transmission of Candida auris in health care facilities - United States, June 2016-May 2017. MMWR Morb Mortal Wkly Rep 66:514–515. doi: 10.15585/mmwr.mm6619a7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 275. Osei Sekyere J. 2018. Candida auris: a systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiologyopen 7:e00578. doi: 10.1002/mbo3.578 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 276. Eyre DW, Sheppard AE, Madder H, Moir I, Moroney R, Quan TP, Griffiths D, George S, Butcher L, Morgan M, Newnham R, Sunderland M, Clarke T, Foster D, Hoffman P, Borman AM, Johnson EM, Moore G, Brown CS, Walker AS, Peto TEA, Crook DW, Jeffery KJM. 2018. A Candida auris outbreak and its control in an intensive care setting. N Engl J Med 379:1322–1331. doi: 10.1056/NEJMoa1714373 [DOI] [PubMed] [Google Scholar]
  • 277. Lyman M, Forsberg K, Reuben J, Dang T, Free R, Seagle EE, Sexton DJ, Soda E, Jones H, Hawkins D, Anderson A, Bassett J, Lockhart SR, Merengwa E, Iyengar P, Jackson BR, Chiller T. 2021. Notes from the field: transmission of pan-resistant and echinocandin-resistant Candida auris in health care facilities - texas and the District of Columbia, January-April 2021. MMWR Morb Mortal Wkly Rep 70:1022–1023. doi: 10.15585/mmwr.mm7029a2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 278. Centers for Disease Control and Prevention (CDC) . 2023. Tracking Candida auris. Available from: https://www.cdc.gov/fungal/candida-auris/tracking-c-auris.html
  • 279. Yaeger RG. 1996. Protozoa: structure, classification, growth, and development. Medical Microbiology. [PubMed] [Google Scholar]
  • 280. Castelli G, Oliveri E, Valenza V, Giardina S, Facciponte F, La Russa F, Vitale F, Bruno F. 2023. Cultivation of protozoa parasites in vitro: growth potential in conventional culture media versus RPMI-PY medium. Vet Sci 10:252. doi: 10.3390/vetsci10040252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 281. Visvesvara GS, Garcia LS. 2002. Culture of protozoan parasites. Clin Microbiol Rev 15:327–328. doi: 10.1128/CMR.15.3.327-328.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 282. Wang R, Li J, Chen Y, Zhang L, Xiao L. 2018. Widespread occurrence of Cryptosporidium infections in patients with HIV/AIDS: epidemiology, clinical feature, diagnosis, and therapy. Acta Tropica 187:257–263. doi: 10.1016/j.actatropica.2018.08.018 [DOI] [PubMed] [Google Scholar]
  • 283. Cordell RL, Addiss DG. 1994. Cryptosporidiosis in child care settings: a review of the literature and recommendations for prevention and control. Pediatr Infect Dis J 13:310–317. [PubMed] [Google Scholar]
  • 284. Fürnkranz U, Walochnik J. 2021. Nosocomial infections: do not forget the parasites! Pathogens 10:238. doi: 10.3390/pathogens10020238 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 285. Herwaldt BL. 2000. Cyclospora cayetanensis: a review, focusing on the outbreaks of cyclosporiasis in the 1990s. Clin Infect Dis 31:1040–1057. doi: 10.1086/314051 [DOI] [PubMed] [Google Scholar]
  • 286. Menezes CB, Amanda Piccoli Frasson AP, Tasca T. 2016. Trichomoniasis – are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide? MIC 3:404–418. doi: 10.15698/mic2016.09.526 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 287. Feng Y, Xiao L. 2011. Zoonotic potential and molecular epidemiology of Giardia species and giardiasis. Clin Microbiol Rev 24:110–140. doi: 10.1128/CMR.00033-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 288. Carey CM, Lee H, Trevors JT. 2004. Biology, persistence and detection of Cryptosporidium parvum and Cryptosporidium hominis oocyst. Water Res 38:818–862. doi: 10.1016/j.watres.2003.10.012 [DOI] [PubMed] [Google Scholar]
  • 289. Medema GJ, Bahar M, Schets FM. 1997. Survival of Cryptosporidium parvum, Escherichia coli, faecal enterococci and Clostridium perfringens in river water: influence of temperature and autochthonous microorganisms. Water Sci. Technol 35:249–252. doi: 10.2166/wst.1997.0742 [DOI] [Google Scholar]
  • 290. Fayer R, Graczyk TK, Lewis EJ, Trout JM, Farley CA. 1998. Survival of infectious Cryptosporidium parvum oocysts in seawater and eastern oysters (Crassostrea virginica) in the Chesapeake Bay. Appl Environ Microbiol 64:1070–1074. doi: 10.1128/AEM.64.3.1070-1074.1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 291. Kato S, Jenkins M, Fogarty E, Bowman D. 2004. Cryptosporidium parvum oocyst inactivation in field soil and its relation to soil characteristics: analyses using the geographic information systems. Sci Total Environ 321:47–58. doi: 10.1016/j.scitotenv.2003.08.027 [DOI] [PubMed] [Google Scholar]
  • 292. Dumètre A, Aubert D, Puech PH, Hohweyer J, Azas N, Villena I. 2012. Interaction forces drive the environmental transmission of pathogenic protozoa. Appl Environ Microbiol 78:905–912. doi: 10.1128/AEM.06488-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 293. Feng Y, Wang L, Duan L, Gomez-Puerta LA, Zhang L, Zhao X, Hu J, Zhang N, Xiao L. 2012. Extended outbreak of cryptosporidiosis in a pediatric hospital, China. Emerg Infect Dis 18:312–314. doi: 10.3201/eid1802.110666 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 294. Wang L, Xiao L, Duan L, Ye J, Guo Y, Guo M, Liu L, Feng Y. 2013. Concurrent infections of Giardia duodenalis, Enterocytozoon bieneusi, and Clostridium difficile in children during a cryptosporidiosis outbreak in a pediatric hospital in China. PLoS Negl Trop Dis 7:e2437. doi: 10.1371/journal.pntd.0002437 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 295. Ben Ayed L, Sabbahi S. 2017. Entamoeba histolytica. In Jiménez-Cisneros B, Rose JB (ed), Water and sanitation for the 21st century: health and microbiological aspects of excreta and wastewater management (Global Water Pathogen Project). Michigan State University, ELansing, MI, UNESCO. [Google Scholar]
  • 296. VanWormer E, Fritz H, Shapiro K, Mazet JAK, Conrad PA. 2013. Molecules to modeling: Toxoplasma gondii oocysts at the human-animal-environment interface. Comp Immunol Microbiol Infect Dis 36:217–231. doi: 10.1016/j.cimid.2012.10.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 297. Lélu M, Villena I, Dardé ML, Aubert D, Geers R, Dupuis E, Marnef F, Poulle ML, Gotteland C, Dumètre A, Gilot-Fromont E. 2012. Quantitative estimation of the viability of Toxoplasma gondii oocysts in soil. Appl Environ Microbiol 78:5127–5132. doi: 10.1128/AEM.00246-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 298. Leiby DA. 2011. Transfusion-transmitted Babesia spp.: bull's-eye on Babesia microti. Clin Microbiol Rev 24:14–28. doi: 10.1128/CMR.00022-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 299. Cursino-Santos JR, Alhassan A, Singh M, Lobo CA. 2014. Babesia: impact of cold storage on the survival and the viability of parasites in blood bags. Transfusion 54:585–591. doi: 10.1111/trf.12357 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 300. Eberhard ML, Walker EM, Steurer FJ. 1995. Survival and infectivity of Babesia in blood maintained at 25 C and 2-4 C. J Parasitol 81:790–792. doi: 10.2307/3283978 [DOI] [PubMed] [Google Scholar]
  • 301. Mintz ED, Anderson JF, Cable RG, Hadler JL. 1991. Transfusion‐transmitted babesiosis: a case report from a new endemic area. Transfusion 31:365–368. doi: 10.1046/j.1537-2995.1991.31491213305.x [DOI] [PubMed] [Google Scholar]
  • 302. Grabowski EF, Giardina PJ, Goldberg D, Masur H, Read SE, Hirsch RL, Benach JL. 1982. Babesiosis transmitted by a transfusion of frozen-thawed blood. Ann Intern Med 96:466–467. doi: 10.7326/0003-4819-96-4-446 [DOI] [PubMed] [Google Scholar]
  • 303. Zhao Y, Love KR, Hall SW, Beardell FV. 2009. A fatal case of transfusion-transmitted babesiosis in the State of Delaware. Transfusion 49:2583–2587. doi: 10.1111/j.1537-2995.2009.02454.x [DOI] [PubMed] [Google Scholar]
  • 304. Tonnetti L, Proctor MC, Reddy HL, Goodrich RP, Leiby DA. 2010. Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma. Transfusion 50:1019–1027. doi: 10.1111/j.1537-2995.2009.02538.x [DOI] [PubMed] [Google Scholar]
  • 305. Etkind P, Piesman J, Ruebush TK, Spielman A, Juranek DD. 1980. Methods for detecting Babesia microti infection in wild rodents. J Parasitol 66:107–110. doi: 10.2307/3280599 [DOI] [PubMed] [Google Scholar]
  • 306. Vincent J-L. 2009. International study of the prevalence and outcomes of infection in intensive care units. JAMA 302:2323. doi: 10.1001/jama.2009.1754 [DOI] [PubMed] [Google Scholar]
  • 307. Jarrin C, Bearman G, Doll M. 2018. Guide to infektion control in healthcare setting. Parasites. International society for infectious diseases (ISID), Brookline, MA. Available from: https://isid.org/guide/pathogens/parasites/. Retrieved 24 Nov 2022. [Google Scholar]
  • 308. Fletcher SM, Stark D, Harkness J, Ellis J. 2012. Enteric protozoa in the developed world: a public health perspective. Clin Microbiol Rev 25:420–449. doi: 10.1128/CMR.05038-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 309. Haque R. 2007. Human intestinal parasites. J Health Popul Nutr 25:387–391. [PMC free article] [PubMed] [Google Scholar]
  • 310. La Hoz RM, Morris MI, AST Infectious Diseases Community of Practice . 2019. Intestinal parasites including Cryptosporidium, Cyclospora, Giardia, and Microsporidia, Entamoeba histolytica, Strongyloides, Schistosomiasis, and Echinococcus: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant 33:e13618. doi: 10.1111/ctr.13618 [DOI] [PubMed] [Google Scholar]
  • 311. Haas CN, Rose JB. 1994. Reconciliation of microbial risk models and outbreak epidemiology: the case of the Milwaukee outbreak. In: Proceedings of the annual conference: water quality. p 517–523.American Water Works Association, New York [Google Scholar]
  • 312. Katz DE, Taylor DN. 2001. Parasitic infections of the gastrointestinal tract. Gastroenterol Clin North Am 30:797–815. doi: 10.1016/s0889-8553(05)70211-9 [DOI] [PubMed] [Google Scholar]
  • 313. Rendtorff RC. 1954. The experimental transmission of human intestinal protozoan parasites. I. Endamoeba coli cysts given in capsules. Am J Hyg 59:196–208. doi: 10.1093/oxfordjournals.aje.a119633 [DOI] [PubMed] [Google Scholar]
  • 314. Weber DJ, Rutala WA. 2001. The emerging nosocomial pathogens Cryptosporidium, Escherichia coli O157:H7, Helicobacter pylori, and hepatitis C: epidemiology, environmental survival, efficacy of disinfection, and control measures. Infect Control Hosp Epidemiol 22:306–315. doi: 10.1086/501907 [DOI] [PubMed] [Google Scholar]
  • 315. Bruce BB, Blass MA, Blumberg HM, Lennox JL, del Rio C, Horsburgh CR. 2000. Risk of Cryptosporidium parvum transmission between hospital roommates. Clin Infect Dis 31:947–950. doi: 10.1086/318147 [DOI] [PubMed] [Google Scholar]
  • 316. Pandak N, Zeljka K, Cvitkovic A. 2006. A family outbreak of cryptosporidiosis: probable nosocomial infection and person-to-person transmission. Wien Klin Wochenschr 118:485–487. doi: 10.1007/s00508-006-0637-7 [DOI] [PubMed] [Google Scholar]
  • 317. Xiao L. 2010. Molecular epidemiology of cryptosporidiosis: an update. Exp Parasitol 124:80–89. doi: 10.1016/j.exppara.2009.03.018 [DOI] [PubMed] [Google Scholar]
  • 318. Keystone JS, Krajden S, Warren MR. 1978. Person-to-person transmission of Giardia lamblia in day-care nurseries. Can Med Assoc J 119:241–242. [PMC free article] [PubMed] [Google Scholar]
  • 319. Alfano-Sobsey EM, Eberhard ML, Seed JR, Weber DJ, Won KY, Nace EK, Moe CL. 2004. Human challenge pilot study with Cyclospora cayetanensis. Emerg Infect Dis 10:726–728. doi: 10.3201/eid1004.030356 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 320. Lindsay DS, Louis M, Weiss MD. 2011. Isospora belli. Available from: http://www.antimicrobe.org/b04rev.asp. Retrieved 24 Nov 2022.
  • 321. Olson ME, Goh J, Phillips M, Guselle N, McAllister TA. 1999. Giardia cyst and Cryptosporidium oocyst survival in water, soil, and cattle feces. J of Env Quality 28:1991–1996. doi: 10.2134/jeq1999.00472425002800060040x [DOI] [Google Scholar]
  • 322. Fayer R, Nerad T. 1996. Effects of low temperatures on viability of Cryptosporidium parvum oocysts. Appl Environ Microbiol 62:1431–1433. doi: 10.1128/aem.62.4.1431-1433.1996 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 323. Jenkins MB, Bowman DD, Ghiorse WC. 1998. Inactivation of Cryptosporidium parvum oocysts by ammonia. Appl Environ Microbiol 64:784–788. doi: 10.1128/AEM.64.2.784-788.1998 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 324. Chalmers RM. 2014. Chapter Sixteen - Cryptosporidium In Steven LP, p 287–326. In DW Williams, NF Gray, MV Yates, RM Chalmers (ed), Microbiology of waterborne diseases, 2nd ed. Academic Press. [Google Scholar]
  • 325. Crucitti T, Jespers V, Mulenga C, Khondowe S, Vandepitte J, Buvé A. 2011. Non-sexual transmission of Trichomonas vaginalis in adolescent girls attending school in Ndola, Zambia. PLoS One 6:e16310. doi: 10.1371/journal.pone.0016310 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 326. Patel A, Hammersmith K. 2008. Contact lens-related microbial keratitis: recent outbreaks. Curr Opin Ophthalmol 19:302–306. doi: 10.1097/ICU.0b013e3283045e74 [DOI] [PubMed] [Google Scholar]
  • 327. Niyyati M, Naghahi A, Behniafar H, Lasjerdi Z. 2018. Occurrence of free-living amoebae in nasal swaps of patients of intensive care unit (ICU) and critical care unit (CCU) and their surrounding environments. Iran J Public Health 47:908–913. [PMC free article] [PubMed] [Google Scholar]
  • 328. Aksozek A, McClellan K, Howard K, Niederkorn JY, Alizadeh H. 2002. Resistance of Acanthamoeba castellanii cysts to physical, chemical, and radiological conditions. J Parasitol 88:621–623. doi: 10.1645/0022-3395(2002)088[0621:ROACCT]2.0.CO;2 [DOI] [PubMed] [Google Scholar]
  • 329. Mazur T, Hadaś E, Iwanicka I. 1995. The duration of the cyst stage and the viability and virulence of Acanthamoeba isolates. Trop Med Parasitol 46:106–108. [PubMed] [Google Scholar]
  • 330. Gelderblom HR. 1996. Cahpter 41: structure and classification of viruses. Medical Microbiology. https://www.ncbi.nlm.nih.gov/books/NBK8174/Structure [PubMed] [Google Scholar]
  • 331. Yezli S, Otter JA. 2011. Minimum infective dose of the major human respiratory and enteric viruses transmitted through food and the environment. Food Environ Virol 3:1–30. doi: 10.1007/s12560-011-9056-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 332. Johnston CP, Qiu H, Ticehurst JR, Dickson C, Rosenbaum P, Lawson P, Stokes AB, Lowenstein CJ, Kaminsky M, Cosgrove SE, Green KY, Perl TM. 2007. Outbreak management and implications of a nosocomial norovirus outbreak. Clin Infect Dis 45:534–540. doi: 10.1086/520666 [DOI] [PubMed] [Google Scholar]
  • 333. Fraenkel CJ, Böttiger B, Söderlund-Strand A, Inghammar M. 2021. Risk of environmental transmission of norovirus infection from prior room occupants. J Hosp Infect 117:74–80. doi: 10.1016/j.jhin.2021.08.026 [DOI] [PubMed] [Google Scholar]
  • 334. Gelber SE, Ratner AJ. 2002. Hospital-acquired viral pathogens in the neonatal intensive care unit. Semin Perinatol 26:346–356. doi: 10.1053/sper.2002.36268 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 335. Rawlinson S, Ciric L, Cloutman-Green E. 2020. COVID-19 pandemic - let’s not forget surfaces. J Hosp Infect 105:790–791. doi: 10.1016/j.jhin.2020.05.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 336. Khan RM, Al-Dorzi HM, Al Johani S, Balkhy HH, Alenazi TH, Baharoon S, Arabi YM. 2016. Middle East respiratory syndrome coronavirus on inanimate surfaces: a risk for health care transmission. Am J Infect Control 44:1387–1389. doi: 10.1016/j.ajic.2016.05.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 337. World Health Organization (WHO) . 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/mpox
  • 338. Safir A, Safir M, Henig O, Nahari M, Halutz O, Levytskyi K, Mizrahi M, Yakubovsky M, Adler A, Ben-Ami R, Sprecher E, Dekel M. 2023. Nosocomial transmission of MPOX virus to health care workers -an emerging occupational hazard: a case report and review of the literature. Am J Infect Control 51:1072–1076. doi: 10.1016/j.ajic.2023.01.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 339. Yinka-Ogunleye A, Aruna O, Dalhat M, Ogoina D, McCollum A, Disu Y, Mamadu I, Akinpelu A, Ahmad A, Burga J, et al. 2019. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect Dis 19:872–879. doi: 10.1016/S1473-3099(19)30294-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 340. Learned LA, Reynolds MG, Wassa DW, Li Y, Olson VA, Karem K, Stempora LL, Braden ZH, Kline R, Likos A, Libama F, Moudzeo H, Bolanda JD, Tarangonia P, Boumandoki P, Formenty P, Harvey JM, Damon IK. 2005. Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003. Am J Trop Med Hyg 73:428–434. doi: 10.4269/ajtmh.2005.73.428 [DOI] [PubMed] [Google Scholar]
  • 341. Hernaez B, Muñoz-Gómez A, Sanchiz A, Orviz E, Valls-Carbo A, Sagastagoitia I, Ayerdi O, Martín R, Puerta T, Vera M, Cabello N, Vergas J, Prieto C, Pardo-Figuerez M, Negredo A, Lagarón JM, Del Romero J, Estrada V, Alcamí A. 2023. Monitoring monkeypox virus in saliva and air samples in Spain: a cross-sectional study. Lancet Microbe 4:e21–e28. doi: 10.1016/S2666-5247(22)00291-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 342. WHO . 2022. WHO recommends new name for monkeypox disease. Available from: https://www.who.int/news/item/28-11-2022-who-recommends-new-name-for-monkeypox-disease
  • 343. Adler H, Gould S, Hine P, Snell LB, Wong W, Houlihan CF, Osborne JC, Rampling T, Beadsworth MB, Duncan CJ, Dunning J, Fletcher TE, Hunter ER, Jacobs M, Khoo SH, Newsholme W, Porter D, Porter RJ, Ratcliffe L, Schmid ML, Semple MG, Tunbridge AJ, Wingfield T, Price NM, NHS England High Consequence Infectious Diseases (Airborne) Network . 2022. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis 22:1153–1162. doi: 10.1016/S1473-3099(22)00228-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 344. Gould S, Atkinson B, Onianwa O, Spencer A, Furneaux J, Grieves J, Taylor C, Milligan I, Bennett A, Fletcher T, Dunning J, NHS England Airborne High Consequence Infectious Diseases Network . 2022. Air and surface sampling for monkeypox virus in a UK hospital: an observational study. Lancet Microbe 3:e904–e911. doi: 10.1016/S2666-5247(22)00257-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 345. Centers for Disease Control and Prevention (CDC) . 2023. Mpox - cleaning and disinfecting. Available from: https://www.cdc.gov/poxvirus/mpox/if-sick/cleaning-disinfecting.html
  • 346. Lee SE, Lee DY, Lee WG, Kang B, Jang YS, Ryu B, Lee S, Bahk H, Lee E. 2020. Detection of novel coronavirus on the surface of environmental materials contaminated by COVID-19 patients in the Republic of Korea. Osong Public Health Res Perspect 11:128–132. doi: 10.24171/j.phrp.2020.11.3.03 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 347. Razzini K, Castrica M, Menchetti L, Maggi L, Negroni L, Orfeo NV, Pizzoccheri A, Stocco M, Muttini S, Balzaretti CM. 2020. SARS-CoV-2 RNA detection in the air and on surfaces in the COVID-19 ward of a hospital in Milan, Italy. Sci Total Environ 742:140540. doi: 10.1016/j.scitotenv.2020.140540 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 348. Marquès M, Domingo JL. 2021. Contamination of inert surfaces by SARS-CoV-2: persistence, stability and infectivity. A review. Environ Res 193:110559. doi: 10.1016/j.envres.2020.110559 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 349. Kampf G, Brüggemann Y, Kaba HEJ, Steinmann J, Pfaender S, Scheithauer S, Steinmann E. 2020. Potential sources, modes of transmission and effectiveness of prevention measures against SARS-CoV-2. J Hosp Infect 106:678–697. doi: 10.1016/j.jhin.2020.09.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 350. Nelson SW, Hardison RL, Limmer R, Marx J, Taylor BM, James RR, Stewart MJ, Lee SD, Calfee MW, Ryan SP, Howard MW. 2023. Efficacy of detergent-based cleaning and wiping against SARS-CoV-2 on high-touch surfaces. Lett Appl Microbiol 76:ovad033. doi: 10.1093/lambio/ovad033 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 351. Deyab MA. 2020. Coronaviruses widespread on nonliving surfaces: important questions and promising answers. Z Naturforsch C J Biosci 75:363–367. doi: 10.1515/znc-2020-0105 [DOI] [PubMed] [Google Scholar]
  • 352. Suman R, Javaid M, Haleem A, Vaishya R, Bahl S, Nandan D. 2020. Sustainability of coronavirus on different surfaces. J Clin Exp Hepatol 10:386–390. doi: 10.1016/j.jceh.2020.04.020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 353. Xie C, Zhao H, Li K, Zhang Z, Lu X, Peng H, Wang D, Chen J, Zhang X, Wu D, Gu Y, Yuan J, Zhang L, Lu J. 2020. The evidence of indirect transmission of SARS-CoV-2 reported in Guangzhou, China. BMC Public Health 20:1202. doi: 10.1186/s12889-020-09296-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 354. Meyerowitz EA, Richterman A, Gandhi RT, Sax PE. 2021. Transmission of SARS-CoV-2: a review of viral, host, and environmental factors. Ann Intern Med 174:69–79. doi: 10.7326/M20-5008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 355. Colaneri M, Seminari E, Novati S, Asperges E, Biscarini S, Piralla A, Percivalle E, Cassaniti I, Baldanti F, Bruno R, Mondelli MU, COVID19 IRCCS San Matteo Pavia Task Force . 2020. Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit. Clin Microbiol Infect 26:1094. doi: 10.1016/j.cmi.2020.05.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 356. Wilson AM, Weir MH, Bloomfield SF, Scott EA, Reynolds KA. 2021. Modeling COVID-19 infection risks for a single hand-to-fomite scenario and potential risk reductions offered by surface disinfection. Am J Infect Control 49:846–848. doi: 10.1016/j.ajic.2020.11.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 357. Harvey AP, Fuhrmeister ER, Cantrell M, Pitol AK, Swarthout JM, Powers JE, Nadimpalli ML, Julian TR, Pickering AJ. 2020. Longitudinal monitoring of SARS-CoV-2 RNA on high-touch surfaces in a community setting. medRxiv:2020.10.27.20220905. doi: 10.1101/2020.10.27.20220905 [DOI] [PMC free article] [PubMed]
  • 358. Pitol AK, Julian TR. 2021. Community transmission of SARS-CoV-2 by surfaces: risks and risk reduction strategies. Environ Sci Technol Lett 8:263–269. doi: 10.1021/acs.estlett.0c00966 [DOI] [PubMed] [Google Scholar]
  • 359. Kampf G, Pfaender S, Goldman E, Steinmann E. 2021. SARS-CoV-2 detection rates from surface samples do not implicate public surfaces as relevant sources for transmission. Hygiene 1:24–40. doi: 10.3390/hygiene1010003 [DOI] [Google Scholar]
  • 360. Wang Y, Tian H, Zhang L, Zhang M, Guo D, Wu W, Zhang X, Kan GL, Jia L, Huo D, Liu B, Wang X, Sun Y, Wang Q, Yang P, MacIntyre CR. 2020. Reduction of secondary transmission of SARS-CoV-2 in households by face mask use, disinfection and social distancing: a cohort study in Beijing, China. BMJ Glob Health 5:e002794. doi: 10.1136/bmjgh-2020-002794 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 361. Santarpia JL, Rivera DN, Herrera VL, Morwitzer MJ, Creager HM, Santarpia GW, Crown KK, Brett-Major DM, Schnaubelt ER, Broadhurst MJ, Lawler JV, Reid SP, Lowe JJ. 2020. Aerosol and surface contamination of SARS-CoV-2 observed in quarantine and isolation care. Sci Rep 10:12732. doi: 10.1038/s41598-020-69286-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 362. Grass G, Rensing C, Solioz M. 2011. Metallic copper as an antimicrobial surface. Appl Environ Microbiol 77:1541–1547. doi: 10.1128/AEM.02766-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 363. Ojeil M, Jermann C, Holah J, Denyer SP, Maillard JY. 2013. Evaluation of new in vitro efficacy test for antimicrobial surface activity reflecting UK hospital conditions. J Hosp Infect 85:274–281. doi: 10.1016/j.jhin.2013.08.007 [DOI] [PubMed] [Google Scholar]
  • 364. Mattison K, Karthikeyan K, Abebe M, Malik N, Sattar SA, Farber JM, Bidawid S. 2007. Survival of calicivirus in foods and on surfaces: experiments with feline calicivirus as a surrogate for norovirus. J Food Prot 70:500–503. doi: 10.4315/0362-028x-70.2.500 [DOI] [PubMed] [Google Scholar]
  • 365. Tiwari A, Patnayak DP, Chander Y, Parsad M, Goyal SM. 2006. Survival of two avian respiratory viruses on porous and nonporous surfaces. Avian Dis 50:284–287. doi: 10.1637/7453-101205R.1 [DOI] [PubMed] [Google Scholar]
  • 366. Porter L, Sultan O, Mitchell BG, Jenney A, Kiernan M, Brewster DJ, Russo PL. 2024. How long do nosocomial pathogens persist on inanimate surfaces? A scoping review. J Hosp Infect 147:25–31. doi: 10.1016/j.jhin.2024.01.023 [DOI] [PubMed] [Google Scholar]
  • 367. Chatterjee P, Kelly S, Qi M, Werner RM. 2020. Characteristics and quality of US nursing homes reporting cases of coronavirus disease 2019 (COVID-19). JAMA Netw Open 3:e2016930. doi: 10.1001/jamanetworkopen.2020.16930 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 368. Tang JW. 2009. The effect of environmental parameters on the survival of airborne infectious agents. J R Soc Interface 6 Suppl 6:S737–S746. doi: 10.1098/rsif.2009.0227.focus [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 369. McDADE JJ, Hall LB. 1964. Survival of Staphylococcus aureus in the environment. II. Effect of elevated temperature on surface-exposed staphylococci. Am J Epidemiol 80:184–191. doi: 10.1093/oxfordjournals.aje.a120467 [DOI] [PubMed] [Google Scholar]
  • 370. Robine E, Dérangère D, Robin D. 2000. Survival of a Pseudomonas fluorescens and Enterococcus faecalis aerosol on inert surfaces. Int J Food Microbiol 55:229–234. doi: 10.1016/s0168-1605(00)00188-4 [DOI] [PubMed] [Google Scholar]
  • 371. Stowell JD, Forlin-Passoni D, Din E, Radford K, Brown D, White A, Bate SL, Dollard SC, Bialek SR, Cannon MJ, Schmid DS. 2012. Cytomegalovirus survival on common environmental surfaces: opportunities for viral transmission. J Infect Dis 205:211–214. doi: 10.1093/infdis/jir722 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 372. Tanner BD. 2009. Reduction in infection risk through treatment of microbially contaminated surfaces with a novel, portable, saturated steam vapor disinfection system. Am J Infect Control 37:20–27. doi: 10.1016/j.ajic.2008.03.008 [DOI] [PubMed] [Google Scholar]
  • 373. Abbasi F, Samaei MR. 2019. The effect of temperature on airborne filamentous fungi in the indoor and outdoor space of a hospital. Environ Sci Pollut Res 26:16868–16876. doi: 10.1007/s11356-017-0939-5 [DOI] [PubMed] [Google Scholar]
  • 374. Espinosa AC, Mazari-Hiriart M, Espinosa R, Maruri-Avidal L, Méndez E, Arias CF. 2008. Infectivity and genome persistence of rotavirus and astrovirus in groundwater and surface water. Water Res 42:2618–2628. doi: 10.1016/j.watres.2008.01.018 [DOI] [PubMed] [Google Scholar]
  • 375. John DE, Rose JB. 2005. Review of factors affecting microbial survival in groundwater. Environ Sci Technol 39:7345–7356. doi: 10.1021/es047995w [DOI] [PubMed] [Google Scholar]
  • 376. Morris DH, Yinda KC, Gamble A, Rossine FW, Huang Q, Bushmaker T, Fischer RJ, Matson MJ, Van Doremalen N, Vikesland PJ, Marr LC, Munster VJ, Lloyd-Smith JO. 2021. Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses. Elife 10:e65902. doi: 10.7554/eLife.65902 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 377. Schuit M, Ratnesar-Shumate S, Yolitz J, Williams G, Weaver W, Green B, Miller D, Krause M, Beck K, Wood S, Holland B, Bohannon J, Freeburger D, Hooper I, Biryukov J, Altamura LA, Wahl V, Hevey M, Dabisch P. 2020. Airborne SARS-CoV-2 is rapidly inactivated by simulated sunlight. J Infect Dis 222:564–571. doi: 10.1093/infdis/jiaa334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 378. Heilingloh CS, Aufderhorst UW, Schipper L, Dittmer U, Witzke O, Yang D, Zheng X, Sutter K, Trilling M, Alt M, Steinmann E, Krawczyk A. 2020. Susceptibility of SARS-CoV-2 to UV irradiation. Am J Infect Control 48:1273–1275. doi: 10.1016/j.ajic.2020.07.031 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 379. Gsell O. 1968. Meningokokkeninfektionen. Krankheiten durch Bakterien. [Google Scholar]
  • 380. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. 1995. Microbial biofilms. Annu Rev Microbiol 49:711–745. doi: 10.1146/annurev.mi.49.100195.003431 [DOI] [PubMed] [Google Scholar]
  • 381. Matthes R, Bender C, Schlüter R, Koban I, Bussiahn R, Reuter S, Lademann J, Weltmann KD, Kramer A. 2013. Antimicrobial efficacy of two surface barrier discharges with air plasma against in vitro biofilms. PLoS One 8:e70462. doi: 10.1371/journal.pone.0070462 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 382. Matthes R, Koban I, Bender C, Masur K, Kindel E, Weltmann K-D, Kocher T, Kramer A, Hübner N-O. 2013. Antimicrobial efficacy of an atmospheric pressure plasma jet against biofilms of Pseudomonas aeruginosa and Staphylococcus epidermidis. Plasma Process Polym 10:161–166. doi: 10.1002/ppap.201100133 [DOI] [Google Scholar]
  • 383. Centeleghe I, Norville P, Hughes L, Maillard JY. 2023. Klebsiella pneumoniae survives on surfaces as a dry biofilm. Am J Infect Control 51:1157–1162. doi: 10.1016/j.ajic.2023.02.009 [DOI] [PubMed] [Google Scholar]
  • 384. Schapira AJ, Dramé M, Olive C, Marion-Sanchez K. 2024. Bacterial viability in dry-surface biofilms in healthcare facilities: a systematic review. J Hosp Infect 144:94–110. doi: 10.1016/j.jhin.2023.11.004 [DOI] [PubMed] [Google Scholar]
  • 385. Donlan RM. 2000. Role of biofilms in antimicrobial resistance. ASAIO J 46:S47–52. doi: 10.1097/00002480-200011000-00037 [DOI] [PubMed] [Google Scholar]
  • 386. Donlan RM. 2002. Biofilms: microbial life on surfaces. Emerg Infect Dis 8:881–890. doi: 10.3201/eid0809.020063 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 387. Costerton JW, Lewandowski Z, DeBeer D, Caldwell D, Korber D, James G. 1994. Biofilms, the customized microniche. J Bacteriol 176:2137–2142. doi: 10.1128/jb.176.8.2137-2142.1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 388. Vickery K, Deva A, Jacombs A, Allan J, Valente P, Gosbell IB. 2012. Presence of biofilm containing viable multiresistant organisms despite terminal cleaning on clinical surfaces in an intensive care unit. J Hosp Infect 80:52–55. doi: 10.1016/j.jhin.2011.07.007 [DOI] [PubMed] [Google Scholar]
  • 389. Gillings MR, Holley MP, Stokes HW. 2009. Evidence for dynamic exchange of qac gene cassettes between class 1 integrons and other integrons in freshwater biofilms. FEMS Microbiol Lett 296:282–288. doi: 10.1111/j.1574-6968.2009.01646.x [DOI] [PubMed] [Google Scholar]
  • 390. Tribble GD, Rigney TW, Dao D-H, Wong CT, Kerr JE, Taylor BE, Pacha S, Kaplan HB. 2012. Natural competence is a major mechanism for horizontal DNA transfer in the oral pathogen Porphyromonas gingivalis. mBio 3:e00231-11. doi: 10.1128/mBio.00231-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 391. Von Borowski RG, Trentin DS. 2021. Biofilms and coronavirus reservoirs: a perspective review. Appl Environ Microbiol 87:e0085921. doi: 10.1128/AEM.00859-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 392. Flemming H-C, Percival SL, Walker JT. 2002. Contamination potential of biofilms in water distribution systems. Water Supply 2:271–280. doi: 10.2166/ws.2002.0032 [DOI] [Google Scholar]
  • 393. Mazaheritehrani E, Sala A, Orsi CF, Neglia RG, Morace G, Blasi E, Cermelli C. 2014. Human pathogenic viruses are retained in and released by Candida albicans biofilm in vitro. Virus Res 179:153–160. doi: 10.1016/j.virusres.2013.10.018 [DOI] [PubMed] [Google Scholar]
  • 394. Vasickova P, Pavlik I, Verani M, Carducci A. 2010. Issues concerning survival of viruses on surfaces. Food Environ Virol 2:24–34. doi: 10.1007/s12560-010-9025-6 [DOI] [Google Scholar]
  • 395. Sherry NL, Gorrie CL, Kwong JC, Higgs C, Stuart RL, Marshall C, Ballard SA, Sait M, Korman TM, Slavin MA, Lee RS, Graham M, Leroi M, Worth LJ, Chan HT, Seemann T, Grayson ML, Howden BP, Controlling Superbugs Study Group . 2022. Multi-site implementation of whole genome sequencing for hospital infection control: a prospective genomic epidemiological analysis. Lancet Reg Health West Pac 23:100446. doi: 10.1016/j.lanwpc.2022.100446 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 396. Sanjuán R, Thoulouze MI. 2019. Why viruses sometimes disperse in groups. Virus Evol 5:vez014. doi: 10.1093/ve/vez014 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 397. Andreu-Moreno I, Sanjuán R. 2020. Collective viral spread mediated by virion aggregates promotes the evolution of defective interfering particles. mBio 11:e02156-19. doi: 10.1128/mBio.02156-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 398. Sanjuán R. 2017. Collective infectious units in viruses. Trends Microbiol 25:402–412. doi: 10.1016/j.tim.2017.02.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 399. Baig TA, Zhang M, Smith BL, King MD. 2022. Environmental effects on viable virus transport and resuspension in ventilation airflow. Viruses 14:616. doi: 10.3390/v14030616 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 400. Asadi S, Gaaloul Ben Hnia N, Barre RS, Wexler AS, Ristenpart WD, Bouvier NM. 2020. Influenza A virus is transmissible via aerosolized fomites. Nat Commun 11:4062. doi: 10.1038/s41467-020-17888-w [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 401. Khare P, Marr LC. 2015. Simulation of vertical concentration gradient of influenza viruses in dust resuspended by walking. Indoor Air 25:428–440. doi: 10.1111/ina.12156 [DOI] [PubMed] [Google Scholar]
  • 402. Smither SJ, Eastaugh LS, Lever MS. 2022. Comparison of aerosol stability of different variants of Ebola virus and Marburg virus and virulence of aerosolised Ebola virus in an immune-deficient mouse. Viruses 14:780. doi: 10.3390/v14040780 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 403. Schubert H. 1989. Über bakterielle Absterbekurven. In Ergebnisse der Hygiene Bakteriologie Immunitätsforschung und experimentellen Therapie [Google Scholar]
  • 404. Neely AN. 2000. A survey of gram-negative bacteria survival on hospital fabrics and plastics. J Burn Care Rehabil 21:523–527. doi: 10.1097/00004630-200021060-00009 [DOI] [PubMed] [Google Scholar]
  • 405. Smith H, Sweet C.. 2002. Chapter 11: Cooperation between viral and bacterial pathogens in causing human respiratory disease. Polymicrobial diseases. https://www.ncbi.nlm.nih.gov/books/NBK2479. [Google Scholar]
  • 406. Hanada S, Pirzadeh M, Carver KY, Deng JC. 2018. Respiratory viral infection-induced microbiome alterations and secondary bacterial pneumonia. Front Immunol 9:2640. doi: 10.3389/fimmu.2018.02640 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 407. Manohar P, Loh B, Athira S, Nachimuthu R, Hua X, Welburn SC, Leptihn S. 2020. Secondary bacterial infections during pulmonary viral disease: phage therapeutics as alternatives to antibiotics? Front Microbiol 11:1434. doi: 10.3389/fmicb.2020.01434 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 408. Lawley TD, Clare S, Deakin LJ, Goulding D, Yen JL, Raisen C, Brandt C, Lovell J, Cooke F, Clark TG, Dougan G. 2010. Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens. Appl Environ Microbiol 76:6895–6900. doi: 10.1128/AEM.00718-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 409. Pang XL, Joensuu J, Vesikari T. 1999. Human calicivirus-associated sporadic gastroenteritis in Finnish children less than two years of age followed prospectively during a rotavirus vaccine trial. Pediatr Infect Dis J 18:420–426. doi: 10.1097/00006454-199905000-00005 [DOI] [PubMed] [Google Scholar]
  • 410. Paton JC, Paton AW. 1998. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11:450–479. doi: 10.1128/CMR.11.3.450 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 411. Porter CK, Riddle MS, Tribble DR, Louis Bougeois A, McKenzie R, Isidean SD, Sebeny P, Savarino SJ. 2011. A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC). Vaccine 29:5869–5885. doi: 10.1016/j.vaccine.2011.05.021 [DOI] [PubMed] [Google Scholar]
  • 412. Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR, Schiff GM. 1986. Human rotavirus studies in volunteers: determination of infectious dose and serological response to infection. J Infect Dis 154:871–880. doi: 10.1093/infdis/154.5.871 [DOI] [PubMed] [Google Scholar]
  • 413. Venter JME, van Heerden J, Vivier JC, Grabow WOK, Taylor MB. 2007. Hepatitis a virus in surface water in South Africa: what are the risks? J Water Health 5:229–240. [PubMed] [Google Scholar]
  • 414. Kothary MH, Babu US. 2001. Infective dose of foodborne pathogens in volunteers: a review. J Food Saf 21:49–68. doi: 10.1111/j.1745-4565.2001.tb00307.x [DOI] [Google Scholar]
  • 415. Schwartze VU, Hoffmann K, Nyilasi I, Papp T, Vágvölgyi C, de Hoog S, Voigt K, Jacobsen ID. 2012. Lichtheimia species exhibit differences in virulence potential. PLoS One 7:e40908. doi: 10.1371/journal.pone.0040908 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 416. Blaser MJ, Newman LS. 1982. A review of human salmonellosis: I. Infective dose. Rev Infect Dis 4:1096–1106. doi: 10.1093/clinids/4.6.1096 [DOI] [PubMed] [Google Scholar]
  • 417. Hutson CL, Carroll DS, Self J, Weiss S, Hughes CM, Braden Z, Olson VA, Smith SK, Karem KL, Regnery RL, Damon IK. 2010. Dosage comparison of Congo Basin and West African strains of monkeypox virus using a prairie dog animal model of systemic orthopoxvirus disease. Virology 402:72–82. doi: 10.1016/j.virol.2010.03.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 418. Price D, Ahearn DG. 1988. Incidence and persistence of Pseudomonas aeruginosa in whirlpools. J Clin Microbiol 26:1650–1654. doi: 10.1128/jcm.26.9.1650-1654.1988 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 419. Maurer E, Hörtnagl C, Lackner M, Grässle D, Naschberger V, Moser P, Segal E, Semis M, Lass-Flörl C, Binder U. 2019. Galleria mellonella as a model system to study virulence potential of mucormycetes and evaluation of antifungal treatment. Med Mycol 57:351–362. doi: 10.1093/mmy/myy042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 420. Leleu C, Menotti J, Meneceur P, Choukri F, Sulahian A, Garin Y-F, Denis J-B, Derouin F. 2013. Bayesian development of a dose-response model for Aspergillus fumigatus and invasive aspergillosis. Risk Anal 33:1441–1453. doi: 10.1111/risa.12007 [DOI] [PubMed] [Google Scholar]
  • 421. Forgács L, Borman AM, Prépost E, Tóth Z, Kardos G, Kovács R, Szekely A, Nagy F, Kovacs I, Majoros L. 2020. Comparison of in vivo pathogenicity of four Candida auris clades in a neutropenic bloodstream infection murine model. Emerg Microbes Infect 9:1160–1169. doi: 10.1080/22221751.2020.1771218 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 422. Schmid-Hempel P, Frank SA. 2007. Pathogenesis, virulence, and infective dose. PLoS Pathog. 3:1372–1373. doi: 10.1371/journal.ppat.0030147 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 423. Jankie S, Jenelle J, Suepaul R, Pereira L, Akpaka P, Adebayo A, Pillai G. 2016. Determination of the infective dose of Staphylococcus aureus (ATCC 29213) and Pseudomonas aeruginosa (ATCC 27853) when injected intraperitoneally in Sprague Dawley rats. BJPR 14:1–11. doi: 10.9734/BJPR/2016/29932 [DOI] [Google Scholar]
  • 424. Ministry of Health and Family Welfare . 2015. Government of India (MoHFW). National Guidelines for Clean Hospitals. [Google Scholar]
  • 425. National Health and Medical Research Council . 2019. Australian guidelines for the prevention and control of infection in healthcare [Google Scholar]
  • 426. National Health Service (NHS) . 2021. National Standards of Healthcare Cleanliness [Google Scholar]
  • 427. PICNet . 2016. British Coliumbia best practices for environmental cleaning for prevention and control in all healthcare settings and programs.
  • 428. Fauci VL. 2015. An innovative approach to hospital sanitization using probiotics: in vitro and field trials. J Microb Biochem Technol 07. doi: 10.4172/1948-5948.1000198 [DOI] [Google Scholar]
  • 429. Vandini A, Temmerman R, Frabetti A, Caselli E, Antonioli P, Balboni PG, Platano D, Branchini A, Mazzacane S. 2014. Hard surface biocontrol in hospitals using microbial-based cleaning products. PLoS One 9:e108598. doi: 10.1371/journal.pone.0108598 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 430. D’Accolti M, Soffritti I, Bini F, Mazziga E, Cason C, Comar M, Volta A, Bisi M, Fumagalli D, Mazzacane S, Caselli E. 2023. Shaping the subway microbiome through probiotic-based sanitation during the COVID-19 emergency: a pre-post case-control study. Microbiome 11:64. doi: 10.1186/s40168-023-01512-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 431. Dancer SJ, Kramer A. 2019. Four steps to clean hospitals: LOOK, PLAN, CLEAN and DRY. J Hosp Infect 103:e1–e8. doi: 10.1016/j.jhin.2018.12.015 [DOI] [PubMed] [Google Scholar]
  • 432. Sax H, Allegranzi B, Uçkay I, Larson E, Boyce J, Pittet D. 2007. 'My five moments for hand hygiene': a user-centred design approach to understand, train, monitor and report hand hygiene. J Hosp Infect 67:9–21. doi: 10.1016/j.jhin.2007.06.004 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Tables A to E. cmr.00186-23-s0001.docx.

Additional data and details of recultivation and expanded environmental conditions.

cmr.00186-23-s0001.docx (323.4KB, docx)
DOI: 10.1128/cmr.00186-23.SuF1

Articles from Clinical Microbiology Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES